var title_f4_21_4432="Vein distention SVC syndrome";
var content_f4_21_4432=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F76917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F76917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial venous distention in superior vena cava syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 278px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEWAXADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDe8Q6o7ylAfbBNcncyjYRnvU19cl5WbvWZIWZgD0rixWJcmz0MPRUUhhUMdxppRR0qULjoKRl4PGT2ry27nWkQkZxkHg8UOAG45PvUqgYUkYJpsgHXmhMtEJ6nge1RPnBYjirDAAA+lV3POQcc5+tWmUtinPFvHPGDULqcelXHO5wwHFVymWPzYxVplojCEgH14qGSNlyo24xxVwR8EehyKbKc9RzVpgUsEx/dI7UiNt75qcgklSe1VW+UkHr61aYWHSytGGKDJx0qMzEoNw4Pamli31I71AzHBHcdKHK6sKw+C58iYxOT5Tngn+E1BqMTI5ZOD1yKbKA8XzdafbT+aht5eXQZUnuK0jK6Ia6Ghp0n2+zwP9bGcEe1WPspEe7bwcZ9qytJm+xarHn5YpDsb2rtbyKNI3QEAkcCumCU43Zi7xfKYWpWvlRxAclgcA9RWKqHzTkfL6it/XZH2RhdudoyR6iseMZbk5AFc9aylodNJXWojINhA71A67VYDtxWmsQKFuxFVIYyw2kZNc6kbWILdd3QVvWUAtIllZN0jcqtJDDbWixtcFR35rQsmF3KGAIiHOMc4rGpO/oUlbQLC0lvJyWzjua7HS9PSKPJPyjGWHX6CotLgSRFWMFEH3gRzW0FR9sUSbVXAArhqz6Iu1h6YKk4IRcYHtT7eEBWlDcdePxpt2SssUKkhOhNSqSqsqjhcZ+lcruCdjVsUUxjoRxzV3ytyBR8vGCaq6eoEXqevPatKEDaxY54xUWGVLiJUSLGQFU8+tYN9GI0bAwHNdPd4ZF288YFZt5bhon2jJIz9TVJkM5lGJZs9vaqs7jaQ2QD3rRmh8uT5lyzHOfaq13GM7h9MVojOQtmSUCgglehrSQhkO5QRxkGsez+SY4PXnmtGIlgw6E802jNu5vWNxh4wPXmuwtZAY6830+eQ3bhoysaY2tn7x712thNuQdazlGxMlbQ1JFDBhg157460xopReRA4b5ZD6ehr0JDkDmqWpWiXdvJDIoKOMc1dCs6M1JGcoc8eVnjRBIC8qfUVHMAMbs57HNX9UspNPvZYJCWKHg+o7Gs+U5bLKCD6V9HGaklJHmSi4uzK8vzEqSAM8+uagO3BAHzelWgoy2Oo/DFVpeH5GTV3JsNklJc00HJqMDLnnpThnJ4rzZSuz0lGxMAM0rAY/wqITDzjEA2duc44/OpgeKhlIgZTgZpJVO0bT9anPJwOeKjwTn0oRSK5UqD3FQSqD1FW2zjHUioGXIBq0NFZxtyOgqEplhkYz3qy0ZLbhnimsBlc8CqLRXKsHKnPTrUaghipySB1NWnONpH40kgIHA+hHequUilKNod+MgZqlKckMo5rSnG9cbee4qm0S+SVUnjoapMdik4ctx+XpUT8jjrV2RcDPcVWZSrnjg8iquFiBh8m4d6rTxGQb4siReRirq8fL2NRFGWTiqTM5RJrRE1C1bcQlxGOR7+taCau1wyxTN+9UYYY6+9Y90AirPBlXHDL60yTE6pLC+JRzkcEVspaaGaept3M3mZB7HiqoTd9zk5qml2+AJkIYdx0Nael2095OphjO3PLEYGKwndas6oWZZQCO2ZnIVR61mvqUdqS8Q3ufu8cV1Gq+G2e1Gx2JA5Hb61xep6dJZzIrg4rKk4T6jnzLYFeW7uA075579BXd+FYo3IQZPOBXI6ZZmWZcnCk8e9eoeHbIWUdu5TLEbsY5FZYmaSsjSlFpXNu1g2goi8g54rT023GxgRhyTziqtiZJJ9iKqockDHJrdiAEJUHBAyfavNkypPTQ56SNgZiyEFnwox6URtt1Da4+/hTjsM5q9JCTI7BuFOSDVZ4WO+WPOW+UUr9CXE2LGQyWytEp2tzz6dK07Ulc8ZUjGTWdpsLQ28Y3HCgAitFGIbHJ/Ss2C2C6XlC2RgZx70zywWXcOvJFSb1lkf/ZzSxjKg4Jb1Pap2JZiatakZZQCOtc1OG2fMMA+p6V3lzGZE24PA61yWrWxUSEr949K1izNmOhIAboema0kc4z36kVkK5Vzk9D0q6syyojRsGBxyK1sQ1qalix39eK6rT3ygNchbE5z9DXRafINoxWckZvsdLbygoBxgmpWPpjHvWbbuVYGr6tlSeq1ixo5Hx3pXn2wvEU+bDwcdStcBMeCWjBNe1TIs8TxuAVIwR615Dr1k+n6lLAWYKDlM917V6uX17r2bOTE0/toymJJDMMr04qAKCDgjOeBVl1J5yOe44qswUNgtknptr00zksQADOB1p4QZORSAANmpI8ZPHX1rzrnpiFcLnvTeCRjjBqQjtSgAZHftSuAxc+1NY4brxipAuee9DxjH607jK8mMZHWoWGVO0VaYAk/zqFwBx0p3BEB+8BjjvULpmQ88CrTL8p7nPeoJAeoHsaaZoiNlBXJ6U2RSytzinEHbxwKRsMVA6d6sopkMpGGz7mo3UB8+tW3AYlQcHtVaZgmAwpryKbKWTIW3DBB/OoyoPU4P8qv+WOGTuO9RtHgc9afMUUjHjqME1HIGXOBkitIweZj1HQ00wbl4HIp8wmjN2K+GTHupqCS1IbfFwe4q8YCWyF+uKegPlsHXIHRqvnsZOnd2M3LqQWQkeq10Gkar5KqojYn6VlQEowOQea6HTZ0OO2OtZVpJrY6KaaOjt7x5ol3qdrDrVTUtPS8fJUYQcE9z1qxBNvQBCOOKt7cxFMncTknPSuC/K7o2sYek6WP7RHA2LyPbJ4r0e0gAjUlVyqhTgdKwNKtxG/C5zxmustQAm5yM46VnUk5FPRFeHbFdAtngEVeSfcVVemMAmsaaXZMBxvc4AzU0d0VZkHJ3cfSs5IlGiR5j+WV4HzN9KtNbEsNp6DIHoar6Kw8x2c5I7dTWkzCVwVGcjNRexFrsZbIeOc+xqdEw+1iDzjjtioOYnTjCA5+lShySGC8k9aTARE2Z2nqeSe9Tq5DBTg4HPaomI2jqSBx7+tIuc8nOKRDLW4NHhuD0z6isLWLVmUkdc9MVrqcfd6Z9agvxmJyTyKcdCDz54Stw6tjDAjNMtrdLeFYoQVVeAK17iH5ncgAdPwqsqBFz36c10X0sZkkD7XXcep5rpYGCMgGOlckMt869VBx9a2I7zEUTq25wvI96mSMm9TrIW4A6e1XbdsDiudXUVGwkE5Az7Vr21wgk2Mw+YZWsWg5kaiHcv6Zrj/iBpfm2gvYv9ZFwxA6qa6pXGMDmku4VuLV4nAIZSCPainN05KSG0pRt3PD3yp5JIPWoXGAQGwCPxq/qlsbO+nt5Mq8bY+oqnhQxDntxX0UZJpNHmyVnZkIXnrgCnHrxUroMnFMHTiuC56AhAJBHWkY469qVu/PNRq+44JxQgHIxzU5X5AeKrNw2fSpRLkAfjQyxjgB+KikQZOOlTNnNRHofWmCWpAxyPaoY0wHwSQTnmpiMEYNC+oI5p3LIdgdPUUwoAMJwasIhIGRhu+KQpk4/OnctFURkliQCao3SbrmJuQAcHitUgLGx5yO/rSCHdk9CauM7A43ViosRXIxkA5H0ptzAXj3pxWjDGfQZXmpRGFcxvjJ5qJSsaRVzAgLJMA5xWwtoskEpjwJkXcAe4qpqVmVO9c9atafMr4ilbaxAAY96JO6uhSTMadhIrOo2sO2a1/DhtdQMlpdrsyOG9Kq3Olyx3T5X5CPlYdDWekFxZzCSGQ7R+lVeMo2TM7SvdE+taQ+nTlVIeM/dcdDVKMOnK10ltqUVxbrbXoCE52sfuk/0qpdWG1N0ZIJ546H6VKk9pGxHp94UyH610dlcB1GcE459a4ss0cuZD8w4zWvpt8qkB5B7CoqU76mkZPY77T5kdVx27YrR+1o7nc+EHGMd65iwvUkkWNGUkkA88ZrWI8qHLBApOeuSa5JRKclsPnmEao7MG5zk9RUdjOHlwzHqBu9c9BWdc3KS7jkgAYX3pLKdi4XadgOWJpOLZmmd1pZSNS7tlm4yeoNXjLtcEAAdCa561kLwxkqVU4+taTShkO0n69ayaCKaepcnOEBZs56E9RUlm/mRFiSQBjP0rNmw80bOxwgIxng59at2cpxIi4CggLnuO9FtAloWUTJwD0PT1zUsi7VzwcjBzURuUycIwYDGKkWQSIGzwOGFKxDZLGCFGBwfWobsYQ5zgdqngmRkZCfmAzioL2RkAymc8UjJsxNThBLADaTkgetZb27AYBOQo4robuPzNuR04qs1vuZu/tWikZWMeC2O3HI/CphEEIAQ4xy1bENoMYx04pslvt3E4xRzXHYoLyoU9a0YcnYOcDv6VSaLEpx6CrkDYPNRJhZG3ayHbjvirituGCeCOayrOUH61oREKDuHUdagF2OE+Ilh5V5DeIABIuxj2yOn+fauKZiMZx+XBr17xTZjUdInjAyyjep9xXkcuM7GwBjrXr4KpzU7djjxEbSv3LBAZeOtV5TtJGeRUhbB/wAKacE5xzWex0LQjcDHtULDBGOTUkpxUDn5s8gU0MexyB70IeoNRM3I96chG4/SmWhzSAOgJ/DvT+3Peqsqbnjc53KTUqTZAVvTrTtoMa+ACPemx9j2of5SSTmnLyPw5oKQ9RycUybci5Ubvmxj2qRcgcdafkcnp2NFy1oUwrNuDAjsR6inQHYQD0B71LcbkUyA7iOgqAuZII5ihWRgMoe1PdD3L0keMsvBphUtw/3h6VZUZWM5xwPoaXZuyU+8vUCsyl3IpVEkIJUEdDWVLDslIIzjkYrVVvMjyFAcHBB71HcIuwEgq6ihOxVnJEtjOTEY3G8DnP8Ae/8Ar1Hf2isvmQrkH+HvUdqwW7LZwduTj+dX7aVBOsMxEbuMoT0IqHo7oSdtGcvPCVcMF69Qe1WrQMF2M5UNjp2rfvLCO4X5V+ZRhiB196yDby2pVni3IvG4elWp8yNLDpdISc7vMJyOhANNg0ZBOEWH5VGd3v8ASrcLtNGBHK0e0/dx2x0rUtGLx7QnzxgBu2R2P1qXUkluTyrYp6BAkcbQzSGRlkwGVACo7Z7/AI10Zs47exd4JTJvbdtduVPoKNOsz5jSMh3EAZHUj0q5JbZjCumz5ctz1NYznzMhLlZzksIY52HPSrtnGrkkthR7Vaez35RSV/2q0rSxATZkE+3+fxqHI3urXHWtrm3XDMuOnvVuEMsbgncFOBge1NsozbROjOzvuJ+lSSyLB5ZH3HbLN/d9akzejuPm2iMu4+UjAqQBRMpRsqq5P8qh1C/jNihSBsA8EjAP0qSJkZ9qgjgZGeootoS22yXcCAS2RnApYGaIMFyVY06QbcYOQOQaWEgNtIz71FwlqiKPzhM7scZ4H0qyT8ylj8w609ERY/XFQdZMle/ekRyoS4YDJ6/0psL5HTA7ZqOckNz0p0P3QOowOgoZPKWoRt4UcUsqZOOMGli5PTr7U+fJG4Dj2qbktGdcqoOOM1DFnJ5GKdcygM27rUETBnBzTuQakJKlSOavrIccHPtWbZg8HPU1o46nJAFAMtxgGMqxBOM15N4z00abrEirxDJ+8Qemew/GvVLfDDrWJ460032k+dEgaW3O8HHJHcf59K3wtTknrsyasOaGh5mw+Y5qNkIOQaumPHFQuoB9K6uYdrlOTJbkc1VnbtWhKDuAA471nXfyt600wSIxLjAJ6dKdBJyM9Kqjk81Kn196plWNFYsr0461SkBVgffAq/bPuiHrVbUU2YPPtSi9bDRHIMD5u9EXJwDTpjvt0bPzd6jt2G6rsNMsqflyVKkfrSycJ061NgGMGoXbK7RzipQ9yB32qyuCuRTMMFYMOcZU1YZSVbPTGMVXVnjGxuV/9B/+tVblxiaVnKkkCRPjfj86nSMpKCDhWGG/xrltQlmsriKeP5gp3bO1dPp9wl9bRyohXzEyUbqvPSlOnaPMgjUSlyMfNFifcpA3c8dKr3QZ0zgZBx1rRKCUkDh+CB61SuYmRWJ5B7GsUzoS0MZBJJc5t/v4wVJxWlHOzmSK4XIUAo3dTWbNEyyCWFysg6j2pI71ob3zJlZ0PB9xWtrmMk2bN3dPEwaI7jjtWvpUVve2AaVm8wg8MOhrBLJLE0sAIHXaav6XcCOJTyT6elYTjpoXCTehPc6eLZgzLuA5GOlXtJgt1jVSMHO7DHr7Uz7Rk4JXJHU9KsQ7WAAYZxnFZNt7jaNeCYxsoCEAHGT0FS3EwdWLEFen1FZ0D45dwxAzkdvapEbf+93fVe1RYzerNSC3Qx/KflOCKn2R28Y4w3XPr71krcFHEu5lC5OM9astfKwIEZY4xRytlK8dCZLmNJFMhyD6VXu7mMzDyiCSMEEUFjKV/dhVHGT1p8togQZyW74709BvXVjXkgnswhYebGfmTufTFW7WEBN5GZG/zimfZY3ZWaLD4GT0q7GuBsYc9qmT6BFaXGkPg+qn0psOQwB6EZzjpUjE4POCCfxpIk7tmoJehYUjBB6Z7VFIMzKw428Y9TTwxQFcd+wpZM9euBz7UiFcrXI6EHJHUGoInG5cZAIyPermzgkCojD8qkDABoQmXomGM8Z9qbM2IiCDg96bABuAPbtWd4q1SHTNNeaZgP4VHqaS1dkZyTMXVrtVlIDcg80yxv1LbW654rin1Vrq4LE/eOcVqWc5LL83zZrZ07LUix6FZSggZx61pqSQPSuW0a48wjcCD2PauliOTxWTVmUlcsQkq4Jxj0q3EnmIVJJyMY9KoKMHg5I5Hertqcgse3pTK2PI3Ug470wrnGRzVuZRnIqMKCa67isUZk2854rKvMZJxW/OowfzrCvBwauDJaMtDhyOtW4l3KD3rN3EXAxjrzWpBjrVtlotRRlihHBXgkd6kvFV156Ec0+2OF4Ax1qWZNy9vWovqUjFkBQ8D5aSHlwPSrlwgK4xVOA4lIx3raL0EzRgJw30qJ0VgQvykjg96W3kUyBc/N1qz5W4senPepehSRSffvAIO0r1pxQSxnAI/hqxGnmsUwN+01H+78xBggKecUXLXYpywxTRSibKypGMZHX1q9o4RYbRrdzgJgj37gipZLYPCzunCEgkU+yjUIpRAg9AP1pyqe7ymfI+bmNOb5Asg6gZNRvsuoN6kAZ6VMQRFtZTwcEiqrQleYiVHXFYHQkYl4QkmUz3H0qvbyiV9hAbPHA71qatGzRq+wHjnArnWkNrdB/uoDnIFdEFdC3OgkjMKbIz8g9R1ptuWGSSQR0qeG8t7sqqypkj1p01vtTAbj2OKyemjKVkPaRWVlcnkcc4xV+ylBUBmI9GPBrJhXewMo25OCBW5bRoVSNecdBWcrDdtiyUWNSsnzPJgkjp7U9y6hQnyjvj0p+CCflzjpV2ONH2GVdp64qGybWM5FkuIi7ZAAO33qaykWIqtySMDII5q20CRgbCMD071ZhtY3j34CkYHPepv3HuPjkSQEwKSBzginRXMTwy5IXa2CpPJqO3T7PJIwRmRh8xHT8Ka1jG581VzuP40gaujTgYNCrA5B4/GplUBck5I96ydEhmgidJcjdJlQTniteFQD6kiokrB0HeQknD8kg8ClGULKq5C8ZqeJQiDB+YHgmh1wWAI5GeKgiXYjkAABPcc1HtwcMSM8ZqWRQYijAkdsUkkfACnGfxpXJZXj5JAPK1YUeZEfSmKgyOnPB4oJxJxgDHQUrkAo28k9OK8g+LGqm68QpZo37q1QAgH+M8n9MV6lfXkdpayzytiOJSzZ9q+f8AUrqS+1G5u5vvzSFz7ZrrwsPe5iHqTWsu0it+0uSrYLfjXMxGtG1kw3fFdM46Ebs9C0e4OBg4x6966zTrhZIslhn8q850m6JQZNdXp1yPLRQeTx/kVwyjZmh11s4IyM++asLIygYHBNUNOlDxBgTnpz3q0j4JPvipQJ3PO5EOCe57elRiM/0q66DaCM59KrYy2DkYra4FS8OE49OKwrtf3bZPNbOpkDnONvNYly+RWkBWOcuW2Xae5xW1B9wVhawyxyxyHorDNbVuwwMGt3smUjTgkAU1Z3ZB55NZkbfOAOMc1bjlGw5rNoBZkz3HWs5kAlLYwB3rRlyVXHQ81Wxk4wePXvVRYyuiETA4rVtjuD88AVQQ5LewyKlspS8Z8w7WNW1dE81jQtYj5i7hjvkUzUrVUnhlC7VY84qGCY21wiy42E4rf1WMPpkctsysDIAc9AO9S7IXM7mbH8kgVvuScH25q19n/d7cbdp6VWgKMvJP3ckHtV6GNn2kHPPr1FZyRpGVh0akR5JODyARTbrIb5R+FXVYOjYxu96qOpHLEZ75rO5pF9TOlR8cnjqR61hXL26TMs0Y2MwwSOldDdR5G4N261kXtoj5MmSCOAa2gzW2mhDc6ZaynzbFGBx1Q5FW4hOIY1dcnON2O1UrXTpbbZJFPIEz0zW9NeJLsBQbu4ApzfTcheRFDCxdNpHIq8oYADeqHgjHWnWSx7d5X5Tz6Fa0GhUIJIypOeQeawbC9nqLA7k4ZeFHXODVosJRjecAc8c1TtsEDKgEdOamVgCCFBPQ7qVgLIAKgKxHbpU9ukodt7Db05qLaGBK5UYwcdqrwyNDlQeM561JSfY2IbgrbOhJ+RuvtU0V0pZVEZJA4wOGqhZpucEhWilUg89DVmG2+zSDMh2D15IqdCWTN5pZQMKf5VagJLAdDg8Ux9uckHdmnRo28bjjIwc1DHsi4gDnaTj3p7gYUMPxHao0DKOnQdBU33mIfI4xipZDepGOmDxTejA84+lSugCq6nOeo9O1Ix4xxg9DUEPUrsQuSTxnnjpVd3AGc0+eQZIU4z+tY+t3wtLSWTG5gOF9TVqLk7IlySVzjPiRrm6RdLgYZbDzY7DsP615/cRHAZRxTNSef+2bl7hy8sj78nuD0/w/CrKMHiw1elGn7L3TNPmV0Uw201LHLsOc8VHOux+aZwRWlgtc6LSr0BgDkgda6vT7xWK/Nk4/OvNY5TGwIYj6V02i6gvkYlIUDAyf61hUp9UM9K0W93RMpONx4Oa20LPjHykjBrz+yuiXQqwXa2WBHGK6rTr3zVADnI6g1zSjYV7bGXLgNj+dVpDnJHbtUsjqWIPY0ydFRCw6YoNLGBq0obKng1iyPhKv6o4MvqMVk3D/AC4B7V1QWhJheIGBhfntWnpspMCAnJwOa5nWpxLcRW+75nbn6VuaeGXGOgHSuqcOWCJg7yZuxnIqaEkLhjmqsbEc1KG5HFYNFssmXKgjp3pp+Xv1FCkFT6HvSnDAjnipsFypIrhW+fhj8uB0+tRQeZDAqPIWYdWPer+3eD6014EP3hnn8q0TsKyJLtkmsYmHOBg+3er+n749OiicuQcnr3PtVCOJRAQvADcitayKvD8vDAc1EnpYSWo2KIrFIj8n+Fx12+hq1p8bxYXO41Gu4sDxsAwav2IZCJOoA71k33NLJLQnLB2IB6HvVOaIF2foxG3Oe1WoypDM3ymoJnQTrGQRvXIbHHbjNQtTeKKr4aPCjPGM1nXkR8nGOOnWtfy0WMFSCeuBVS4Ab5mOGU4xVJ2HfQj0aaM2rRSDPPGfWpBAGdggAI+Y8UumwpcXOEwJF65PWtTYiSYWPk8HJ7USdhJkFsmI1weBxVkl41JBjIJ6YpEhP2slZGEZAGzAwCO4q1NGn2dsA5BrO4nruZjT+SzKYepyCD0qeKVZouVKMOeuc1SnJOfLIJA6Gls7mRM/dKgZAI5qraCeha+0zRJtmIZT8ucYNTo0Dqv7wnI7ngmqTuLhSy445zmokZc7en+zSsNM3tHuFWZoS43gZAFdBbIHCeY3LdK4yEiGQyIx8wc9K6TRb5ZohvbcwOCMdKiatqDNSeIKxw2cHBB7U6Dp8wwabNIJXxuw/XHrTtwXhhwf0rJsTeli3B8z/Mc46YqTaCQ5HzDtVS3mKlW29Bgn1qzMSU+Xbz0qWQ9BAxII6D1pryrgjbj3/wAKjyRGQ7Z9vWq0rBFKqcAdBSJuV7sgKWOMiuP12RrmeeIsf3ajIHGMkZrqWIluFB+4OTXGXT77y7dW3ebI23A6jt+orswkbzv2OXEytGxxPiK0Yos6g74jz6layrdw2Oea6tzvZw4zng57Vy1/bfZLsqnEbDco9PavUrQuuYyw1T7DC5T5eeap7/wxVsH5QTnkVSmIU4XvWMdTqvYUsSRyKtQTtGw2njvVHeAcU9XwciqsNHZ6beKQhIADdCe3tXXaTcbWXHAA9a8ts7oKdpPeuz8O353IDggYBrkq07DOmx6j3qveviBhnOBUm5tuPwrH1a4McTDPJrGMbuw3oYN5Lvfj0rH1C48uNiT05qwZScnrmqc1g+oWl5Nk+XABkDuSeB/OvSoUXOVkYVaihG7OOt3N1qxnOducL9K7K0GEGOorAgsxFJtVeQea6SzXaBmtMU1dJdBYVPlbfUuRsTjIxUqsS5GOKiLBUZm6KMmpIXDqGX7pGRXKjoZZB4G3pUiZJBNV48hiO3aplYr161LEkWEGD6HrT0XPGffHrUakbcnFSRNnt1pDH7QCdvIPU1JZErIQD25pqqVBO4tnNTwooAYfU1L2As8GM8HpmreltstWZgSCec1TlH7sY9KuWrbLUKOT6Vk9hrckEhyf3edzgfhU0/KgN9096hVirFiMgH+EU9Sct3yCQKktFV1MbBVDFW6GobmIgkIMr15q+CdpyNx7UzGckZBHb0oTNLmNb28sdz5iMVYn0610MCF5FL5LYqCEKzpvA3DnOK0LaJ15HJLd6JSbC5etrUlsbcjrRdRobdlYYwc49auwBlhZgxGRgAjr71VlXeSMlsDp1zWdyGzAkhUtlFIGOvpVFocIxQ/dHQ81p3Py3BYgheQQD+RqhdxyqGEfBxlT3BrVA7mXOu2TnKyY7Hr6fWoVmZtrbtrDvRGzFmWcHIJ+9ximzRAhmQfhnpWlhGxbzebtWQAHoMHrWjYxGC4SRW55HPTHrWPp5aMR+btb0I5ro7Bg80cYK7euD3rOS6DbNW1aYuBIRtGChHP1rTTBQEncvTmqKxCN2xkK2OB7d6uKR5BVBk46DvXO1di5tCcMWxgYzxg+tWC2QAwyB19qoaessduqytl1wC3976+9Tzt5Druc7W4yT0NS1roT0uMlkB3EdOlVJ2x1PPPFPlYllyo2g8t6UkcDO4OMgdQaWxO5WvQLbS2mzghWcnv04rz3TJmEMmWAcg7R3z1/mK674nXg0vQY2yS07iE4Pbkn+VeWx6xECGDlT7V2YWo6avy3TMK9L2lrPU0HYgnJHWsTxNCTBHMh+aM4/A1f/tCCVyxkyx/WkuAl5aSQq6sCpwR2PavWhVjU2OPklTd2c3FOHjw3BHpTLgADIqAIRIRyCDyKmKEgEnArG3KzvWqK568dKeHz34pWTkgVG64HvVXTHZj1k6f1re0PUhBJtPeuayakilK8jrROCkrAj2aSUYP865HXbvzJSqngZzWnqF8IYGIOSTxXn+samzFlhPXhn9fYVGGwrm7mFbERpq7H6nqKW6eXEQZen0rqPBEDXHhqSMjdNdThxnuBkD9a83ERndEj5d2wAO5Ne2+D7LylW1T70MA49x3/ADJr3sPQUItI8WtiJVJpyOGu7A217IrLwDjpU0K8D1rq/GFgI7zcoxhRmuaA2txXjYqFpM9zCSvBDwMjHGPSlUAADoKVenNKy8/yrkWh0tAmdw6YqdcMcd6hj69uKmThifWmxE6YAwadG484qTwMVEcsflp6xIwYOM7j8wqQbLgIAAGKkilI4I+tRR4ZgAABUjpyQahhYtoQUTHO/wBKuwq6xL8oyQQM1mWu+PG08HgA1eglO/acn2rOSAsHKKzJjew/DP0piyGOTDjI6ZqyFBB3HB5xikZN56AketZmisxI5A5KgNkcnjtROpGXUbuKkijJ+ZQCo6/WoribypItyZgcgFgeme9NLWwN2RWtLlJ+RkMp2MpHQ1sbiqqSoottMjjd2j2lCdzEc81dWPzUAAOT+lOTXQmMrj4Zz5YjOQ2DjcODSorllIbAzye1MVZVnjQtwAecdatqEjHCZ3fpWTBGbOjNJg7Bjue9Zl4rodrRghuuDXQzxJ5eZCpYng561nXUSvEeQoPZuoqosEzidQfZIQMbOmagtp1I2jGRxmtHV7crngZH6iudRzFMcevXuK6YrmQ0dDbqVJ4IGMirltKd4ZGPmR9M9CKz9NmV0xnnOQa0gC7AgDI9azaHc66yvUuLZVJG7HI9Ku27nzcgY44NcjplwbdyWUEdCB6d66WC4AjBxlT90+tYTjYjyNhTkL+gFMmCudxySPX+dMhmV1DJgk9qmjGXJOc9KyYyubbceTjNWVjVFUsG496dNA0kX7piJEGRimDzgqM8eXI2sB6VL2uJLU8h/aFvZIf7EWJiYm80svbcNvf6GvIYdRDcMcH3r1n9ouMJaaGuQD5sx2+vC814ifevewSToRuv6ucVdPnN5bjd91qetwykFWIPqDWAjFG+UkGrC3TAfOM10ckTK8kbAuC0pLcsepq3C6nGawUuVyGVuc9DWxbuGAI7is6tOyub0Kl9GXCFPzYH41FMgI7n6U8bMDPWnM4PB4rBXOoz3jbrjAoVQPvVJPKkYyWqFPMuOEGwH+I/4Vqr2IbSLevavJfXDLGxEC8ADjd71jys7L7U6WQEYAqs8pC7RXsxgoKyPnJzc3dnReA7I3OqtcuP3duMj/ePT+tep+C7pV8Uw7m+WQNCQfUjj+lcn4WsxpuiRBhiaX94/rk9B+WKs207Wt9HIhIZCGBHrnNd9KNlZnHOXvXO78bWeCXUe1eeSIVY46A16x4iIurGKZeRIgfOfUV5pfxbZCBXg4+nabPo8DP3SkSBk9qkU5XgHmocEE8cVLFnaT3FebY9C5KoBHTBp696F+YZOKUDGPSp2JHLkjPepEJyOPrTFXHU05D3IIOcUhksJIc5GFq0Hz8rHke1QQ7SSB9761KABI2e9SxplpRsYHI5ORViwMYugS2D0HNVxhgNxG3tSJHh/wC9joazewbnQTwoyEdFPpVN4WiJ+cAHnn0qOG/YkIwDZ6+1WZpEdFUgHP61FrDTaVhYf3aM7SKEAy3/ANepmkSS1gMexlYZx7dqpparKNmMR45XsauWtpGm3CjCcIOwFDskQ4u5dsVAhK7sqTk1cGViAPDDOAD2qOFchTjC+oNWiQDnGG7GsXrqVHQa3ABbqeOetKwfaPl+6eSTjI9aljJdegI7nvTLeMRJseR5SAQWfqcmpuX0KtxCr7Ny9ORk8j3qtLtVTGwJPY9a07hFZSpxhvlJz2rBndonTy2LYODj0960jqQYGuIQwCn5e/P8q5uSOPLRGQtKo3ZPXBrc1qfapd87ScY9KxXcNKJFxkjGRXXBaCuNsbgxXGxuB/errLKRXwFIwRXOfZVmi3RnDdelSWN3JbyBJux4YUSXNqO500kZV9yD5j15rVsXJgUMDkdAf6VmQuJ4gYuWzzWjCWj2nkAY/wA4rCQm9TbsfmAdRzkmtKJ+/wB1jWRHKojLEqqjk88D3q2lwMFu2M8elc8lqVc0o5CQwyAQakyxUn37VSjuAwGCpz39RT3kfawiIz2zU2GecfFxIb68s7a6iR0WNmy3qT/9avItS8LgOTYScj/lnJ/Q16d8R5vN8QbG4KwoMemcmuXBU/ePPQg9693DLlpRPLrSaqM82ubSe0fZcRPGe2R1/GogDXpksccsRjljWRPQ81zesaLbxW73EBaLaMlDyD7e1bhConozligPUdasWc8tqcDLxntnpSEEHB4pFwTjvS5tLG3Kr3NWHUYiOG+Y/wAJ602S6llfbGmB3Y1msisPmFWrRwo2Hr2qbR3Rd5X1ZdtrbJzI25q0o9qLhMCs+J8HirUbZPNYzu9zeKS2MVinl9s1Z8OWovtXiikGYl/ePx2HaqRAIOa6LwTDtivLjH8Sxg+3U/0r6GCvKx8tN2VzsWlzKvB2rzVW6P8ApEfvSl9xBz15Ipt71jeu5HIej+Gboan4e+zE5ntuPqp6f1Fc3rVvtkYHOc1maRqkulXMd1Fkqvyun95T1FdlfJb6tZrd2TqQ4zx1/H3rixtD2seZbnp4HEcnus4F4253euRTIztJAH51qXNu8cmGOR71EICGyR+lfOyg4vU9+Mk0QBwVwe4pynjHIqR4wOgPFRscn1IrKSKRIqYYnPJpQNnOc5Pc9KahJ464qVCQwGeD0FQUkPRCHB5we1Txggb8npikjdCeanjAO70PIqQCMsT2IznFWY+fl74qsF+6MHrV1FDAn+73qGVYckQViwXO7rxyasCAOyuAcqKgZwhjxnB/SrqAtggH1qGMuQRgsjAjHfNWIk+Ybsbc4wKrQEeWP4T/AJ7VbiUYyQPeoZJZCiQfI2FB5Ap8qO6qFOOQeKjgCNuBU8HNTs23AA61DDYmRNicZy3r6U92Gw7DyPWosg9WweoGaHxtdifm7AUrE3IbmXZiNEyGXk54FYnnJHfJDJHxJkZH6VpSnEbOw4HPvWU0Jng82YhX+8uP0rSCRLkc74hj2TFWB8vPBx+h9q5o5Xdg5z09q6vVdz5VgXB71yNwpgk4zyelddLXQTdi/aXACEscYGW/xq3JGtwN0ZycZz2IrCjlJO5TtI7Ves7kry5wnt0qpRtqHMX7K7udPcHBKdu9dVpmsx3S/vQAx7muYglWYMGAZMc+tWYY0Q70JAx+dYzSY2zs0bBIOGSraSAqSp7dK5KK+kQgAEqeM54q9DqgXAZgPQ1g4Mdzo1kbyondUDZHG7p9Kbc6rFbRl5MLtGTk4zWLd6zDbxF5Cu1RuA71wN/4h+330sZglWPYw8zGBntTp0HP0HzLuHiPUf7T1m5ukPyuflz6AYFZu45HGfaockHJ70pcICB1r2YpRVkeTJ8zux6gnPHHuaz9ecf2Y43dSB+tXg2Dnn8ayvEb/wCiIPV/6U2xwXvI5wckZ5BpnlDtwT2qTHp2pygZ+n+FY3sd9rkG0jr0oA9M1Y6g56VDOdhXA6mmm3oJ6Int5ScKTyO9X4n4xWOrHII6jmtCF8gGqauVTmjKk5713HhiDytAt1/imdnP54/pXDFWkkVFHzMdo+pr09IVghijXhYowg+uK+gorW58tVeliJSGdvrUlx80HHY1UVsSNVhGyhHqK6LmNh0R3RMvtWh4SvZLbWI7QyFYZ32kHpk9D+dZVq2GYGmXJaOQSxnDodwIpNq9yoNp6Hoer2bJJ86gN2I6NWPNHsxzzXeQeXf2UEkgDRzRKx+pAOa57V9Me3ZiPnj7NjkV5+Lwn2onsYXFfZkcvPkK2OCaqI2X5FXr6Pay9eOtUCTnJ/SvEqQaPWhJNE6kYO7j6UqAKclskGqysTxwRUsZGTyBmsLGq0LaKOXGQD2qyjFlJTlh2zVGKccqW9setW7ZhI7mMfdxkCoaHexdiUsBuI6c4qWIkZDd6qq5DAYOD39Ksxbdhxz9aza1HcmUFuVwcH0qb7R5QXLd88VBDnGMnn2qVkVhtUAn3qWh+pdt2jldpABuIALd8elXIWOCOMVnxNHG20KORzVlZgGJ4NS0Iv2zYyx4A61Z3qe3as+JwB94nPanmYgkdjU8pDZakmXyiRyOn1pbG4863OU2qG9etVVbgKcc1KgAjZTxn0PalbQze5BqVwvlugPzHjnvWQb6L7VHaRNtdkLbAMjA96u3cQllyQcKOPemIkGzC7cjnp3qk7AYt0jOrn51ZT2HasK9thMhII81eGBHX3rs7wxBDheT1rGkeCR8OpA6VtCdhNX1OHuYXickggj9abDc4Uoehrr7iwgnBKEECuebSo5ZGChgQeSBgVuqqejFYhjuGRgUJ/A1ftdSMe3d0HqahXQZSfleQDOK1NP8MIZALmZzz61M6kEg1G/2mXASJdznoFrf0jRL+9QSXe23iPY8sR9O1auleHYLV0cKPl6etbk8iwRfMQFUZPPQVxTr30iUl3PMvG8a2OprawuxhESsQTnJOa5skEELkVf8STTXOrXNzOpCyuSh6jb0A/KszlenOa9ahb2as7nBVvzu4o7g0mSOmMU0nngkn0zSk4A4/HNbECliBx0PesbxEwHkKD1ya1c8AZwPpWF4gbNzEv8AdTn86XQun8SM9TgketA6nnjmowec9qUHgA/55rOx13JG447GoZfmIJ7c1Ix4GPSk2l2AFOOmpM9rEtjAZp0XHHetjVoMIsqKBt4bHcVLolpsheYjoCatufMQowyCKmnU55PyM5/u+VnHW8g/tC3YjgSL/OvTpeUJ/GvKHkAkQr1DA8D3r1WR82St/sivpaOzPnqvQyWb941WY3xg1S3fOT2qaJsg1pcixOpxM3oaJ2xg+vFMB4z3FJOd0WR1HNJ7Atz2fw+AdBskPaBMf98ip5gJRscA8YINUdAkzolge3kJ/IVakI8zGSCelaTOiBzOt6YAcxg9OBXLTxFGwRz24r0idd6bW+8K5zWNOByVHPrXlYnDp6o9TD12tGcbIxDckg0oORkE1au7ZgxVsZ9aoyRsi98j9a8udJo9OFRMnWWJSPu5HStCB1ji+8vJ6g1ycsw3src56H0qxpd4Vn2upeIkZI5zWTp6GjV9jsFcBgGbn2qdpCA2MH0FY8c42LsJx0yR90+lWEmw2S2a53C4rtGrC5IySRxzU3nLvGDz71mG5LDinxzKBwefQ1LjYOY0jMyyZ45qWCfkswwRWWbjjc5AFN+28nGMf3jU8rZLmbcl2E5YheKVLgyYLZwelYMd1EzEs5Yn1q/btJPjblRnqaiWm4r3NuGeMBld+gyT3q59ptkCkSEhh1AqhYwIrfvPmPvV2aRFRiEXHpisHJdAsySJYbmN5fOj8scbR1rLbZFIzhhjoPerMd9p0IYXmUx1Krx+NVxqOlSLiB25GFPXn3oSYrjxPl0XYBnqapyJFFdBiVaMH5htySTUM0jtG2H3LztIXBrOtb97eUbw2D3PNWotjOgFnBvaS3RSOu31qC7t4oY97wEL3AOauW9xviWQOpyMgCrEYFzGVIJJP6VLbQWM60i0+Qb4pRj3PQ1ZdQiExhWH94Cq1zo0EZZoyqt7Cq0EOoW0pRH82Ij1paPqBuw32+1Voss5+XbjnNcl8SPEi6Ho6/MHvLhwqIP7oPzfp/Otm2splI3uw3c4BxXmHinQNR8QaxJc3FwkVspKwoq7gi57nPU9a2w1KE5+9sjKrU5FoXdH12y1eHaCPMI5ielvNLPL22SO6d/wrl38C6jBKr2d4jOOQcFTXRaS+r2gEWqQpKo482J8n8RVzw08M+fDO67CjXp11y1dH3KYBBKsDnp70zhc8c+lb93Hb3S5ZhHJ2bGCP8aw7m3lgfsynoy8iuvD4lVdGrM56lHk2d0RNllA4rmNbYnUWXPCqBXTvnqcYFcdqsm7UpyD/FiupK5ENGMDcD60obpVdWqTNJxN1ImLe9XtOgMrg44rNHJx+FdboFr+6VmHWubEVPZwua01zyNNolttJOR1IH+fyrOMhIwRgDpitbXT5dtCgHVs/kP/AK9YrP07LWeX60uZ9WZ4z47HJ6PCt3qcSYyq/O34V6LMwGnqV6GuO8H2Mkdm11KuGm+7n+7XUXLbLONa+tpLRnzdR3dipnJqWM4PNV4zn86kU81TBFnOD9aFPBWod1W9MhN1fxR9ict9KQJX0PU/C8hGiWCt95YgCKs3MvIZeQDkGqtl+5gROgxS3Evygn6VpNnRBaky3IYZb7p61Xu3VlII+939KyL27a2kO05U+tMt9TSRirnr1zXJKa2OqMLalC7VZ4fM5D8gg9QawZ5nhY7hvX3roL4gyM4PJHI9ff61hXSBm45rza107o9Ci7qzMqRYHl8yMhXHO1xxn61NeSefFBLbwhJ0OGK9xSy2wJzjFR/ZsHglTiuVyTabR1xquMXFElk0wl3SrhfQ+taSTAYOKyljlxw7/nQqE/eckj3qJOLI5mzVlvY0GC4FQtqqg4jBP0GagW2XI6evNWPIQKO3rxWTkl0Ha40XU8p+VT+NWoo5jgSMNvsc1VSMqSQxYfTpVxEkKqVyPrWU5PoNI0rNI0YHbz6mtaK4CjAOc+lYkMRGQzD1yatwnHIO8egrmlG5VzbjkY7SWP0q9E3GcndWLZyFcseF9607d1aRiWJBGAOwNZNWDcsFFaIhUBJ9ayVj1CNpY7cwEbvubMc/Wr146xpkuwwO3Aqtdxzw6at9aykktiRQM4HrTWgWBb147byri0YSRZBwRkmqkUsE5CsArt0Vq0baVlgS8eHzInPlu/UD3rJ8S2zR3cFxZhAP7knCt7/WqjZuwnobGnx28tqz2k8cjrw8Q6irkcE2UNtPs4xtI/rXL2pngMki28MbsBuKSkZPrxXQ6Q0klqEM4ODkr3UfWlNW2ZCbe5b+yvNb4mlVH6A9TWhbWSrAu4ksO/rTIp41IJ2k5xmnNqKLlUbcc4x/hWDuzQr6yTbaXcPGv73Y23HWuCt9jWZKN5SN1J616CI3miYTEncuMEcivPbhXhu2soVLFG2ncM966sHPdI5sTDRMdbhbYK7Etu4A9R61cWzt7iMyKgXn6VeisJDGjeWCoPLYqHVblrIotugaSXCgdOxrtUm9TkaS0RUOl+Y4LRjb6g1k+JIGs7N/LjT5htUdPm967uCxZ9KEUjss7Lu69K5HxGWmJhmX5o0+Yn36VpCTbI0RwaSOlqHvEaKUNg5GVx9a4i6n8y6mcd3J4+td7qLLPafZSwG0/OcZx6CsSPwtCZdjXEvuxAAzXXBWu2NzRzitxVhPmNa0/hiURiW3lUK3KpKcMfb86zZLea2l8u4jaNx2YdfpRLyNIzuEWC6YHJIr0bS4PLt4VxjjNcHp8XmXUK46sK9JgXDgdgBXjZnOyUT0cIr3ZleIZB9oiT+6ufzNZDkkDcOO1XtdfOoyjGQuF/Ss77wwcjHSu7Bx5aMV5HFiXeo2am0CJRGMIvAx0qLUpOEUelW8ZjIXpWdIfPuiey8V9ZayPnFqwRSEpScVJ047VExwayZohN/NdR4ItvMmuLg/wjYK5ByQTXofgKMNokjgcs7fpiqhqy4rU6aXICY+lQSNkDOOf0qa45jfH3lIcfSqsxAcDja/3T70VDogtDK1RS6KF98n0rEwUPGSD1Fb9wSCcnCtWPMiiQkYINedWWtztpPSwhnBUB+MdDUMihm3KevX0qtdlgOPumqqSuDwcVzSmnozdQa1RcZeOOcVAxUHBB/Km/aWDYIBpROjnkYPcGsZRT2LTfURmwOM4qs4feSANnt1qxKhIyhGO9RqT07isWraFrUBKMZIYle+auW582IyLnI4K1Sw24khTVy2UqoA4Gc8VjNaFx7IlXz1IAAq5CsjH5hT7ZSRjO41pRQM+AOD61yylY0SuVY4t7dMfXir8EL7cIuWPQ54qWO0yfmIJHarUcHllSo3beaycx8okNq5UF1/A1et7J2fg7fUVPDeCSIsECt6mpob6KNNxwpHU1k5PoUkV3sXDuZmDxsBtQrjH1NMMkVgpByIsHIzxirkd8t5MUtVL+pP3RU0mjR3K7rgCYg7gnQflRe247HLxata2ET2yXStDNltpblfyqG6vrK7tAkt1sdANuFOB7c13FtZaW7Lst4kYDGAg61ckeGIqoiVsdRgU3PyCyOA02eOW3bY0s0g4ASItkfhVi2s9RmlD2+nXEbdMswUfrXZi/iTiOMJz2XFSfbBwUG5v5VLm+iFZGNaaHfTndcyRRAckL8xrVttLgtQSqhmHdutWFuPfk+tN83Lc54NZSu9xqyGOoLHHpXmmmlr7xjqZT/URStlu3Bx/SvRL25CRMIz+8IOB6e9eOaDNLomo61aeaAA+9SwyWDc9frmuvBwu2jmxUnyXR0Mmvz2V3cQu42qfl/lxWlokEuoXEN7MmRw6BxwOKytB0k6vdSXEyFoI24yMljn+VetWGmpLYxgRlNg67eV9sV2NdEcjnFWujJ1VoY7X7UQq7E5/CvJtduXOk3d6MySXEvAB5HoPwFemfEkpBp32OP5SxCj1xXkvjq0uRpVhZWLfMXM0px2xgf1rqox2uccmr6HLXP2mTbBHAytIMFsYyfXntWs0H2ZIopWeRhGVLJ03AkVys1zqlqzGQk4HBC59Ku6Pqt2ylXIdcnG5e/Wu3ke6E56WOmjWF7dTOwIiOMH8+vryaa8VvfwyG4jMsRfCqBgrwMnPX0rInu5/MRpsDPPB6muk09n/szyFiO4ZYkY3KT2HqcDpUOLW+w7xto9TAg0RrXVIXibzoAeSBynsfy611VvjcT05rJOpbTGlrvSRW+YMmSa196S273EJwQnmOhXGPUj2rxsyws52nDU9XBYhR9ypo2clfN5t5M+cZcke4qsz4PU59aHc55PNQsTjrgmvThHlikck3dtlWHxB5x2qJFz9K0re7ymQuM0UV9FF3Wp4sklsTC4HTBppkznrRRUsEMdh1r0n4eN/wASED0mZf5UUVVPcuJ0N38irJ2Xgj1FV5Yg1vIh42nKkdRRRSn1OmBjOxlUiUDcAQce1YtyxjkKk8UUVwVuh2U97FSZwBxnmqhJ3ZBoorhnudMRpO4njmmSDB3DqOtFFZlofHKRVlcOAe9FFJq61B6DcBTVyHjFFFcs1oaxNawwxz6cVrxEDgDpRRXDPc1RLu2fMOtH2r5HyDgDtRRU2KK1veyT3HkWyhfdzWpZ6UJXZ7iQysD908L+VFFTUdtEUtrmzAkcKZRAKrHUpUv4olHyurHOemKKKUEg6gLsvOWAw479qvGZ2VWzgHrRRRIgVYwxO4mm7lRuNwxyMUUVAMSS7KgYXn1qtJqTvKsCD94R1Y8UUVSWgluaSWSxWzMzF5XHLH+VeOTgXfi+6tzwrj5jjspzRRVYNvmk/ImuvcPTPCzslxBGgXY3yhey+9eiOskNvDHGQjOSMjt0/wAaKK9CnueXiklsef8Ajlhe6hF5w+7heK4fxlGRI8kLshSNVPbow/8AiqKK6qfxI5XsYNl5dxcYkG9VIxuHPIP9cflVO80aC5aQxqIZB0ZenI9KKK6HpJ2BbGBYLPa6sLa4k3lDjK+ueozXa26pfRoIWaLy3CFccE0UVUnqXUStck1W1jjlEpJ3xsYWYDmQ8E59un1qjaI8OqeYZGMeD5if3l7j8qKKmOxDMm+0iW3S6kEiFLdwh65OelYz5LYooqInSf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 65-year-old male smoker presented with non-productive cough, fatigue, worsening dyspnea on exertion, hoarseness, and a six month history of progressively enlarging veins over the anterior chest wall. Chest imaging study showed a right-sided superior sulcus (Pancoast) tumor that was compressing the superior vena cava with a serpentine-shaped posterior extension impinging upon the sympathetic chain, phrenic nerve (impairing diaphragmatic motility contributing to the dyspnea) and recurrent laryngeal nerve. Biopsy confirmed a bronchogenic adenocarcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Vaibhav Parekh, MD, MBA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4432=[""].join("\n");
var outline_f4_21_4432=null;
var title_f4_21_4433="Myofascial pain points posterio";
var content_f4_21_4433=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F79295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F79295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Posterior trigger points associated with the myofascial pain syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 474px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Trigger points and zones of reference are also present posteriorly in patients with the myofascial pain syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Sheon, RP, Moskowitz, RW, Goldberg, VM. Soft Tissue Rheumatic Pain: Recognition, Management, Prevention, 3rd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4433=[""].join("\n");
var outline_f4_21_4433=null;
var title_f4_21_4434="Aluminum in bone";
var content_f4_21_4434=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F65065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F65065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Micrograph showing aluminum deposition in bone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 265px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone biopsy with Villanueva and aurintricarboxylic acid stains. Deposited aluminum appears as a red band at the osteoid-bone interface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of L Darryl Quarles, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4434=[""].join("\n");
var outline_f4_21_4434=null;
var title_f4_21_4435="Gram stain bacterial vaginosis";
var content_f4_21_4435=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78328%7EID%2F54837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78328%7EID%2F54837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bacterial vaginosis: Gram stain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAWwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDoltsbdrBV9BUsIw6A4wKIm+VmIJY5P+HH5VUkufL1CNUyeQCR6GvgYps+6s3c1s4PPX6U11BAHGT2NOK4J649KY4KHPX61NzBeQka7UYseSay9aaXzY0H3CcHgHir7yOyjYpB/nVZUeRl81QMNgZ69OtaR0d2b01Z8zLqhSkZPDsv+TVLV4vKCzBiAvJqbzlS6CF/lXgn1o1GRZkiAKlW7YzkU4rVCheM12OF1qJ9RvYmM6JanmUNwc9q5vU7qQS+TCQqLlfmOM4rufFNnAbOS3EaSIwyFXrn8K87Nusk4SRmiAfOHGc+1enhneN+iPSp2aujobCUQ6YvnsYXIxgDP41SW9ltFfYsSMx5KrjcOxp4kWWKUQyeY0R3bWX+HuBS3Cx3YguIoz5bLkKy4I9qcUk9epq97GhpZ+0M013KJMrjb0IqA20NvP8AuZFeNzypPNUtQmW0RZy/koQQwHfiqWizG5jyjHyyTlnPNUou3N0M2/esdlFPFa27lGZmUcL61TgVpxJPcRMZicouetUrjUWtbOPOxXDd+pFbcJ+22sUgPGNwxUcvKr9+oMydSFxfWuwQYSNwCR978qmlt5HuRBCwdVUYUjBFSH91eBXmaORsnaB1qZdQs47tclTMOCR1NaXaWiJv2GQySxn5wWcfIO+KpR6fPJJysRkViSAcVryWkM7vPBM0Zxk8cGs6zuBOlyYj+9Hy7x3qU7ptDuPuLAWsImhJSZj84U5q/GkJ0lgWdyPmBI6GsFb10mC7nOw4yemavWetx+Y6ykMV4bBBJNa+ynYzbGy2csNtFKG/1j457VeaaW0T7NM5kldlI57VaQNem3bcnlE8oRjp6VNrVoiL9q8zy2j7HkVlJ6qMg5+jMbxFds4S4tnfzVXGwfdJ96mTUpTpeLZN9yibmReWz7VQntpjcTKx8uMqJS453D6Vs6XFZR263EI27wPmbgk1M7RitLjaViro3nrEJLhG8yVckSDkfWtGwiSE/aiQTuwAhwKtxyQtGxLDBGMt/SsHVkSyCR2820Md+N4B/WpjLnbvoRa+hvvdrFPPMhG/YAcdaz/D8C3DXc8srsZXzHuP3aNNePUo53giKKo2knnefzrT0+yi8qEtui8vtnGaTklFoiSUfUjttVitL37M4maQ/fHZR6k1o+VbXVyl5HKSY+Bg9fqKp6jaWs3zzy+VJuVzyOQpyKCyW1ujwMxhkfAK9Dn1qbJ6x3MmlLVbmrEPMDOxyCeBTzZxNhpCC38JI5FWYIR9nAOCfUd6gkxLMsUoI28qaw5tdDm5227EcunNJOjISVHBGeKfNNHa3cdvCjgkdQvFau9UjzjoKItkqb1x+VTzt7mDrN/EtCOzMO4lB8/cAVcTOTkfSqEljctIjWkywhSC65xu/Qg/jWqg2oAcFscn1NZyepz1Wt07iqeNvJxSoyDjPHIqOEtIh3KY23MPwBIBH1xn8aY4KqBkn3Pf61Bgld2JiqnPYmq86uudihmIO36+/wDn+dSK+0c5/wAKeW59qoavEgQOUXzVCsc5UelOQDn5s84xUd1Nc+UwtrUF9p2s2SM4+op1tHO1svn8Tc5A7c8cjvTLe13oTIBnqR+FK65OSM/rUUCSKFDHeeASwxn16VLuPsPwqGiHucUt0kT4JLhs5PpUsMSPcJIzbj1U9qzb90CrGwd5emU4AJ6CtC3ty9qFJ+YEAqaelrnvNJK5rcg4plyxEWF6n1qkLoW+2Pducdj0xSyTs4QkYLttXjIH4fnUWMFTad2RW1067g0bKATgE1j3urebc7dxTHAzjit2eRXt5DbscngnbmuM1fTrjCyeSwct84AwFroocs5O510VFu70ZsT3C+UwQ/Mw4YtjBrMvLy60/TY98gkk5IKdh/8Aqot5mjsLhJs7gMIAM1R1INHFAkwbZImVwOtdFOHRm6irkeky3d7J50avuXJye9aQ0RbmBZ5yEmc/Nj1o8PTrbKxVwFX5WUnkVBqet3LSzWlnJFCzAskkgO0Y9TWj5pTtHQcnJbHPeJLQ6ZqEaWcg+1Km98thWWm6GZdTimk5XcueW4Ujtj0rSt45L4M0ki3TNhWZVxg06OzntGmkDrvOF2f3BXQ2uTl6lRbvdszLgx3lvFDdQuk0Yw2Ohx3BqhBAHDQxSOVVsgMcHmt5kFuk8kDrJK2Moe3qRWNZmWXUo/lDhMnBOM5qovR22KS7hKTcwMGGJLfu3Q1oaddzSMqxyeVIgGUA7VDexLFE9raDzg53MoPINLZxtEQyMokTqT3PpVaOI2bUm+O38y+mUSbspsGT9Ks2miwSsLqWQsG5AIweaw/tLy6iTJ8gCjcOuK1YLmXUVESMxii/jPBasmpJb2Id+hsJaRpFJErnB6e1c1fRzWV4lrbiOKFgWOB1PvUzpdWkSMjmOTeSwfkEVh3U13cTTRyktj7hzgZ9DVU6erbehOpHdIwmkVY5ML828tkE+1OsJIkfjmRhucle/TrTC8cflqsjblG0g+verUQWGVldlIkXKtjmu9aKxnY6TTLwohOQGVSBuXv7Vo3UGoXdnbSRTKcMGkTA+Yelcvpy3AubZBCJoXzuYthsegrpYLiTSyqSjNqBhFHLD1zXBVWvu7hJdiW20tjNc3OCLmYhcueEUegrRuIEt7RTLH5pyAdozj3qizztI1zA4CSgFQ/ar9vdq6bLsorMMDB4Ncs03q9SHzLbYSWxjKq7AFQMqnSnNJaRQiZ41jYLtOeG+lZ3i5Zms7dLWMkBt24NjGOlGi/aryFJL+FUjYbTG3U+lNQ9xSbJXvK7ZVi1mQy5hhBgL4bb1Iz1rcmjiuI1JJyOVKnHNNi0a1SQuocA9EzwBVc3kSXpgiAIj4Y46Gk7Sd4DvGXwlSLdHdyosIluFXgu3Y9avv8Aaba0FnGscs0gLIDwF9s1Vjnj+3SPCiuxOGLH+VW4pJZVlMaqYm44PKGtJPa4STNa3nltLGIXKgTY+YA5HfpTzcRywi4D8Dp61iC5tbye3sbiQideVVW+961ZFsXm+ywAiNeWUnmsHBLc5/Zq+u5eW9juioDMGDYx2rQlma1iCxg4POK5+4t7iwdJoAZEYgbP7ta0VrNeLG7OChAyBUyirJrYznCCSd9DW06586IlhjnH1qWYkkKpA9c8Zqk9s0CxmAnjkg1oTReZF3DY4+tc7Wtzz5qKlzLZlW4v47XCSMcjkkdKuRSrKoYc+9c9BatDqzR3hUxn7ueuO3A9TmuihiCKFUcDoBROKjYdaEIJWHOobv8ApTGQnJAxj9f8+9LOwgQs2cDjHT/9VKh3KrDowB/CoOdXSuCLheQKUZP196aZMUKxx25oCzJe4qJjzyGP0XNPJycdG9Kbn0x+JoEjy++mhEsbyKGYHGVbGD7iuh0ydJLd3zhU5Oa5Wa1AZXuQecMWJxj8K05pCllDBbcjrn+8a1cbpJH0tSCkkjeihguGLN0Xgr3NWWijkK/KoUHjHasmzjltIVXHB+YsepNalkSzMRyB2HespK3oclRNa3K0ES27SYB2465qrdxEQSzoVfAzhiTn8K15AuHV1OM8ED/P1qu9qHgZASR0IHFNS6jhU1uzjLKQJLJLJCCvJI6Vuz29vqVlDLKNoVSFboVzWetoh1VYgrGHuyjpVnXFUpBAXeO3zlig6iuqWrVjqm02rHKWixzy3E1rMVO7yWZBnJH9aIvDv9p3nlrdytbwAmSRuhbP3v6AfjSSalYaSn2AKTHu83AGWPPX61W0bVJLK2ubW1BaNmAEknU9f8a7Gp2vHT/Iuzat1LUuprpd29pa2oEQXHmIBhz05PUn3rOFz5YCyZEs5IZc5xXSaBZK80j3DK0mM7c9KnudJi+1NIbdZI1GUXPQ0lVhF2sUpKOhlQrbJbCSUgBVySK5vUJZ7XMlujFGO7fjG0V2lxZSwweZFbRLERkoawdRsVeNJI4pQmQX5+X6Yqqck3dmilfYZol3BPbyXMMBWQHaZPWr1rbpeXFwXRV2cqCMZPqKb4eihs5naTEMbnKITySfat640uO5kjlhJjkQ5yv8vepnJRk0vvFKVtzB06zF2XXZ5S5O8t1NPa0XSmnlnk6jEeDjitq8s2ilWe3QNIBjk4zWTqd0JVCTwjyjwQ4ziiMnJ+Qk77GNdagXUQR5kaMAuHbGM+9FsY9jFkYYblsVbmsYHEbTbvsrdGHAx9a30t4LmBAoXymHylPStJVFFaFXtuccbbzHdpV3cZZIuTg9DVmwSNbsRqkzSAfJuXOPb2rsIbOKAMyRgHGC564rJkErXMjW9qdseAkgbiQHqa0jX5rozuh1leSjyi/2aJCMMW+8rZ6Crl9dzGRYQmRsL+YCMH2rLszGupM+xBcEEANyOKl1dba6mhnVnJX5JY04x6mocU5bCsb+lMslh9mmg8k5KhJGBLj1FT2ekw2whRGYomf9Z8x/OqOk29vLbQXqIcxghSWyMVU1HVXeG4jtS6SBgACPveuKw5XKTjH5mfK76Gp4jtpr2AQxP5UQG5pAeRjtS6X80ayNE21R8mT0P0rH028SFbyS6ikIaMCQZzkewrQtJmjngSzDPayIWO8/cFVKDUeXsCi0uUli1WeWJzbx+a24gKDmrDQi5ja3+ziCadNzNjvVPR3gW42zIIpklIQDow9a3bRzPJcrKFG04G3rtI7+9Z1FyP3UZzly7IyNH0iBSqyHM8bZO08ZqTULA2itHYW8iR3EhaVlYnBPerEqPpqEQrmHbwx+9ms6bUphbtb3c3lTE7k8vnevpVR5pO97oPek1JF6y09La3gZhG8qniU9ffFaSllvEkwoQr8zE81zulXC3N2bcows4hu3u2G3Z5GK62zggZC65OR35xWNVcr94yrPl+IjEMl9CW3DYOmBV3SoVjRijkk9c1VeY2iCEtuY8qw6E+lWNHDspZvusaylflfY5Kt3B9i+N5uF+U7MVayM0zonA4xSkevB71zs8+TuNliR3BYdOlSL/k0xl6HGacnQUmJ7DiMk8cUHHIY8+5oB6/1qjciYbm6E9B7URjcIR5na5Oy/N9acqemCKyVupvMIZTx3HrWtGxKKe5FU1Y1qQlDcNnlkYHGew/P+pqq8km84jBHrWgvJ5prIM8BT9Tj+lIzjOz1R5ULk3rFJdyrg4IXO30NG9UWGIOXdSfmJzirbrC0ZEHBHygA8NxWe9okSpIssfmA5IPOD71vG3ofTXTN+zmeaTa+UPQc8571fsH8uRkPGRz2rE0Nyb5VYElhlm7E1uyIFkOFyzdfespqzsc9W1+UvQFJs5wcGlaZZZjFGFx7d6xrwT2hRoTkPyR/SpLGZ4Q0j5y3GT6UuVWuYOhdcyd+wy4jW3drdAsbydGzzWbqOyzihae4AJOCrnANbOsorWwnUfPGNymuP1S6jurVDe7XwxKtn7premnKz+86aF5K5xer3aTaxuSRgmNyqB1IPQVp6DMHeY3MaSxbgUAODzWBqYkkuo3YK7vn5k6ewq3shtb9Gs5FRyoDpI5+/6V60oJxUfI60vM9EWexeZkgkiSd1wNrAtUWnXF1dCZJZY0iibYJkbJf/AAxXHw2jr5N9CoLBiwZTwjd1rW0mdZr4vawypaSE+ZER1f1BrkdFJOzIlCx0ep3IisSQ6SHGNzd6wLrUFubKSMbovLG4kdDUCFJL+4sQZFj5cRk5Jx6GmSr5atbLlowAzBxjg9qFBQ9dyoRtoctNP5l9G8T7nU5TdzzXT6V4knmdYioD8LuJ4J78VzOp227VnETfZ40XPAzu9hUpQkReXNbsV6Y4Yf8A1665wjOKNIrfQ77XJmlsmdHdBgDI4way91vHZSCSOWXcfvHkk+1Y1nrMNtA9rqBlkUN/eOc/4Voy37XTxrbhihIYMMED2xWHs5U1ZrQmNuh0VpCn2COORVaMjoRxj0xUsaLEqqiJHGvCqoxiuevrq+hcMsiC2KEEEc57Yqwl1aywRiaZ9yjlum49+Kx5HvfRicTbuJyiqQu5f4vasUXImup4lL4K5UDt7Vo2FuBdAs8jQuvyqSMH3rWFlDG0lwsSCQrywHNUpqnoZNqLOOZ3s79fNGGxt2OR83+17UrxztcG4uI18lQfkDfeB6g1YeP+0EjvJbVCUcrJyQcDoa1zp9rfW+XP7mQfL2OelbOolv8AMtuyIdLvkksHCQJBbKAsKFsZPeo0tYbZyl3Od853AqeF9hWXa6PHO01grOfshxGNx4U9jU0LC91JE8oi3h43Zz8wFDilflf9dPvFGxqXk9tEqTRRtORx+65Y9uavQ2tsZjJOwWRhgLvxx9KzbRHjmljEccdvnKAH5ifeo/JkkuppFtyIzgbZMg8dcetRyrZMmSZsaxpkd5ZyLbDy5gPldOoINW4pVtniLofNkRVZs4yah0uQCUyBXCygYB6DFSaxLax+X9oV23MNu0dGrK7k1BnO1Z2Y2Vxc6mYWWZdq53/w/SiDRrSG+N2iiW6VCAztn6cVBcCRrhJ1km/e/IVHCip4rMpdLPO7x7O2chqb0Wj6A46LUabIi6M8oRF+8xx39TVxZyIYj9qSN2b5dvRqghdpNQuIXO6IqPkx0FXTYwlI3SNCEJ2+x781EpLaRE5bKRbsgLpZI7hHDKep7/StKJUiUKowBVS3nVY1Vzh+nApHkeV1WNGVVOWJNc8tWcM05O2yNWEc7vWnuTg4rPs7oMSd+VqKCZjd8zZXsDxWXKYOjK7v0NZQeCRzUgGRVCLU7aaR445VZlOCB2NXPNGM9PqalprcwlCS3Q/BHB60yRdwI9RinB89iabJteN0bd8ykHBIOPY9qRKumU40DS4cfj05FW02hBjp7d6r/uyjRYCKOBjoKr4lh+Xd8hPpxV2ub8vP1sX94OSvb0o35+8pJqKALsOCCf7vpUgCf3SfpUvsZtJM8reKYucKWOeBjp71cgtGa3BkzmNj24H+NatvDsZmI56D6U+UhQVOQD39Kt1HsfROpd6EthDG0MM4AJ65HGTUwuAJfLxhic1BbPsXys7h1GB0qRIxJKJT1Heoer1OdrVuROqtKTvxjPXOKrXK7V8tB93nGc1oMSeneqU9q0lx5wkOAuCvalFkQlrqYeo3M3krbO4KyDAKnNc/Jp7B2hdvu9sdavTQMtzJK5cMj5BA4q5qjxFI5yyJIvJzxmu6EuSyR6MVy6I5i8tFSZULBJCONoq5FZ7YnmuEUlQGG6MHcfrVdJPtOqCSe4CbDgLj7w9asXGprfMZLYSJDG3ltkYB966bSdinJrQbJemO0lkhtlafosZGFOaxJWvI0WDc8UkvCquTsPeuo0+1hvA6zRn72Rg1ek021bWFJnIlC58uhVIwb0JlK2hiDTp7SKG5mlVY2GGc9c1Hrriawjt1y25vnKHnA966rWYEOkyxOuY9u3muJt7eSysnfcxXp84pU5e0957phCXMYt61zHdRf6GY0RcBmOR7Uxh5KTBo4opgMuO9dPLplotosl5cvPO2GUY27fYCs+70+BtPknjJeeQ7VXOCPc5reE46f1+ZopOz/r8itbmzudOSWUMJEIyQv3wfekW9fTPLktbZWikO0c9qqQSupmjuoZF2kbWc4U0EebLI0hbyo1yBEuRW3Im7PYpO6uWX1BZWd5rksc/LEB0qa0L3UilQ0hLbQvGQPUDvWO0NtNGtzE4Rz0QjH511Hh3TDYvb3k6BpIwdpH3QSOlKaVNXE5XR0mkKbnyra6t3EkceQw449T710C2yrAIcEoBjk81l6dqaOWUxFMDJYcqR9av292l3Ym4jYrEQcNj07ivNqKTe2hxVG+YdFZJEpCR8HrWdcQXTXkcUUcaWgBJb3qE6u4k2cMIwNxLc1QvNdvTJHLBAoi80RkO2Bg960jTncpKa1Z0VhZrAhZ1j+0yf610H3vSo7KKGKaSNVG+M53Y65qh/aNxAjtcvEcDIVAST7+4qdoZ7uETWVzHFKxGTjIx6Y9ahprd6MTi1e5at9KgjmuJcs3nHJDc4+npVybyreENI3yKQAzGqE11NaSwh0EkLna0gONnua0H+ztbuWVTGRlgeQfeod3qzOXN1M3VLxEAWN2ZmGPLjXJOemD2rJmNx9stIhNIQmDtJ5U+hPenWk1ot+JftKMwP7tlPGPQ1tRJEZ1mYgY+8F7mtrqnpY3XuEerWd06JNZyKHUAMHOBj1qCG6mnlCbPnUfveOOPSpda1SNLWWOINLJjJVDyvPesGPVpoIFIRzJu2pFtyWz3z6CnCMnDYiCbXvHZW5iJecIQ5ABJ7gU231aGZpYwGXyztbeMVycc97cRCO6ieW2kB3XEMmGHqCO1dHBHDfS2sVjEjwFdsju3OAODWcqajuYzhGPxF6aRZHWOORAqqS2Qc5qxpq3Mdr5Txq8fIL5wWzjkY6DqOec/mceHS9VsmkmSVbiM8BJFwVx2FdBpUzT2Sl4GiYcEGsatkvd1RzVWlHTVFWK2ksVdkGV6hT/npWexle6Mknyt/Diujh2k7W+Y4/Gs+6jhludqyEOOo/pWaldu46Vb3nzI52+urWHVo7d4AzyFS779n/wCs13bAGEKmQu3jPauc1G1ihMTxRMZ1GBImNwBGCOfatG1uWwoXI2jG1j2oneVn0JxC9pGMo9DRtkZB97IzUkzhV3c8elRrMDFuJAxWedSjmkMaknt7VkouTucUacpyvYzNT1AqzlU5GenetDRpjNAS+SM8e9VzEks7xFiccEAZH41qWaLAFVmyc8grgD0rWcko2SOytKKp8qWpBcRyiUGIkj0PH61ZjEgQZwpx0Jqd5kHG5QcVly3rpKwQ5GfXGKz1a2OePNUVrbGRAC0nAITGCM1HqCt5eUxu6DI6f5/pVqNSqkA8nuOgqcICozzxjNZX6npc/LK5lqkyJGxwNw+Ygcn2FaID+SAcDHOPSpWUgDbnp6ZqnbSyjUij8rjuau/MJyc1fsXVVtiDk9qq3sgULEGILECobvV44rgIjByOGwelQNc2+pTGHDh4uQW71ag92tAhBpqUloZmu3Bt4/suSTIclh2HtWXqNsLoxPBcKzJghW7+1X7i0nkvmIYApwG7AZ/+tUWs6dJgbW8yE8gJwRXVTklbudsWlpco3NpCtyzxohkKclume+KS6tLY2CurqqbDviHBqC2tjhRmSRCTtycsp9DVKeR/tksbBgsfrxn6V0R33NbX6mr4fJs9P82c7st8uDzt7Zp013LLd22pLC0aqSrk85HauSuJZ1kJjcnecMueAK1tPvbiOUFZGeP0ParlT3l3F7M6/TLp71J471IgVkKqq8hl7GmzadZmBoHdmO7eNzD5D7D0rkZtQU3iCL9ysZLCQE4bPam3c8jXjvjejLyTxioVB3unYzVPXRk2oFbcu05ctym9hwMdwKx8rdWszK7rJnfhsj8a6KDUYiIDdlSF+VI9m4sPXNUL9I57tyGkWIZIUjOR3AAreDa0aNrs5mS7luVO6WR1QgZIyD61s6JBJ5booBZvlXccYX3p8+nTOdsCxDKZTa3Yeo7U9vMisxKjkscIwxyK1lJSjaI1dblJokXU5o0iRkXA9Rx3rpII5JdJCmUPco/yCInkkVmwW6Xd6MEkqmSycEr3rpPB/lbpWWZiwztXjAHr9ayqzaV+1iZ2URbFPLs5I7hpkaUBCnGfet97iOG2VIUOzAVAuMAfSo9QaGO2klRcySDG5VyTXPrp8l5cm2M1zvwCdh2BVrmSVT3paHM7T1ZRnimuJprdWiWeVgwlb+IZ6Y+lSvEbW+WKPc0JGWDDKk+ntXWWNjBIqO8IaaElVZ+GOPWtO8skuYD5sabxnheM+xpyxFna2gPERhKxk6ZHBKFmW2xIibA3UbTVk2y6fCzWsJZS25lDVn2z3EO/y3jW3Q4AJ4Dd1q5dbZoclJztO/CE9faspRfNvoRJPm8jL1AyahaGNoG2FiGAPYdOfWoEnuLW2ERVnLf8s2P3R7mus0/To4YIypY5O5g3U59aV9Ptpb4vIA7hcCMjCj3pe2jtbQlYqCdrHml1YHzNjqke8h/lyeO/I710VvLut5mt0cM4AEW7DLgfep+opaR6hNaR7rZFj3CTGRuOeB71m6RA4vW1G22TmNfJIZ+SPX610t88btnRzpxukXrO2SxjETokTyZcZYtvY929/appobmWOXMcX3Vjj2/KW9eO1dBY6D9oVJbjdCCRJ8pySfetuOxhSR3UbmY5G6uWeJV+7OKpjIQdo9DkrHTdumpcyxNaGLPyA/561paLHAt3uSFwmPlJGAK3njGSDn8ar3Vn9ogEW8pg5UqehrB1nLRnM8TzpqXUTUbjy4l2H5mOAMcZqW0lV41HRz1ANUPs1zGfNmG4jj5en1pIrdVuQ4Vi+cgt6Ht9c0uVctiOSPJZM04bZUkZy2d1Vntw90WAXKnJPcVYmEwkRg4VRy3pVe+ufKw8QBLY6elSrmcOZvR7kGpyxrGVBXzB1Pesp5JpMsuAR39q1UtDcP5rx9e2alubMrbMAMJ1PvVxko6HVCpCnaPUp290QqxOQWYfQCobyJ47geUgXIznGSf8KfaweYpZBnacnjGTWpDbg2/ztuI7021HVBOpGnK6M2xt5o7oTEnYeSP8a1JhvGVfj86SWdGj2DGRxxVa4lYISSeeOBUTbbuZNyqSTehTvEdpAYpOR371WLy7jtIx/tKM1HMHLGR8iMdOaxJZ2MjFWyCepzWsNUdcYN6G7qEjJbF0B454qXT5jLbqxwGwMjPINY2maqLu1Cygkgc84J961LV0wDGOvJ9R9a5nHlVmaSg1GzQarczWyLJGpaM46Y4/rVe3Y/a0nPKsCMeua0mVZYwJBlTzUUluCmEOMUKSSsKMopWZkLFFBqoYg7255xgVRuLh4NUfadsRPJUc9O9XNWjdJY0kXJHRwetYd3N5W5mlQRgfMW6D2rphG9mdcFzanTiFLl4iWODzx0p8jR2hGX3IeAveszSbstHaNGdynjPrUV20k96YYpgw3Z5GNuKlQ15W9DNwd7PYqXF2sOoSRW5it0dh97qTnmsrxBpd3PeuUeNEYEqx6sO4FaEmnG9llmeASTICEdjjb71nubm4CskzF7QH98RwD6CuulpZo2Wj0MG0S2toxJdmSKO3+95h5PPANW5b6Blk8mJ4wxCqo+9z3q9Jb5t5H1GAv8ylyVzu54qnqNsZdQaRMIkbgIx7Z9vaupNSd2Vcak4tzuuowwDYBI6GtGILe28ywnd3UoPWs6+sZ45EZmAVTlscg571b0q9ls9X2wqfLK5Y7eCKbXMrx3KehBqMdx5Cg7VdUKqI+OPWkjvJ4hawRWhWNFAe5ZsMwPU1spC97fNcbIhbgnEeeSKzNVg8hmmU78gqo67fTNKMlL3WLcdd26RCSWOfyypzvXjPtXSQac01tC8iKWA+ZAvB9M1wsN5exvbLKFaNW5VhxnrXZaZrEcs7R+c0RnAO1v4WqKsJJadBSvujW0/QYYZhNIfMbk424Az2rIv0lEtxDpdt5En3RPtwhHUjIrrI/MW1VDiRsYJrE1SYwtDptoXgcndlRlefWuenUk5Pr+RzRlKTsxuk3AsdJFwHeaEkgEHPPc/SsrT9TutQ1hxb4EZBzLu+6KsvFeGW5QSM1si7BGmNnPfFbVlosGkWNpNDbeYJl3hwfvHvgdq3tGKb3bHKSi9epfgs72S3jLXoQgc7Y8lver17uSBI1kCE4Bdv506eZ7ZIyLaR1PXYMlfrSW88N9I8bRltoH3h1zXDd/E1p8jgcpP3mtEQx6ZZSbWEecgfxnBxznFXrhvItpJAhbaM7V61zGt3N1a3zLbGVIoVPEahgSfY1bi1hLuBRcJcW5OTt7sAPUVUqU2lJ6ouVKUrO90aWn6gt1Hna6FRyD1WrMMsU6ldynI6HrXn93cqkqzWLmMMxwRISWP+0DWzp891NcW9sr7RHCXnuEQFWP8AdFVUw9lzIuphkldFbxFo2/WI2jSTZjeWYnBPvWlof2KBEWWCERbh+8XHD+laU9usxQXG9+NoHI3A0t3pwje1gs4I4tzb2A6DHc0nV5oqMhOsnBQkbzsUUORuXgEdxUc1wLZgvzOX+6veo5DNJOjDJiQ4cdMmqaajZzXEpj3vNGxUKRgqRXJGDep5sad/M03hnlCvG6Jxnaw71LHDwpZhkdQOlZ0WptLp7PGrTTrlSoHINXtPSYIHlG3Izg9qmSa3InGUU76WCcgEL61WVCkjggnuD6+9XJm2uS6hh601s3CHadrGmhQlZGbcbpY2Zt3AIH19qq2NlHMpkaWQsh5VjWobZoYyzNvcDisg/bEut0SgK/B9K0i7qyZ2U5c0WoOxptcLAu1d0jZzxxgdh+VPguTcxSDy2BHY02zt3WTfI4PtV75VOAOT3rN2WxzTcY6LV9yGOONYDhApbrjjNRIuzA529qtzWyzKN2QPbrTfsvyhQeB3pXRCqLqyCRYh8wUcc8CqNywkXADD0AFbHlAZByeOhqGWNQSQgyfwp3Kp1Umc/LYPLCyjILd656bRLoTyfvXXLdAK7hD++AcAD0zVzyVYZIz2q41JU9jq+tunujhdG0+G2DAhS2Mgda1RGAMD+VZBedL5WjkdVTHyjPOTz7dOOa1mlAGcVlJt+8d1RSuPDKkYzgAVD9tt+vmDbz+NY+r6sYIWGGB+mc/SsZZma1LRcO2eWNXCnzK7LhQvuR+Gbi98WeJp7i8tntdPsgQhVW5PYEngk89K2bvQLaS5m+2IWtevzHAFU/C2sFpTASUkDHgrwx9QPX3rs5I4p4nSdQQy8jtW1WUoSSWiIlJ05PszLsrW0MMQsRHsQYGw5qytid+9Sq5HIHWqwthpjKLQhLYAkpuyTVePWzcFwkbbl7GoavdoSVSXwlvfFbGWGYqFbjPc5rA1K2ksYyI3LGYYCFfkAz1JqTVUmJhupirR5ClO+c1vSxs8EfmLuTArRPkSa6mi9yzOKv0v2gj86PBA+YK4x9TT0tW1DpHFHI+N8j8h1HYVs6nplw96Hja3CuNuxmxuFYs0ztOsNl8oiPlpH6n2rohLmWh0RkpLQlvo0+zGN5YkCDa0ROOexrCNtJK2xJAjAgSA9CvoDXU61plo+kyfa40FxtG6c+vauZFlKrSNFGTGw+dwxPT2rajNOOgRdy2LRHOyBdqZwfm61rSrZSWbxquZFXG88jIqpZ6c1zHF9pY7cYQRnbkf7VZTE2Mk9rNLsMspRShyU/DvwM0fG7J6ovdlPUIUvYlRYmj2nmQ8A/SrNvC0SxO6bdx4kI4HHrWr4ajtC0iusjFAQzy9CB6CtqW7tDblZFDBvkQAVUq0vgSE2okb6rLp1pHEIzcTJkBgeGH1rJudagvJHlnLwyqmflORgetahsJJYUtxMqtn5lQcAev1rBfTntJrhLiJ5ArYO0YVqVNQd31Jio3JtBk+1zM8lwsRJ3Dbkbh7g9q6C31IoHhzgMPkbPQ+ozUFxDfm2hkuILc23lgIMbHjX+6fWquliG81PbdlorVR5aoe7emaptVLvoQ7ON2drYag7xDdsZcY77yagtIFtr2S4eUgTAsCzcjHUY7CqypHZ3cVuBJE7DzPkAwNvHJHQdKdFdi7ughdcK+0juQe341iklfTRnF7NauOzNJ7O3mRHiZVIbeXHO7isSEi4SSOAFPmKbmGN7DuPatLXFTS7eOZNqjO0KDgMT2rK0y7jk3xIdkjOdska7h0yR9aiK93mQ6N3HmTuhlhexfbUgMdubbcUeQqcl/QVv21nb2c7pZqiSyEuVJ4+oFYcE08F09oynGT5DlAQT6tjoa6mOFQYZ5dvmqOSBjJxWVbTbZk4iVncsQQhcEnc2clj61Vm1OEXXk5O9Tz8vANRajrENqpjVg9xtykQ6sfSsMNqV3IcRG3J+Y+cuf5VlCnzayMKVBz96Z2cB3Q9eap3Wj293crcurJMoIyhxn61JYo0dpGsku6XHzN2Jp9xfCC28xgzHcFwoyck4rKKafunJ70ZPkZQuIY9MtgkEnlyCTeATnce4NaUd280AeNOvBBPSnpaRsrGaMM7HJzUqQqh+UEewOP/wBdEpJrzFOrGS11ZCiy/NuIGentUlpAIAw3sxJyc1KF70rHbjjr+NTd7GLm3oNmRZUKsOKY6KEAA6DFSMQRzx9KaDliCBgdOaSEm0VYrUrcGVXOD1U1ZJ+YHHvTyeOKNvQ/hQ3cpzctyQnjnrTM1FcTeUoJPGfTNNRi4B7Gi3UlQdrlLUDcuoWBMktzz0H+NXo1KxhHO4gDJPOeBTg2O9MEykkA81W+xo5OSskJJGCckc4xQCFGN2Me9UvtxN2IiAM57VcLrnlee+RQ01uVKEo2TOGdi8uwN83AHamXly1qqglBjg7z976VozQxrknA/CufvhNPd7NoMS85xkCiC5j3o2kzI11lfDICrEZODWZC5OFB+T86nvIJ5roodwU8itDTrHJCgZI7le3tXTzcqsdUUorUl0uDyZEmVSzgjr1zW99scbnmmChuMMe9SC0kE8bKihBxwcH3JrP1uykLKkURO4/e7is+dTauZXjNmfe6yZTIkiyFYjnOetRaVqC3F6ZbdiYeuetQNZyCVw5bDD7pHWs7yZdPwYl8iDPzZ4ANdMYxasjXkSO0nvI3ILFGhGCOehpL7U5GjjVI2UZ+9nqK5zT285pEXAB5Ug9/UVY1KzN3AsTtN8owGjbgVKppSRm6SRp31xK1pBHchUbO4yjnisOSzkF9Ebdst94OP4QeprV0ezaSQJI0kgC4AbkH61NY6dEjzCQSgE7duf5VopKDdhJqCsPj+zhDLfRSTpDjZg8H6jvV3SprYmZ4ERUIygxiti1t4Y4fLeML8uAD1P1rnb2xv7DdLE37l3yUKbtq+2KyUlO6OdTjNtGjbW73di63PlrKxIYxdh6Vzl5ohgDq6/aHcnZIoww9j612lktslukVoVEeM4DZPNZM84sJZYfJdogC7yFst+VFOpJNqIU6j5nY4myt5be4aC4kmt1jP3ivMh7L9K6EalNLdiFY4F4CmTbit3TtOkgjdw6SrINwaVeQD2+tQnTY/tSy26kj7pUfdNazrRk9Ube2izLsGbTdR2FZvLfhdwyGJPaurLW9xGVJVgvJVhj8aytcu0gSO2UMsxG5Ng+7WFFfS28jxzGRhKvzI0eOvGRUuDq2l1M3D2yUtjX8UMWt7aQbTb7s7lbgnsPpWBZhYpDaCRT8wlBYEHd14rZhES6ZBZmCJ4c/ug7dD1xTbqdEktoBCtvIRuUyAEe4HvW9OXLHlXmOmnBcpk6teSXF27TTZbywihGIRucnPoa0NBBRjLdIn2WEh1KgsXPtUOl2kdxdvDJOF+YncyYEp7qPepdX1ddLuUtIQFY8Bh0XHrVyk5fu4ot8tuSJo+MdU86COztthkkIZt3G1TVfRNHm0aeFMONuXcBsjHrUMWoRq0d7HBG7yHZjG7eO2Pxrfs7kv9pmW3/0jhCG6D6e1c8m4Q5EtP1MHB0Y8sVoXYD9ls7q5cffJf6gdKjt7ma4hDGAFWGRhqbFMs0pikKCIja8QO4VOqW9jIqWwyoIBjU8/Wua1umpytWbutTN07QzZXktxEF8ouHzKcn3HtitOS5mEzOEITopzlT61fIiWLrjfwA1RpEhi8oHCdSuOOamU+Z3lqZOtz6yRlaM+oN9qd3ikDSZTcei+ldFCrB1KqFzy31rIe0+zuq2yuyO4LY/hFbh+VR1OBSqNN3RjiJJu8epJ07kmlxn603dwWA7dqVTu5AxWRxC4APHSk4OecUUxyf4SRQNK5BdyMqtjoP51U0+d5kO8qWB7GqV7fy/a/s4Qsp9+tTW7R2oXbtYt82BWvJZHcqPLDVas2hx17UpJyaoW1+shKvlGHXNWPNCRoCWY4xk4yffjufaspKxyypyi7NEepwxTwhZ2KgdCMcmqZvRDGAh3qOSan1VxHCzMCcf3ep9q59rzBVYwWHTGO9aQhzK52Yel7SGuxvSXa7QwJXjkYzj61Q2t5zSoxKnrjjn0pssgSNd6nBAY4OCauMyJbHBzgjPPrT+HRFKPs1otyrbTFLna4G8kAqvOB9asTCcyMVViD0wahsYBI4kZwxJ5UVrp8gIBIGeKUpak1ZqMtNzjpQbmIFdwyM4qvqVsRads1Bpk5mcMG6A9fSrrXKTboyQGC9KhxcXZHqpOLRzE1xGGijkCl9vJxWhbXAUZtlJboSRnFRXOmlp3kw23HI64qfTYmtynyHaSA2R+tbtRaujobXKbul3LS7UdCDwDu7mrt2P9HbYBvA446VStd0N/IzEeVIOMnk1qHBiJXoelYT3ujzajtNNHHPBczzKZsgoSRz1FZWswymSPerSRH76kcGu3uoUaF5X4KjscZxWVDdPcaY7NH5cysV28HIBxmt4T6o7IVr20Obs7dVuAsERXC8IB/WtrTtJ8yxnT5wwGcZ71q6JBHLiQ4Zxnn0qeZorWdSrbmJ7elW6jfuompXvLljuQ6TYXNpAHQqC/UN1rVWKKJ1aSNd55yKswsrxK3IyO9UdctZbiwY2hPnqQyj1rDmcpanC6jnK0tCdisrEbcvn07U5nREWIsuW/gbvSWKuLSMyqPMCjP1qCea3+0wTSw5k52v6UkruxNruy6DoLSKK5J8oI7j7w71Hf2i/bo2RAJXG1n/2at2tw986tB9wMQxPers6KULEgbeck8UczUtSXVlCWu437Iv2YRgnG3G7pVZoRBbuIFUEL1bvUseoQyNGsTpISdrbTnBqaRQyMMAqRg5o95bmSc4/EcteWu+WGaV4pZFb5s+mKxri8SeQ2lwDcRpktgbSB2wa6abSLWZ/NjDRzBNp2nAxWZd6Eb21cSeWj5+SRO6+ldcJx6/8MepSrQt7zMSKWz+1WkoE/kRHiEnLZ9TWzqmq2LWySL5bP1QsvT/Cs0+H7uCVUimV0Zf32EwxXpgHsapT6TFbWl0ipNKpUCOLduK4rb93Jp3NrRnJNGPqeoyy6v5nnIYlHGDt+b2qa4sDPLEibllnIfzGOSeefwpmm6LciCSZ7OOSKNhuEy4b6itm4M8ZhhtVVoT8rlFJKAjgk1u3raHQ15lHQvaHpZgnIZ3W3izs2NyatX16dzh5Nhi5znaW9j61b8MWVu9o8SmR3j+R3k7n2qaXRmdkmnVHkQ7NgGe/X09K5HNc75jklXg5vmYuk2kost8Dxm5f524455Aq5pguJ7zfcqiSBcFR396v6XY/ZfMkkwCQAAOmKr6t5y3dvLbDepO0qBjGe9YOfNJrucTq883FdepoQbC7byDgYx6U8CKM/MSRj8KjsNPSyt2WMsxkO92c5JNNQwo7jfnt1zg1i7N6HJpJuzHwXkMkqLECwbPzKOB9ana4USMn8S9eKx/DoKG7kjDLA7khT2PfFXLaYJdTxOfm65I6iqlFJtDqUkpNLoWLe7jYkAOF9T0qeB1YEIysM44PSqs1shtTHG7IucjFROkMCrNxG+eeeDU2T2JcIy2NJjgk9earuDLnbkHH4VRe9uHmHkxB4wfmYGrEjOSssYJUD5l9KXLYFScdzMuCYSZblQOcAqcGrllDbyrHKgJftk9PasSSRr3UzBDMRxkbh/OtuMi2uIojt+YAcVtNWVup11U1FK+pckto3OXWnRRhc+WTnqTmpwCfanGJXjePJAYFTjqM8Vz3PPdR7Mo3UJni8rqp9O4rLOnx2sqtMBs5JAP5CtXQxOlgUuh8wckEHOQRz+o/Wk1KETR/JjfVwk9jop1XCTp30MO/lRRycqBhcVWtpprhCGUhemT6VV1EXEtwqAAhiAwHpWxYQpDBtfYXK4APP0rqklGPmeg7U4Lqx2kx3EZBOAMZJHIxW4jDaN65NYuk3LJlSeeScA/yqzJdPu+XJHqKwnFt6nHXhKc9jidJzFlHBU56kUl1MLS4Z2A2NwD+NF7cRLIShKg9So603VpYbu2jYYOOoPGKW7Umj2kve9TcsbiCaFdx2kjkN3p7iKQ+SyqMAnk9q5q0ge4kAiYhccAdc1BcaheQXBXkbeMgdaap3ejM/Y66M6UTJOy2+8CRSANvap9XMtrZx+W3I4LHPNYxjZXt7pFxL8rPjqT/AIV0VtKt9GqSoCQOcn/PoKU1azRlUXI1LoZR1WO4tpIZlKuBghuDWbBHcSwiBZBsB3bic8VpXekvd3f3VTDZyoxn61PY6YsEkjqTyOcnI+tUpJK66lqcILQl8NxkxyF9u7ODj0qS+hiW+gLxseeGHQfWp9NVYpHQK/I3ZCHb+J6fhmr7IJMHj2qHK0rnHUq2qNlVJh86ZIPQe5pPtCWkTPNIScZwP8aZLbPNfq0ZChRk5qeb7LKTCyozEdDSViXykcdw0UfmbCwk6e1Sy2H2lllGAGwcH+H1qKFjNK1uEIWIYXnrV8y+RGu4ZHc0nfoTOTi/d3JbaFII9qY57AYpw2yxspAK9CPWoVuIZAW3iodPnWeQmIkjoSRjNTZ6s53GTvJ7kU62mn4SKFYjIeqDv9aFu0QeST8w6ZPJp+uW8k1oDEQHQg+5FYthas8hm2yPJnKknpW0EpRu2dVKEZw5pM2omVBlpM8Z6YpLiJzaytbrhyp2/WoJLkHzyEBeADcCKdb3hlkjGw7GXOR92lyyWpPLL4kQeHYrpNPIvmLyMT17Ci/sAu6RF+Yc5HWtFLiMzmHcBIBnaTU8qgxsX6Y5+lNzfNfuT7aUZ83cxbaDyTG+d6MMk9qligi+0q1qNowQw7H61A8y3MclratsaL5uD1FY8ovrW0m84SGYoXj2npitYwve7OpRc73dmdraABcEKpHUAAVaAUHIQZ9fWsLwxdzXtnDJcQOjMm7zCeGrbbKgMvUdq5prllY8ytFxm0yQ47ionT96pQDGenpVe9uXEbeUNzAEhR1NLYtO9nDNOgjkI5TPSlZpXJUHFcxdP3sH9awNVaW2eRbWEs8mCGroOCAeKr3iyeQTB98UQlysKE+WWpn25e1gWGYDJGd46VKqos6u+0uRjPtWfcCa5t2WWTbJkfL61fWKOUoB95QO/Srkup1TVtX13JmaVshEDp2qSe3SSILIoPHQ9jT4FWJGPGetV7hpZ5UETKIz1PepRzLV6aWHWdmsG5iT83Ve1WgoAwBj6VGymC2YM5bjOfSodMuDNCzkMAD3od37xMuaac7ivYRpvkhRRKRnOMVhNHPJqEU85fCE9DkEV00UqzJkFSvP3TkVBPGkaYKkgnPFXCbTdzWlWlF2lqyaJwyjb1xzUqknkZqGBFVN0akZ4wanAYfWsW9Tmla+gknyQ8DAA4HoKzUdbkyKjkNnBz1rWAzwfSsea1T7dG8e5Me/GB7VULdS6DWqM9rYPK4xhhlVA64rLm+0R6gGmlYRoOBHwp+vqf8APrXX3ca7TIoAYjrisma2S4hZQPnAxitoVO530a99XscxqFwPtUdwuwyRFmjYrkqSMHHp6fjTDrc44MZY9yAeauw6Q/zJcSCQDIxnFXYbKGNSqp3/AL2a354LTc7nKmulzihILfdFcbtzHqKbBbvtmDbijHIyeAKuG2E15vlQbSd204OKkvbVyOCuMDaM9qw5uh2qSQ3TbgQqigcAdupramgt50G7a3881iRNHHHs48z8s1t20LpaqG3A9QAOcUTSWqMqj6klvhGCBmwOADWjYSIJiBgcflSWNn0Lowzz81WZoUjR2X5TwOfSsnJPQ4qtSMnykrybVJx8nY561TWSPzN4O7Ix0/CnxjfbfNnqajs7cpcMzNvj64PakkkZRSincvfdPl9VIqKKXaxUcjPYVK43KSpBPpWPcXMkUzr0PbnFEVcVOHPoSi98m/kj5IccUy80+2uoma63jeMZViCKS2XennYDSdsVae5jiZDcYUEfxHg1rqn7u5rJW0QlsFSAJbT5AG3nk4HrTbnUPKhySVI5zjjHeqEEgTXXNup8qT/WI3RatTPDcSFJSUiH3Tjj6U+VX1Dks/eRe0eGF4Fuio3MPvZ4xV+yuY5g/lgAKdvAxWbZTPHMLdITsUfhUUd9NHq8lrNCYk2+YsmMK341Di5NnPUpuTdzoOD8ue35VnSW3kqzRuxY8jP8qs206zOdjZ20+U5UFeo6e1QrxZzxcoOxHZQkxb5GyXGCCO3vTPs0FvKXiTG49jxmrqNlRg5Pt2ppj3sS3HpS5ndk+0d22UGsrYXH2kx7pexY9Knui7x7Ux8xwT6U+6gFxJsYlRjGRTLGGe3kaNxuhA+VyeT9atS0uy+ZNczeqMtdHg81J5FJuYG3IEOM/X1qee0uJAZimXZSETPSr89qss0cxZlZDkbe/wBasTnMLKGKMwwDjkU3VbsU8RK6a3K2iaeunabDbAt8oJOTnknNXpFyhGRyKS1XbbqCxcgcsR1p7k7SR1rOUm22zklJubZn30TLHFJHxImRkVPazie0R1OW7mpJQ3kttAMmOAemay7KKaBWaeYCSTrGo4WqWqNlacLPdG0mCoJpG6c1UhR45QWmZlI444qxLlom8tgrEfKT0zUNa6GLjZlaSOKQtJ8xdeQPWsewaWS7Ynh881oRNPcW+1WQSA4dk7mrFpAIBnIY+p6mtb8qaOqM/Zxae5FI8ougjJmFhye9WIIFRSxHzZzxVO8vER0JGQzbeOxq9MHSHKHcR71LTsjOV7JbXGxziSZ43XHp6EU7yH8392wCHqtJHEd7vJtwfuYA4/r+dSo5UnnKgZzS9DNu3wlFbYWE6tb4Ebkb1Jx/nj/PetDAYDJ47VnToLrUY5lkb5Bt2A/rir+9egP19qculx1Luze5Hc3cdsAXIAPAA71JBcxznMbAjpwapXcQluAJFHl55P8AWixiSCZmztHZT2oaXL5jdOHJfqbAHOKbtAOcDPrio5ZQke/kjOMUyOdCcl2IJwT2H1rOz3OZRb1HTKGDDPWsudFt8gZCk5raYZOOKo3tuJBnuf5VUWbUJ2dnsYGoYySvBAz04rJF7FCNrS5PX5c1u6np7XPMchTA243cfWsq40iISnLEn1C5zW0XG2p69GpFxtc5eUybdysMZzxSWkzGbYVwAafZyy/Zojk8jHydK0gkUdmzk5c8g+lU3ZWZ6F0iG1sXnuBJjdgZbtiurSEKVAAEYHQ1h6LMqII5VUgtnfmt150GVV08zsAefyrKo23Y48RKTlYuoQSMcEdqbOPMQrgc9qowOlvhrmZIw5whc4Ln/JH6VcLYcq2QfSs2rHE48stCBYhFAoc9z3walSPCY/lSzqHiIcnp+VMt3H2chTylPdXKu2rjW+VuDkGsTUNlzcJslwycso71bfU41mZXyuB3NZFtJE+oGXAZSf0FbU4vdnVSg46s3bchLYkIQMdPQVQjka/g3tuSSM8Z9BU81xcG5OyM+ScDAOAK17eBVUMV56nA61N+VXIlP2fvPdmZbQHbuXblsDJOMZ/rUn9kSb3WU5Rj2HKtWpNAkyhWUgA5yhx6ipsgk4G36dqn2jWxhLES3RHZW/kQhHbzGX+L1qK6sRdS7pXJUDgen0qw0u084H1NNtruKeR0jdWZeDipu73MOaabmitpcccMk2I3QrwSehq6xG0+Vgk9B2NSOm9Sp6H9Kgt7TyXBDEj0Pam5Xd2S5qbcm9RuniRHlEoxk5A9KkvbryJIxtJ3HHAqwecU2QLjMgBA7tSbu7snmUpczRDJdiGJy5BI6AVHp+oC5kKlCvGRnvUiRW9xuVVU88kUlrp8cDl8l2HQmrTjaz3K/dqLTWpeG084GKf8pwSBx0qjciXyZBFIEc8gnoKdDdI0QBkVnHBwaztfVGLptq6Le75yApCgAhuMHrx6/p3/ACz9WvRaRoCCxYjFXI3BUbjkmlZUc7XVT/vDNOLSeooWjK8lcEdXiDDBBGax9eVzDHJA4WRHBPqR6VogRW8TFF8sHk89KzInS4nYkCRF6HPFXDR3RvRjaXMtkPvBd3AT7NOLZAytuxncO4qxJcRvGyu2AeDnihm5Gfw4rJ1K9igm8twBkZyfWnFOTsawhzu1jbgCRRbYxhfX1pzScdOlZOm3jzK64LRrwH7E1d8wNkHvnNDi09SJ0mpO5T1GCF18xN29G3cHirunTzSRBpSCDwDVea2cv+5cKh6j1qeJBEoAPAqnqrFzacOXcvLIG4ODUSpP9oykw+z4+5/n+prO1KO88hprCbLoN3lE43f0NR6Zq3npsu0NrcDgrJwufx5H48e9TymSpPl5o6mt5EET+aqAOcbsd6qxh/PZ8lY/c/rTleQhllGPf2qOeNniZRINuOOelCXccVbRsnF/FIwUkD05yPr0FB+zll8psMTk85JrLs4kiV1lUvkEMxbk1a0uGPa7S7wRgjdgD8qcklsXKlGCbTehsyqpt8AcMP1qCwWN/MyDkEcA4FWOGjXbymOtEMYj55yckcVjfSxw81otEpJ71Xu22xlvTmrBJA4qKTDqV9aETDR3Ofu7pcFF5fPJJ4U+9Y1xdPDKVdznr8vStjUtLS4jmVGPmcAkdu/NZltbyW0QicxuV4yVOa6oNLVHs0XBx0OWuZ3EkaleUzwvAxUrrcSxRRxklFIyPrVzW4Io5fMwOgHXFS20qNGqqhdjwMcVKl7qaR6HPdJoiiRiIofL2v1JY4zWrNYyRypOjAMeMAVYtrSNpBLGvVcMSensK0QCW5xjuMVlKfY5Z17PQiSCK8hha4jLMmQMsR6ZBx1BwOKluZFQGRzyTz7mlkby0+RVz7nFQ5N1asW25HQjpUWvqcy1d3sT582EkH5c4JHce1RWyiOJ9mdrH5dw5x70+ydZYSmMFR26VM8Y3Z79uKLWbRLfK3E5a/tDLNIybVbGenWsTw+ly13Mt0u1Q2RjvzXV61BmJ/KJ3Y6KK5xg8Em5FG/gDPP+eP8AIrrptuLij0qc+aFzqtIU5dJWyQc/rWsoznpx2Fef2GqS2urEzn7331QHg/0+ld5BKJY9w49ayrQ5Xc4cTTknzEhb5hnOafx16VFI3zDaBz15pY3Vi6gqWU7WAOcHAOD6cMD+IrKxytDZreOfbvJGDU1vbQwMzQxqrNwT3NQysVQtjCinWEjujGUYHajWw5c3LvoW8kLgU2J2Jy34UwTLvKt1HNJHMsqhgeKLGXK7bE/cCkmjSaMq4JHcdKR2CjJI61HK53Jtxg0rMlJ9CeKJI0KIu0EcmpFwqbR0FVLucwFDjhiAeOlSSToEyzADFOzYnCT17kd1dIqOXwVHU4rPW1E2WSIrC3JOeaS6vokBAGS3TNVf+Egt3ml09lf7QqZwoOAQu79B1rWMZLY7IU5xXuo0rQFGCu7EDgZ5qywl+1+aJP3W37uK5yyvrmTyVRSNjENv5JGeua6Iy/uweKJwaZNaEou76kOoykQ/LGz7jtIA6A0lvAsMSRL91RwBSJOJAWQgjOODUd28i28rQgGQKSoJ6mml0Ek7cpPcMkcTFyFHrWNO8UykKS0mflLL19qW2vZ5rO3W/hRJ3yGTORWtEqqiqVXjsAKu3IaRvSV3uQ2aiKDyUCqn8SgdTT5VbA8varE9Wycfh3/MVUuIzDP5sbEZGCD3qZZtwHrjpRa+oOLfvLqT+cIiod+vGSKjvlka3cQELIRlSf60BfM6Dd3wf504Sh0KtnOOBStrclKzuivay3MSxGfBOMH0zUs4juWETg4AwrDgr9Pb26VDdgyxtGjEMRwfSk0y3khjBnYswPBzTdrXLaVufZixTvbuLaZC3y5Rwe39R/KlspxJdSKVIz1U1ZdSOh4z696hn2gB8gMPTv8AjSS6BdS6bmjBbp1UjJ9qsG3QxlQBzWfbzkBSOmKma8kjuVXGUIFZSi2zknCd9C/CvlrtPSgTLKpMZztJU5BBB/Gl8wcg9MZpizq5xgg+9Z2uc1m9R6njnp6VkXUzx3yqCdpbnHetKacRABh19KoS25unLIVLdST1H0rSGmrN6KSbctidp5PukkcHgiqDB2YlIyw7nOOaspC3mnfvZQOMmqk8kiyEKCAPSnFdjemknZHLa1EZxkLnt7VNo1mCP3gYKPuVYlIK5/h9Kfp7x5ZUZifvc84qFP3bHpuT5bI07SIR5I+6eMCppDhTtGT1PtUStjouB/KnbvmOUbP86zuccrt3YQSFpMMAymrbn5QqgAY6Co1KhSQuPQYpofadrMGYe2Kb1IfvPREdqBCzsRjt7GpL+4aCHKjceeAarXrOANnHHOKsKoliCyrnI6Gq8ymldTkU7WP7TC7OpAPQA/nWbqdhgs2ACASAOMY7VvxIEBCKAoHaqd9E9xE8fyYOeorSMnzGkKj5vIw9ItbbZl4wZd24uTk49BXT2gTyxsAC57VhxaNIseN2CRgc1p20bW1s6kkkkYNOo03oyqzU9mXUOGxzioLW68+5eLkMnNRWyzPcqzHgHDZqykCQ3EkyD5mPbGaiyRhJKN09yyFDA55qOYOkBWHr7U/hRUBaSObI6e3epW5lFXZC0Mn2VWyd+eQBVSK++zt5EpIBPy9s81pQXAd2jdSMflVbU9KivZI2U+W69wfStE1e0tjaM1flqEsziVFViemc/SpLaSSZ1CqfLUcGsy4s5bXZufzFJ+YjJIFX47yG1xHyA3Q9aHG60CUVy+5qT3MyhDHMetZlpNvvpEicyqowwPY1LqTA3KZPykZBxVfSJwt3K6lBAcAgDDZ9SauK91jhHlhdDHtZUhdo/n2tkAc1cjuI1R3ESJO67ST1P+eK04jGVIjwARWZdWDvJuj4IOR9anm5nqJVVN2noQCZY4vJ2lZCCeBgkU20ma8jXLExgYJ+lVJpZrib7OqGKWPILMOGFadrDHbWyxRKVBznBzWj0RtK0VfqywVSCJjEihQMnbVO01O3uSyI4Lg4K55qK0855blLolYm+VB6D1rAvNEtLHURNbSyNI7AcE9fXHpWsIRd09yYU021J6nS3iiR4ZIsEKcHFS3F2sSklgqgdTVOIDT41iJHz/MzZznNV9RjiuAom3eWpzgHrUpJvXYagnZPYmS5F3AXXK8kDI7VBeGdIo/s7HduGT2xVWBfKZhFMZYicjjgfj+VXlbKgHr1q7JO6NbJbElteSrdtGY2Chc7z0PtVpX3MecZzVUYaPqeffrVGxumad43Vl2t/Fxke1HLfUjkTu0X1ZjqxQlgMcKehFaZLA1n7QZlmAXcoI4q3G25QvQn8qzkjKa2FmJP+ryfpVa5Z2iKqTuPXPepp5ViiLMwC4xkCqJuhcHy42KN0DAZx70KL3HBPsXImyiqSd2OSP5Vp2jB8BgDg8VjRRzqq/cxzlhn5h9O35n/AAu2koVsjt2qJLsZ1Y8y0NdpFQ5Y5JwMU1URHLICTzk1SkuG3IpZck84FWoQJFR9zfKScDp6Vi1Y43BxVyLULVrmHaDICcjKtg89xT9Pge3QK2f8asu4CsQe3WqtrdLLKFVt3FO7cQUpSg10LTHC4xWVdwB5i28jPYVYurkISOvrVNNVgcZRWGOCD604xlujSlCcfeSP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of vaginal discharge (x1000) from a patient with bacterial vaginosis shows the borders of an epithelial cell obscured by small, Gram variable coccobacilli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal vaginal flora: Gram stain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of vaginal swab under high power magnification (1000x) showing mixed bacterial Gram stain morphology consistent with normal vaginal flora",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4435=[""].join("\n");
var outline_f4_21_4435=null;
var title_f4_21_4436="Carbachol: Patient drug information";
var content_f4_21_4436=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Carbachol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/52/30531?source=see_link\">",
"     see \"Carbachol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F145504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Isopto&reg; Carbachol;",
"     </li>",
"     <li>",
"      Miostat&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F145505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Isopto&reg; Carbachol;",
"     </li>",
"     <li>",
"      Miostat&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691860",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat glaucoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701705",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to carbachol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703773",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have swelling in parts of the eye.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697992",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lowered night eyesight. Use care when driving or doing other tasks that call for clear eyesight. Keep work space well lit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11701 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-4B2100FB5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4436=[""].join("\n");
var outline_f4_21_4436=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F145504\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F145505\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030535\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030534\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030539\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030540\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030542\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030537\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030538\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030543\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030544\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/52/30531?source=related_link\">",
"      Carbachol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_21_4437="Sodium bicarbonate: Patient drug information";
var content_f4_21_4437=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sodium bicarbonate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     see \"Sodium bicarbonate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/56/41862?source=see_link\">",
"     see \"Sodium bicarbonate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Brioschi&reg; [OTC];",
"     </li>",
"     <li>",
"      Neut&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691873",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heartburn and upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691886",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high acid levels in the blood.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower acid levels in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691893",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high potassium levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702934",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sodium bicarbonate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: High bicarbonate levels, high sodium levels, low calcium levels, belly pain, or water in the lungs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt diet (this drug has salt), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696885",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take iron within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696905",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug for more than 2 weeks unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697903",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bloating.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698108",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gas.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698174",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More thirst.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium levels like muscle pain or weakness, muscle cramps, or a heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029351\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695816",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug 1 to 3 hours after meals as an antacid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695380",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mix effervescent granules and powder with a full glass of water and drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11869 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-9D3D6B0F7E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4437=[""].join("\n");
var outline_f4_21_4437=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221612\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029349\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029348\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029353\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029354\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029356\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029351\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029352\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029357\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029358\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=related_link\">",
"      Sodium bicarbonate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/56/41862?source=related_link\">",
"      Sodium bicarbonate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_21_4438="Cocci lung stain A";
var content_f4_21_4438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coccidioides spp in lung tissue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 310px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE2AYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDrtN1CC21FrIuRHeOHiYjhX9/QcVcjtrw6ldW7sfLCFtp6Nz2rJSwkvrXcjMxiIwjDkfWtrSrp73TzGzeVew5Vu5OO9e3JJao9R6XsWdMW5gvVuLCVC5GCp6MP8ah1WNdQ0uRYIxFfJIXZXPWokc286fZ3Cq5yD2B9KluxI0qXEZG5hkFRgn1FSlaSY7a6jIQ1xZQ3EqMCg2SgevY1j694ZNvexatZHjIYNkkN9cdD7109vcMFUtna45U8Z/D1qa3kNvCIIMiHPIbkGrjUcHeJnNOSszhPDepyw3f2eVJFRm2srH196661MlvePAeSGwSelWJFtxcKzRQldwywTGKfe31jd3gntFKFQYyrcEkcZApTmpO6Rd3s0TbJLN8MVER6HPeqerQi4UOi/MOoHHHrViO7F3GY5NpfGceuKjudqIoxgcng1CumJJp6mTNaFArRlWA4IzjPpUkkM8kRVlKzqeCpx9DSTSmFjtHmI3UDmrmmKZI33K5XoD2ArR3SuaSbirkunvvjiguWB4yQTzn2rG8ZxaoXt4NOuHikMy7peMmPqev4VoTmH+1TZEOWZdwfHA/H1rQMTx2C3c7R/ZIeGMozsA6mknySUmc1VJrRjby3ka0s5biZfMIA2tj+YqjJaW73ksMiJMEIbZKoIOacHstcsRdaTqMd7buMxorAtGfpnIom81yA4IZcDJGG/OlHQdPWNr3JfscMzwshS3+zjCxheAR0A9qt2+sPaRy/arnL7SY1QcZrNa4ywSQMx7/LgA/Ws24nZyyxRB06Fu60+Tn0Y/ZKxPa+I5iDuZYps8MgyQe5q/cvMNpiDeXJgsd33m9TVbS9MSPJ2Ft/VtvNcP4q8R6xpvjmzsYLURaahDM84IEp46H2rWFFVZctNeZM3GDujlvjRFrqaub+2nujpmFRo0c7Y2xg5A7Gug8MLNo+lW1/FGfMa2Euwngkiuwh8rVonmfypYp1KsmMg9cj0x/hQI0tjFFhFgjwAhUbQoxwK6fbL2SpNbbijFqbkn0N3w9FPe+HrS6u4xEblfMwDyqnoa4j4s3Mmo+Gjpltue9urqKDYehOcKB+RNegXtwYbeEwo3luu0A/dUe3pXEnRpdZ8daRcrdxxW1lMJtjKcuy/wBea5qFlU9o9lr9xEoydNuW5s2q6b4YstO0OO9giu1GTb9SzYA5/Kmx5RZZGRRcSMfnQc8H9K8i+Ipa0+MVteSzsYZGjk3E9ACQQPyrtp/HOnQ2WsXttNDfyWx2+VE4ySSei+nuK1nQkoxne7lqzSlJRTj2O9s44YwiybI5CPvd2J9TXG634/0zwt4rj0fUUleRiN4iHEeehPrWD4K+IZ8WzXVs1sbWaJd+0HIKg/Suu8U6D4W0i4bxJqFjJqGtfZ1lhiOWQuF4OOnbvWapKE+Wqnr0RlUm1H93rcb8WL2203w5eQBXdr1VCBRg5OSOPSsv4TWeox+DrtL+LbYmbfbo4wVOPm/DpXGTfEWLxlcW4udLxqZuViFupymw45BxwR0r1GKMqq2gSQxY2hVztXHatpQlSoqnJat3+7sZwTm+ZM0NFgW40whpfLknfy0OOpxnFPj0yPU9H1HRtWRoyVIV0bBPofzFcH8crLxDNY6LaeG4bpbZHMkj24I+fjaSR0AFa3irxHd6X4e0qaQo+qpEkdw27O4hRuJHuawVGclGUX8T07qwOfO2nsczafD240DxCLyHUUlA4JZiD7dK7SWW4Mjzf6uQDOAcZHt6VW0XUG1Lwza3Fwvlu0jgEjlkH/16w/EvjbQNGmihvriU3Hy5RQTx7mtqkp1Haau1psXTjyq6OpF5epLJPgneuNsuPmX3rGuvE1v/AGla2t4nkXyEhGVTwpH3TjtXR+DrOx19LW6iu0ns3G8hG3ZPoTXn/wAYNNuvDnj1daSFn0oqjFQMrwACPrxUUIwqVPZ9bf0hVKqTSsc/qPxcZNdTTvsGWhl8nzgTlh0BxXpVxOdTsYYNRskcOpLKVyGBHWsrVvD/AIUjNl4t1G0t440VJMg7SxPTI7nmus1NIr9RJDL+4uYCFK/3GHb8DUy5ItOK7/LyLpOU7qSRzNhDH4dFnFa7pNPUMqoW5RSc8H2JOK6m8e2ku1ayUiF4QzHd39Qa8d8U6fJpV5pOmadqVzK4lMixs33FJ6Z9OtekWd39n8tJQ0yr8vmei/StK1Lad73uVHXpsYHjf7UNJuvsZk+0BfMGDgtg5ANXvg/4ntvFNjLpF6TFfR5YqRwfXNWtZvbK32i5dIxN8sfmMBuPoKxNXuY9D05r3w5YW8OoRqryXAjG51PUU1FVKfs7e90f+YTu9VsbvibQZNPaWJo98EjYI7CuC0nU5/BniSGwnJj0u7l3wXA6RMT91vbnFd/4U8Zw+OdB1BpylvdWK+ZJGf7o6sD3HFYf2Wz8VaTLJhLmyCF1LcEjOCV98iinJpOlXXk/Xoybt+8t1+J39pq99paMrRRMGX5SvAPoa8i1/SLnxBr80+qv9nWKTzknUcFQMkCva/CGj2d54O0+IyPIUjKbnbLcE8E+1chf6Rt1CawnZecpvbpg9zWGGqxpylbccVGV9LNHAQ6iNX8Vt/wjF19oht9puNwKLjuee1d5Bax6lf8Al3E4gQYO7HLe1T+DvBun+C4dSMSie5v12GU44HJxjsOabcWiyMNwIYDDY4HsRVVJxlK0HotEyqUm4+9uRalpn27xAqm2hutKggDMCOVfJ6e1XIfEFvpyG2htSVQnjnjnpSaQZbNiLdhIs6GP5m5VwcjNbFrouk3ECSz3KwzMAZEyBhu9YTlHapsjNxUbpkWg2n2S+nlQs8FwvOf4W9KrXVlNpt611GxaJxkn+hq9A3kxv5jLuZQ3B43d6bcX8aQ26SLmGTHzEZyO4pJts61zc2nUqXLp50NwgBVvm6fmK0NQhMbR3FplbSRQShPG729KgvbeO3KBSDbzDKHrtqra6/ZaRNBYa1II7O7kMaludpx+gqkm7cppOVoqS6F+1MhLQyTK2Dld3Bx61YVpTHGUZWDkgDGQCPeq+t2Q0+eP5fMiYFY3B5PcUvhnM73kCkSLKhOxzghqHZx5kS3ePOirqtzcxWUz2aAXiqcRSLkE9ua8isdI8ZahcPqOqy+Sss/ALFdnP8KivWtEmurnWIdLuSGjdSf3g+ZCAcj3FXXR9O1GVVXJRuCy5BGeK6KVVUG/dTbIqU+Z2T27dRRotxaxwjeWlCblLHBxUEN/DJcRRSxguy43E9D3qfV/EdrYfZ7u5uQJc+WFCMxORzwKxmAvl+1wIJLdxgyRHowPP046isIpy1kioyv7s3qaOpQizubd4fmDnAQDP+c1LMLq3SNkDQMesZFQ6FdmOSeAuJGLYjMnO0Y6+1c34FvdX1XTte/tjUY78294Ugmgxtxjsw6j2pqLd/L9SZTUJKL6ncyQM9vklDKPmyeo+lVjPcR2dzZyqskEq4IPOfaktZXhhZTLkAclu1NW6ifBBzUW7i5b6PVHmXivwf4c8I6UdetNcu9PvnyYIEkwWf0A6/Wum+A/ju88a+fp2tQxXD26lvtSqFJHYEDjNO8e+Ek8VaX5sapNLBuZEBw2f8K5r4H6SvhbxBdXlzHPCHiEflMMAsTz+Fdzca+Hk5u8lt3RxzoSjL3D0rXLd9Mur7L7bMDO5/7uK56w8T6N58cEFzFLM4wFVsnNamqWMesarLLqlzJPZvkNbsMpjtWz4X8OeGdDngnsbKKIsM+YAc8npzXKpQjD37t+R0zm4K1rk+nX0SzATxsvy4QEcsaZqKWF7sN2sBJJCiT+Gma3eH+3pfskRMYjBVm4APfFYqwb5Xad1UZGB6e9ZRj9rYlxvqXItOitotttsMWfugfdohsoJ3xIo25ySBmp7IrEgi3KSMkYHU1VuZxbsxEi5+6Qe/vV3ZUb7E1vH9gA+znOJAcM2QR6H0q1r+pRQ2tvPZ2+Ljdy2zO0fh1qC1hSVBNjzIxgMciqk88cXyxuVjDcknvnila8tR8qk7nkvxB0hta8TaOkUTPMx2MO5y2R/M0zwd4V0DUtSl1EWk0JiuCPs5f5RhsAHNdZ4w8+DWrLUo5Uh2OOZDtCnPc1h6roE1p8S4prOeVrW+IuXWIEx/Nywz0wea9WnVbpqMXbR/8ABM6kUqibV0zvZtG0nSNQD6baQRSSoDKyKM444PtWT8Q77WJZIP7DXy3VVVpDj5QPT8607d2eWc3GTE6eVFkcAj+VGoMIo3+UM4XaGxnBrhi2ppy1fmaezVrGdY6bYDUIru2ht7W9NqpuJUhA3yYGSPTJzWzbzG3gDPKRK6lOnT1qS3neLSoy58xlG4Db0x1qtFHNeTyrbTxee0BaLzD/ABH0x6USk5bmKSprQh8SeOLfw1a6bZ6it1Ot4xAeFAwABA+Ykj9KbrmlWWp2RM6bZHX5G+h/wrjPD1r4n03xPJpHiNobjSwrSebKFIVgOCv49q9KjktprZ1kkIl2ggdRVTiqDXI9d7pip63b2OI8T3t9pWmRxWNuk32dAqocjIx2A/OsO/8ADVr4tsNNuddtxFfmIAmE4JHYEVtSeJbOz1Wez1JmV1cyLLtO3GDjNJ4b8f6be+JILOWykRJyESUgYBwecVuvaQjeMdVrc0lyP4tux0HhfTE8NaUlhpiqkYw7Zzuz9fWt+10W91Rz9pMU288+d8xx6elM0m5jlub2K5jVI7WXbG46SKelYN/4qvfDuu3EOtrBp+lOP9FnDnc7ZGF4J6/SuJuc5NrfchyilaKsZ/xbtLSPQZ9L1CWOElwtsuRliMYKj26Yq14HmvLHw9a2+sBHkt0WNCD1XHA+uK5/xLZzeKvGGlalcwMlnaJu5OQ754FdHrNhe6k0UOmwsZDIsjAdI1XHJroa/dxpye+voOMXG8pdCuPD+lal4mtNUupJDPbbti5+Ujtn6c1c8b6UbfS5TYvkTJuQpznB5xWHPfta+JBaO6NaRsdzY+6x75+v866KLUjpmgXUWoPhLMNOuRlivt681MueLi27+RScX70TzjVtHufFejWWZNt5aDYzvkDaPX3rtvDdhJFpaaezCaXyyGdhnecdP8+lczoskXjKCR01CWwtZJvMMSsN7hTnHqAfy4rr9a8TWumwQwSR+RDvA3PxuHfB9a0rTk/3aWz27AoXba6mF4W0iDT73UpLACJ723aF1foCcg03wt4bvPDOgi21OQSOJGC+XyAvWr3iPUrfQd17cTA2sSKxbHUcdPWn6J4wtPE2jPfWe9o1uNpjcHjA6GolVlLXdO34CVJRmmjm/GOpXOm6RBPBrU2luZT5QRmAl656dD716HJIUi0jUIpEvVFtmSQH/W4HJrm76OxliBvojJCu5gpXIjY5xj2qqfEMelaVNb6gLO2togEtZo/4lI5/nSnFTiuVaq9/mOzU231PR7PRotftYr63vZEQrnyl6o3oTXPa5qunaNq0WnX10DdTYCIfvEVn+FtQuPIlvvD7lwgUz28h4cY4YV518SobzW/GNnrtvI9rJMqwy7eTbuvGR7Ec/nWdGi5zcW9Laf5ESTg9NVf7j1h7e2uLQtp0gjvoOXAPUH2qq8kF2xluGMcx4cc8n1qv4M1L+1EmaN4V1GLMavuyJgverlvqNqVZbm3YSqxBAHSs1zJtNaotxb902ryJns23NjIJLKMkce1ZeS+mRx3YZEQlg5U5UdjjtXQJHa2tp5MVwzn+FnPA9qx7m2kuQqs+xVyGGOHGMVEJHTG71C71nRF0ox3Or2KXMeAhM6/MB1yO1c14v8NN4qsLa1hkKzpKHjkByDuwP8K4vXfhr9o1+BreYW9q3LliSfw9a9SS1nsrSztbJ3cQBQJONxxXaoxoctSnO8r39DP3m5QktDpNYiSw0+wsLiVWuHtlRSx+bzFUc496y7a0mE0d3ZzDzQu/GME+oNHivTRqmo6Zezy/Z7yz58zkow4IBHrXNz+ONNtNXktZcweXkSOSMKe/4GuaEZSj7ur6lUk1Cx2t3c2whF69owuAQzNEefek1KwuJbmJrqQPaSYKbvvRkjIBPam6VcQ6tYZtNrxOuQ4PHTtUFww1K1uNHuJfLuCn+iuWI+dR0NZ6p27ErSV0UfF3hyS8013j/gG6J0ySrY6/SvPbDxFPouuRiGOZonBa5tmO3J7ke/8AOvWPBeo3Nt4fa31bezKxjBcZyOmM1jeItB0vUpUa7hjlt0+UPHlJVPsR/I10Uaqg3TqK6M5Jt+a6mZqNrcanZ3N9oD+XLMu+Bicbc8Mp/wAK2fAvh2z0bT47FLOK2lmHmysrHDv3ODWjpUdlp9lb22mIzQoCGEvXrU9xe4l/fQFioO0p2rKdV8rhHYqznZyWqI57Z0kkRlDAH064qlHJGZgrxCMsfkYH71WA3mywrG5Yy8BWJBrAupgdQkgt1Z7u3k+csflBx0pQTehasZnjC4vNJeZtMUWzEbiR/wAtDnnvxVHwp4/s766Nh4hiEF0+EjuV+6T/ALVeXeLT4r0/X83U11M5lyBy6EE8cdMV7R4RsPDHie0lstQ0qGHU4B+8G3aT0+ZSOevavRlShSpKVRXv1XQxdST20sdfaQIsaqpWWJfzFRajqJglKQxlwgBbaeR9KsWentYI6wMrbDgKDnAH1qpNCJXeUEOWPKDg15is2bQcZP3iUX0NyrbUO4/xN61kXmow26zyrE05tl3uqdWx2FPYM4Aj+Vh1BFZWra1b6FHGdRgkInYQhgepPQfrWkI3dkrlyppLRmPbfFC2Wab7Xo8uF6NFLkgflTJ/HXh++lWWO4ulVx8waLofYiu08OadpdhNcXUYt5UlTLrsUED0Ncld2PhLTbqe/Gl24LOTsd9yKT6A8V0xlQcnaL/r1OeMKik7bG9HKsVglzp8p8iVAw5++DTWlN3BvWMxBGycnO4+lYEGpPrl/GumssdpkDCjCgCurjKoh2puidduOoyO9ROPJvubpO+m5xPxTt1uvDu65uDFFHLGTz9/Jxj9c1bvvFjeHtesNEhhE9vDFEhc9Su3FavjPQh4q8NPpKSrDcmRXRz0GOe341518RNNuNM1LR7mWSR50t0iklXpvjwCfxrow6jVSpy7vT5L/gnNWupXtsdvf641hfEXkTLp05wjeh6Zqj458QyeFNIt7+2SK+t55AoLfw/iK2vFXhweKdDtTpl1HHujEsbscKSeo4rlNAS70+xutD8UWEV1HC+Ujk5Y/wC76jjNTSjCSUu26HKo9Uvkd9FdR3OlRXIWWKC5QFGIOFyM5qh4G04WdmWv/wDj6SRmRpWz+I9KbBqz6tNaRWy+XbQII2iAx8o4wBVPxFrp0bWdI02y0qW5lumO9lPMa55P1rJQlrTXX9DOWo74h2ep6lp0j2CqXc7yxbawUD7oPXnNct8J1kGo3YudQhuL4rhYVm37eecjPWus8TSx2kclrLN8yoSjM204IOck8V494H0+Pw/8SrKYatZeSZfv+bnIPY+hNbUryouCE/daPc9d8F/2pb75IVN1ja2wDKj6H+Vc/wCGPCFrpOume4XfLGCqB1xsPc/lVS38N+L9A8V3OuP4jtW0XPnMZZjyhOSu0/l1rsX1O21dIL60K7ZhuDA8Hj1rD2lSEeVSun26eRpSaqbosajqun6PYu12ylHfftGMivKfGEtv498ceHbaxJzbqzyYPQA5Bx68V1/iPQrjxHA0NnLF9oT51RzjdjtXmOkGbw/4jivYkkF/HMFdGHocEV0YWjFpzi/eVyayUXyn0Jp+kxGzijKgsmMnGD9af4t1+0+HvhgX0sImluJljEecFhznn2GTW/omq2l3Zh4UjE5HzKTyD9K80+NenR6xosd60zt9lyRHngjv1715tFe1rKFTRX1M6s5S0KXiy2h1CaC+09QttepuDlcHtkGrjoJ1t7G7wXlQBmY5BXsPxzQ1jPP4RtdoISOHdwORxWToWv2nii3tLqwtpI3tiI5Qw+bK9AOec9a7Fdx8l/SNVFRSXVnlPxAim8KeORqem+RBbbtkcEL9NuAVYV0GrofHdlYMUvLGJTu3SRkoOOx710Hj7whaXmt2KW+lu0OrXQluLhnIa3AzuH48n3xW5a3coW7EtmIbazdYIFJz5iBcZ9q6FUS5ZxWtv+B5/wBamVK93B7DdX0DTtX8JwaRezOwijWN7jo3GOferngzR/D+h+GZNF064aS6Zi8hIyznPB9OgFOtpIpLkPFGjQvHiRG/nTLTUbCz1P7S1vHAD8u5W4YZrmbbi43ff5m8qd2pJamtPprzlbVIXRGGFUrhm56t+Ga5T4/+EXh8CWl7b2u+5gkUOIxnapHt+ArV1u+u10+41TSJ2e6JbyUwPvAZGKrfCr4g6v4n0nV4vFNpGY7IKFdY8ZJ4IIPpUxlVpuNVK6T1+ehjXjze6nqeVP4g1zRPD9hfWjy295NCtssKg42j+Ij/AD1r1u6iLWun3EiRi7uLVGnjCgAEjnIqr4k0mUeHJf7KIWeRdpcoCVYHI69M03wOmo39pJZX/ljVnjDIJGwQN2KupytKpHpoy43jJt/13HaVo9rZvpsuiiO32TZLZyAc/MT+FdHrmr6HpupzQ3TBZGO/5nC5z3/Q1pXccGi2UNldeUs80gZccc98V82eP9UfWPFl/OrsY45DBHtHAVTijD0vrc7yenc569TROKPpUsk7+VMq7ScnB5qG+lZ7porX97Kw2qxHCD3qNXyyS3D/ALtWxgdSK0ZljhU3Fi6+VJkopznjsDXEtGj1W0mRSaekVsHZg9wGAY/4Vof2XfAOIFik3JkAuA34CubS5kuLeS4gVnmQhyh9M+lUviJqOqwa54ZuPDMVxcCZDG7RMcLk9CB/WtY05zkoJ7/5GVRtdTopbpkULKrCYuAFYcD1rg5/AGmeJNX1aO6eZZreQFNnykqRkdeuM16ELpNVsZmZFSWN9shJ+446kH0qvaBoL1nkiY3LJjzR0Ydj71VOrKldx0Y7cysznPCcN/ZeIHsbaFrPSoI/KgDnPmN/fYjvXUTQrFdedcI26Q4zx19qmgdfPjnTJZCBIpHI7VNqapPOjMpChQQS3APr+FZ1KjlJNoVrMLXUY0sJLN0WWYtlRjHB/qKrTGJLeOKNSkv3ct/Eafc2cVniXG/f8wJ6fhUNxc2mprNHaPvmj+baThgfas1vdBFLdbFuWwa3t4iZl3yHChRxmqcM0yzNaMRHKoJDEZz7Vl2+q3ds7eepniznZIcMD64qaS5N4Fu40KGFgGUHqPY1fI+ppyyWkjQke5LYljYTbfkZTgD3FZP2d7ae5ukixLNjzGzksRXQwLDfs9xG8kccYGABjFT3YszAq9um8nk1Kny6GfOr2aOXES37GWdBbmFQGMYwWxWKl/pem6guqQTRI0c2xznIz6H3xUvxCvZ7Xw7fXOloFmiAGFOSFr5x0bUb+VruOWSQK0iyvuPBPTj8DXoYag63Wy2Iq1lTVrbn0Ze+N9YurwxwafiLzv8AWrycZ610KpPM0V5PMI5WTDRen1xXj2n+MJNEgtxMRKroF6cqoOAR+Fdz4S8SWGoSyyRXLbuGVJOpHcUVsNyL3Y2RNKSctxLe+1iLxpN9sKWuhxxFmmb7vTrn1zWFqHieLxBdTXKRudB0994d15uJB0I9FHX3rd1/w1f+NpotOsJzDp+8S3bDOSAeFA71nfE3w7b6P4et28t0SDEUUEZwhPqQPpRT9m5RT+J6afm/NlTvzNX0X9WOdsb7W9Rcy6dE/k3EhEZK4UDPrWzZeDrm/vEk8Qzbhk4jB4/E1B8PNUulubey2sYZiQI8Z2d8gdq9WXTkaMtLtJ6be9XXrOhLlirfmNWkvedzMi03SdOW2TTydwXDAdBU9/MEjjUny0bCjFYej+KbD+07zSb2BrTUI5CsG85Eg/ocVrT6nBGYHvFG0ZBGByB7etccoyT94qEl9nWxheNTrlvocj+Ftsd+mJFHBLjIyBnvXl2reLfEn9jpZeMtKmaadzi4ZfLfZxwO2evUV6d4l10w201zIDHZRgHy4n2uy5HFYvhfxVpfi+4+wxadKskD+aGuP3gIH3fxrqoxcVzyhdLr2MaifMtbM6fwHp0eo+AdOfRjJGkbMJI7pvnCgnpjvnvUviC3jmuhLK2yVUCh+uT6Guj8LQiRZ1+WOZOqqMcVyniPw/qdprl3d226bT7hkLREZ2ycDcPTgVzxnzVXrb/gjjLl9yWpk63rE+kRhZ0+7HhCrDePy9au+APEsOo2019qKxwNCpPnSLyq+5/Codd0NLzE06yiQjkYzn6elcb4p0y7Twxe2Fgs0SOF3vt+8AckGulQp1Ycv2mS41Fe2xr+MtN0DxXoE+vWuoO9qXO5nUqWYHHGf5Vy3gDw54b/ALdiMv2ibaRtWcAoT9MUvhrwVdyaNZxXmoSCxbMoh5Khj1OM4zxXoWh+G7Gw/wBTmSXI2nGeBWzmqMHDmb/QI0pTs5IpeNrWIaK1sFkELjYyKflUHjp0ArkvAdrqug68un6as91pTgmTzm+WJ8EhR9eK7jx9fWlh4bkur1JFMMitsiH+s7d68/8AgA2oXWv6uTdXM2lvEzfvWOC4IKtz0I/rWEZ/undXIqe5UTPXGGyVCEaOVeHTG0g+xrD8Sy6TpM/malNFHPId0e4ZkYe1dZdW4vrJr2SV1cYYYHHHbNcD4k03QfF2o2x1HUPs8kCmMSLJtzz71jRs5auy6mzqaaK5r6XLJcQR3lsFaOTlWkB3KM9gDUWvtBrE8VlfarDH5fztbGRVZvTIPNTeDvCkPhu8mFprUtxFcxGNGnkHlhz0IHqK5KTwhpem+LZPEGr6lFJOZfNH2hwYlf6/x4q7rnbg9ttDOU3/ACnQfD/x/pmra3qenpNtt7S28xZZBtVlUgMeew4qHwNrXh7UNbvYfDkRCLMzsGBAcnuPao9Q8OaTP4avU037HZxaiwSWaGJVLjO4bW7gkfd9qv8AhLQdM0GO0bSbQpcBf30x/jPTn2pOMUpNN69P8wg5yd2kbviljC9vKRuQHewXqMHqDXLeL9XEPh2a6iaOG63Fi8nTb2Nb3ia5jgECXcoA3b2cnAC+9YWp6TYawJbWd99ncrt3RnnnByKKKSSbKs5R8yp4Whn1/wAOJNa3RaJojHLOCPvdwPeuZ1rwRcpdBE1ITvglVG75a9I8PeH9P8MaPb6Rp00rWkkzSSySHDMxwMccdAK6TUrGyttKV4BG7K2Q2QT+dXHFunLTr5EJSklc898EWPlWzpeapbm5VgVjJwFx9a6TQLaawuL57qUvpV4Cvy/NtfOBn2rz/wAVW10L17zTLXcEw2FBOD61e8BT+INOvmmvbWaLS5Im228ykK0pX5SAenOOa0q0nKLmmtehMnZ8r3R6tL4YfUdJgfT7nEijLKTw47V5v8RU1rw7pw1HTd8eo2rHDDkbT1+vaq+oeNfE+mRW9knl2twfnco2W25+UH07/nXpXxImaT4VSanMkYu0iST5l4LHgj8c1yqFSjUiqlmpOxNSo4xeuhzPhS+ufG/gizvb64/4mDRmGSVRtPU9K5DUvGPhrwZeSaE1rczy2h2yybBln7knufeul+HWorJ4ZsnjjjtUEo3qgPPqceldZ4q+FHhTxNqp1O9WRLiVF3GJwA3v9f8ACs4zp0ZunVuo62sTWcoWcVcEtYI1mVcbpX3semWxj+lJFlLi3tmf5GyUPX8aWPVbSW8trO6iLEk4kXjaR2Jrl/inqOp6XodvqGhGRozKRcIoxtAH8qmEZSko9z1G7aPQ7V7OXUVuG0jUIjJt8pnUjcPXt69RViKKeLyjIETyztfYvAHbn8a5L4Txq3hWDUBGVlug7uO5bJ/nxXQSXscFt+9E0RYAGF34DHt706kHCbp72Oe/M9A0TTtS07xVPbXi+bpF8jMHQAhX6gk9jUvie2bQIomWctAW2xJIcM3dgPfGTUOn32oRK9uHdY2/vdV9MZrqrK+stc0tLO4lUX0Y+Uygb8juDjv7VnUlKLUmtOv+Y5c9OXM9Uc9ZXKtbG4YBwy9Sevcg003F7HslS33REBhuIziqX2PY8kJl3R7mLMowoxngD6VegFt5wLJdmMxjGcYGabUVqjSS7I1J7qK7s13OqqDkBh0Ht+Nc/e6VHNJ5kZaC6j6OnHFW5PLRmFqMNgHAGSakt5N5kSRsSAAEkHIP+GKmN46xCKcEUIjt2yXEMc0g+RpCSQe2SOxqf7QLezu4ioUyL0CgVSlmtUdvMvLaGYN/qmPzMM9cfjVbVDMxZFC8LlSOhFaW5tzRRUmX9IMhbyoJ/IRj824ZDHk81DcXdraXEp1TUIrezQ/vHXr/AMBHeq2gpJ88U5+aVwME8g+tYHxX0+4i8uwkgd0IMnnR9QoGePetIwUqnI3uZVJKF9Rt94s8LLPKlpqLNHnDpcR9Vxznsa4rxleadq2keZpFoib5VUbYQgwD1/pXOeJvCctlNbTwGSW2uIw4JHOfT6ivXPDHw/nXwrDHIUF4wDeU/wDCp7fXvXo8lLDpVObqcarzno10PJNRtnkto5pI8quVyo4XbxipvCcZS+eTzWjwu4AHvkV61qfgtoLGa3lGJ/Ldw0fIck5wR69q8w8W2C2mn6f9gnR50b98n3WP1reliI1Vyx6icGnzHv8Ao15cvoEb6cRbGVVJbb1OBUOoWJvI4rXUnS4Mp+ZepFcPp3iwSeG7K0hmYXMSqszYIx7D1ruvCqm6lF2QxeNQHc9G9TXj1KbpNyeh0xXu8zOD8bi/8KaTfXXhyFbUQlVMoAeTnqec8Afrirnwhv5NQ8JylrqSaSKU7mY5LE4P9a6DVUS4upkLJIj71AfkHtjFU/h5DH/wj2oxabBFAbSYq6EYPI5+tac6dB3Wt1qE1yTXY4n4v6Pcx6zZa7pxl8xQfMMQyVIxtbA9v5V0HggXuraJbSXwD3sgPzMuMgHqRW/NfSXkbwWUyLcxDmMgEbvesrT7TX7zUJpppQuAEAi4HrVe1cqShK2nUqNoSdupe1Pw4lxA8syxy2sYKtGOowP8aNC8PWGn6er2FnFbbjud1PzO3bOa0Pss9jpj29wCd3zcdM98mtz+0bWK1S7VLZ5PLAZAM/NXPKrNR5U7ol3bT3MCwuJNI1HzSwjZhtAduH9B9anj8bgI8d9aPKrD7yY6fSuN+IuizeK4IEE/kzrOJECDC5xitT7JcSwXUFymFRBHK0S8g+ufWtPZQlFSluOSX2kXbzxno/JmhWCBBw0jDcTn61n614l02x8PT6xGplt84TkBSfSvPdZ+EeoXWpRra3fyXDfJ55wee9b+teFLbQPB8fhjUXubiN5hM0sYA2v7fn0rf2FBW5ZXb6eXUwVRt2SMPwNr2sa14vjnf5tNCkvCCAOnH617DNZi3kgnYiNj1IbI/GuX8OaRpuhQwWsMLRKRv81jyy/XvW2btJzIGBJVs/N3A96jETU53grI1pxbV+pJrtpp+rWA/tKBZkcYwc8EdDis/SLKKziK2kCrCeCqKADj2FXR5bQrIB85OApOFUf5FeWeIPFGu6R41f7XI8NtkfulX5Cn+PvSo0pVLwixSqcu6PQT4st7GIQXjrBa7ipEx25xzjNeY+MtT8OLcmS31ESrJlhHHGWKN6eld/qdtpXi7SDeaYEuHVWfay5KsBkhh/WvKL/URpV/bXFqtuJV+/E0SkDHUEY4row1NXbjdPsZTkux6L4M0fXz4ftb6ddlncq2xJTl41zwce+K5740X2lWdlpcclm0t+q4Vt+1XT+LKjp6A16f4a1iXWvD8WqldkGdv7zpkH5gBXO+IfDWh+JNUS8mjndoyFKhsDGc4xWUKr9q3PS19huEpQstTU8JaXpXiL4dW13Np0tnFGEkjJbIyvHy+3bmqug6lbtK8Vuxcw7gwz0PvnrWtfXUtjpKw3c8dnYIB5cZIUEDoD7VjaPe2VxZX93Dbwq6x/LJF0bJAH61kryUm9r6GkI+zOV+Jty1xZBgxEYkEI/2m71au5pvDngO3kjBFzFggsucKST/APWq74y8LX+q3Gh2FkUWOKESyktgmRuW/IAVY8ZWu/wtcwTAHbAIwx5ww6H9K6Yzjywj0uJXlzSXRGpEg1Tw9YTR3a22YwTI2NsZIz3781x1npGvaF4kuy07XOmTg/vGbI56HB71heGvD174h1+xN3JcLpsVnHkA4RnQ4VSPevaoojEDHLtMuOYn9Pb2rKb9g3B2dxxlzWe1jldQukbS1mEqwvEMMRxuycY96tC1S60+CU3k05fYyHoQNw96qeN47eTQrkW8HlzBhInU4OcmtDwzGtz8PBDahXvmhLqrnHzg561LsoKS7lyqShdNWMyJLFLq/ki8q/aZivnuvzKRx8ta+oapPq2jHR9V+a2IAZNuM46A4rySPxrfWHmNaxRLPbufkdcgt3P51Us/Gvi6+m+1xWsUwMmSGgypPpWs8LUvftsZyqU3pJXOg8H69fL4g1Dw9GFWCFg8TWw4XaRlec8EcGvQrbx9pego1jqt15dwrbwjEnCnkVX8A3MWv2NzbWOmRW2spH5ssqrhd3ue3PavOdb8OXuqanPc3+hzzXO4o8kbMFbBxxUKlTr1JKfu29L3MXU5Vy7s9e8Q6TNLNELOJVK4yc4LDPXPrXUJLCvhz7LPsuLiOMkBwOB6HNYN14Z1sWUF9JdRHYAxiLYLKepqe10priGa5s7uSQZJEbckgds+tcUmpRSvsehJxlFXldIzdL8WWC6umnYitLiIlWt+B8vZ1HoQQaytei1O38d/aZXaWxfMgLEtGEwR06cVpHwhp1z4gi1O/t3jvEiwHDHGPceozWnHp5vbKTRp5VEsikwy54PtVNU04yT1W5rh6/sVOyTTVvk+vqipovivTtcnfTr0/ZNStiRbzFsJOOwz7+lbcMvlXjLNC0M2NpZeciuMufCK6HpZbXbmyjkMmI5HcjHoBxWjcW1xPfW93pt5FcOiKsiRvuRkx3/oRWs4U2/cehyc0E7R2Olu5YYo2McM8jH7vlxlgx96IZJLtYh5Z2gB9jEjb6dP5ViWaz2jzXFiZZbS7ciRoWJG4dQecA/StpBJdRCVAyRn5WYcYHTmueUeUb2vfQ5Xx18RrDwOlso06S7vJhyd20KM884PNafh3xjZ+M9DuL3TbVhqEKHej8ZIGQCfT3pus6bpWq3SWmr6el1t+YSMvC/U/WrfhfRrTw5oepR2FvFEZJN/7vOcemD2xWjVH2Wz5/wM+WfNfoV7Wzgu2gvdS0pBdrHkByDsZgMgHocGkW2SW8aK5LkOD/qhynsBV++tpJtItIbSRWkiJKuOMocY/EVXkhuLTUIp5yNhGxmU9velz3N6fW71KulxNDO0iypLGr915yKzPiz9q1XSof7MZWYPubnBHH51tPG0N8JIm3iRiw9Ca5rxXfQ2iS6k6MyRNh44xyRWtLWpGS3QSpe0d2bWjaVYWnhzS4NQmgmMKiUTOo2oTzgepzXU2Er3CmS302+mjwD5rHZkeozWP4F0+31qe2H2dorOGMTmJzk7nGQD9BXrscSRxhEUBQMAVx4qtaTT1Zwzny6I86vwJ0PkCVJlGfs8wwT/ALpryzxR4VkvL5762jd4JFJZY48lT7j619GX+mwXULCVAzbcZ6Y+leNePNauvCS3skIDvCUJ3D7wNaYKvLmtT3NKc+dOLOW0Lw7a2Vg8sw8vcAcuxKjplunFdJrmvaoumQQ+ErMysi5dwvyYxySKv6rcWHiDwjY6l5ptrVwGeNwAB3Iz/SuetPEn2WOS28M6cbu7ul8tVZjhU9frXW5SqvmkrtPZ7FqSjC5wmo6v4tEcrS2rwxWwEnmCLADMect3ru/gXdprd5qIvFc3briVl+USe5HrUvhvTvFWqWmuWHiYQjT54gIFTH7qRTxwO3rWJ8Cr0aR8QJ9NuHyZd4ORjBA7/lW9RxnRqRildK+hzznLr3NXx34N17wj4qi17w0k9/YXpEd5b8u0XP3vp/Ku6F+YLQeXbmPzF+ZweAcdK5q6+N9rJ44k0K4s0h09LlrU3XmZOQ20NjGMZ963Li1xdSmznE6Bsle4FcM/auMVXjZ237rz9DSjLmfvMdPcZtirZAc55OAc8c+1QvYW0SB14IALDPBP0q3cT24dGuEdXCbdjAfn+tSWRVy0yWzvFHzluefpWV2kdHOlqkUPs7oBOQsbMCVBGcVja34lttC0See6lECTOEYuOrH079qk8X6rfQ29xqEeGjgQkKOB0rz3RLmD4n6Fc2up/uRatg+WOhI+Vs9+/FdNKk5R55bLcKstEurPUvC3iPT/ABNYRvbtveMgJKD+f41PrdvLD5vnqJk4Yu/YCvGfBfmeFfifp+h2Vy82m2ylrgseCDyc4/Cu5+LvxAsvDrQWktrLM96hkVkfhUzjODSnR5aiUNU9TmUlF6qx6Tqmi2Wp+H44sCAxxgqVXnn/ACa4yO2azkKAtK6Lhz2Gen4Vf0e9nuGiDSyfZxAu1uzAgVVu0jjvPMglYxHiQ7uX98dqzgpRvFs1pRkna+jI4phcRwHzFhnCkbHGcj6VmX+m2+oySRX6RO8i5Rn4K/TPerr2EZna5klbcAPLJOBTdTszcQwXZcbB/F7Z6fWtYuz0Zq1Ftop+G/Dtn4Q0id3vZGkuH3PuGAMA8AfQ15z8W5PtGpaNZ6Rpqyz3KCXz0jBaZmbAGcdsfrXoXxJhnj8O2t5cPiBH2kKOSCODVX4fRT2UzanqOWs1hzbLIfmGe49K6Kc2l9Yk7s45xuuSJ0F9Bcx2Vpo0axI9uqGSKHCqp2jPA981Q1LUIvDllNeXoVLaB1LyLzubHAHqa0dOWTFzf3hZDLhtxYDCj1z9afren6F4l8DXGlzX1osrMXUmUZVscH9a5eZRaUtr6m/M4QsjzZdWPxJ02+RQ9sY5Djc2QVwa6jwlpttp2m6Lo1g6XX2tPPuLgMGBwSdox2GK4TSvCeraH4R8SR3DRRBl+zxOHwHdiB1+gNdh8HtDuNDMVpeSI9zBE5wGyF3c4H4ZrprtRi4wfur/ACM4atPyOqMr3XiFLrerQhmjVV4IABxn3NUtYsXvdDPnYQMWLFuOB2q9ok8MepyyuFQPMVG7jOPQVR8Z6nmPAV/KR8fIM5zyTXPG/OoxNI9V0Kng/RpJ/D+9HMEMDM/mMdvAOefYVV0DXf8AhI/EV/eW8h2RRmJSTgZA6j14qzpHiltS0K8s7JC9m6m38vGG5GKWbwpF4d8FWkNsDFf3offJIMEFh09ulat6yVTRt2X6kOE3Y5dNc1zU/iBbaWkMLacXEZVWDApnnJ9a7fxBax+F/MmkkEcSnKqvQg8ACvC9a8FeILW9S7tppJFVgVkjOMH8Ohr0DQLi/wDEtjJp3ihD5iACObo+c9xW1airqUbci3t+ZVOpJNqW5W0/w3YahfT69CI5dOOS9v6MeuataF4ssF1RNM06wihtFlDBsY+b6VrzeG5dD0y5gs5zLBOUZ0BxweD+PNZa+HbLQLy2uL1jtLhWf+EMRuGT2pOUaifM79hXimmkejabDaaPp+o3WkIYL25G6Uv0z2/DmvKm+Kd/4fnn0y7xJJbyFdzDqK9N03WLDUNPWVJo3RsKxH+FYfiT4d2Gs6mb2a3ErSIuHQkAjtXJRlSu1iEZypuLvH8TT1/xPKni7TdMvIlbTlsd5lGVwSpGPRvSrGhX2o6PYGW2Md9bTz7YFVNrQKR90+pyetc3e+BNQ13xJcXN5dSLpsS7wVJyVGflFb+mX9t4LsbmOZZpohtmJY7vLOOn8qHGmoKMdX1Xz/M6XFL3VqacNlcQ3rTs7yAfwlhkg9c1c8QWqi7tZYCYcgNxzsPtTrTWLa9gfUbY/ahLGGSBF+4e+SPwrPvb+S8fJVkdONpWsUpOWq2NIczldlPxNo9xq3hufSr6YTrvM0dzu3Ordfy9q8o8Pwat4Y1wwpLhdpxJnIdc9P06V7dYvGAy3OEwAfWkl0q2W5W5s7aO5mJDLvIAB9BXRCvKnFw6Mul7CnNOpG6+45TUJ9W8KWCzWltC1pfIDJuB+XqcgZ9+tdR4Sur680IXSLswcPHxg1h/EKa58Safa2sNtNFd2shDwNgbhjqK0vCj6pHplpaNJ5UdqgMilMFh6EmuZ80k3Jam9VUo4KEo25nJ3XW3Qty6lam7WxnkjhuWHmhOnmew96t3UY0+ZryyiNzbOgPXPHeueEVrqOsI15AFmibKjPKHPUH9cVY8c+NbbwVZ6QJYJJ7e4QrIy9sHBPpn2quRuUYwV2+hwTfKaTSWaXFvcWl4qFmOIpOMeqj8a0JL/TlsFknwlyjfNGTjPXoPpXNayljrXh+11TSir2syh1ZDwff2PY1XvtZ06bT4WuN1vfQoE2lc+Zj0NL2fMluXGHOk1sXbz7KrNPp8/mW7NlkU/cb29qwtUiFxBcpuBjkPzDHOK7rw9aW8ti0YCfvwJUdBnIPrXM+KdJuNI1Ha/wA8cmWQ9vcVVOa5+Xqb0qkZPke5u/C69tRqGoJG5BkEbAN7KB/MV6fE5bqMEfqK8ANvcWV3DqWlP5ZI5XHfuprvdH8b3N1bKksMEE4HJlk2gj1HFc+JoOT54nFiMO0+aOx397cRWttJLMwVFBJJryPW7KLXdUma/ty9vdAEx45C9F/TB/Gt++1U3CgSSfa5M5Cr9wH1PrWfZ+YNRV52y7H5mI6ZpUIOneXUVGk43bMSDwtZ2eg3On3d5LcW+4FFyAQeP8KydW8MHSbKO+8PXskV/wCakaKzAgKew4711l/NEkUl1JII1TKb34BPPrUNw51bwrcR6Xf2i3Ij/wCPhWDkHHAwOhrrjWmndvd69gnTUYnnfj3xTqErjw9pcq8sqzyx5zgjkA/Wux8KaRo3hvTAYoPtN8+DJM2Sd3pn0rlNBtNN8OQC91iZpdSd8YC7iB65rtNPuLbVrQSacW8gNkgcE9+9b1mowVOC93q+7KjTjP3pHGeIPAGl6nrjXd0W01Gcs5ji3CTP8j6Gu6TCaekGmwzMEGwTkYyPcnvxXNn4kxvezJD5M4iYoYXw2Wzjj8qr+JfiJCTLBBaXDTIuPLQ5Xdx0/wD1USjiKijCS2JShGV9jRura8u54BPOXyxQAckVswx3Fhb3OySVCRjaw+8PeuM8Dw6/q2ux6nqEP2PSoI2VY3OCSehx369a7PVL6aeTyEGYVPJznJqKsXFqGnmbKSn8Oxh3yvfRT2d2u8Soepx1GK8+v9Stfh89j4c0e3eXUb1hLLLIclAxwowPXGa767stXutPubvRoVa6jxFGZVJDEn09KueD/hzfi9XV/Hl5Bc3jHbHEsIyo/wB7rVqcYRfO9O3VsyrTSkuXc8k1CxvdAiVJsTazrUpEkiHJQZ4H617FeeEtHufDWljxFYx311Zxja8uQQTyRx2zWtqlnpp8UaUtnBDMI2ZySu45479sU34iai1loeo3kAgc2sRl8qRsb8dQKzq4l1ORR0e/6L00JjGMvj2Ob1Y3L3dpd6dG0BgXaUU/Ka3Yns9XtIgW+z3rgho8cbh6VleG9Rj1zw9a6nH5axToWK7hlSOCKzWlu49bjitIEFtDKCspfJfjnaPahpy916OJ1clO14M6cQA6LfxT/u5ouTnj5c579qynn+yaQIpGWWGRlZT1BB54rXEcWoJJBeOWScGJjnGQe1Z3iCCOxaPT0jWOOGPaFJznHfNRF62ZCfvWfU39CuLHXNHcXMaSJB8jxyDgY5HFc7Jb/bJWFwht4Ef5sdABngfgBVS1vRomhGe23FryQLL8pxFj1/PiruoSlNWW1aYTRMiu74xg47j6UKDjJ22/q5mopSdjy/4r61dajqiafYMRbKih1UEbj2z9BXK6n4L1htdsZdKjeZMRtvU/cYYz/jXt91BoFvcyXl8Yba7lQqrzsADjuAazPBaarHq0wnvLW8sZMtG8IBwOwyK76eIUKdoLbv1IlHmbNrWLOC98GjTtYJjQhXlkTG/d6iuU8F6bcaZqsUt5evOZLeSK338YwO/rxXa6qRPJFE7ECQ7CemCelea6zqjQ+KLfQJFlt2tpFEd23QFvb0Ocda56HNKDguuo5xtK5zVlrN1J4tSK7mYQyXoYtnO07uo9OK9I8QanFL4ltvCNjC89xPG0sj/88/lyPwrye9sTp+r2qrkyRT8tjr83evQxb34+LV3r0X7otbqisDweFU4/KuvEQjdSXZ/fpYyhzNWXcqfD2G60jxbc28xMMGAXLnhWXv8AWmeL/E2var8Qgmjot1bK3lrA+TGfVj6Gu3NxZR3Esl1Fb+bNLudsDOT0ri5fFL2XxRl0ddOQ6ddqEEqrhuRneD6Z61gqinN1HG7sXOHI1qegT2Mf7qVZzBP5Y8wLyqyAdPpVS5s5ikDTQYuB83mRgDr6+tOntp7e8Vo4jNauB14GD61ZmkZ0NmZDGeNjsehz/KuZNq1mdJNbaiswSC6U7dpVyn3lNc/qV9YtdXWg6ozGK5QBJH53H+Eg9jVi6eW21SRQI9oIG9WzntzUPjjw/wD29p9rc2ziK8VdyFe5xnH6U4KKkruyf4MznFWulocR4S0bVdA8QXdnPHIbU5yxHy8dCDXdxeIJLdBCkoVU+UKSePal0dLu60iBNTkxcpGMt6sOozU50aRjueJju5BEecjtV1akakm57iUXFWY3w54iN9YatFp/2wW1rdCLz5TkN0yF/n+Ndt4msm1TwVcGdYkZk+bjg46EnvWBoccVq9rZR4a3EpZwVA6kdfU8Vo+LLuXzLWEuV0+RPMRVGNxziuapaU1yotQd0uurOR0KeTwb4DZSWW8llbZ5a7mOckcHoK4m98beI4WRb1nBkUeWGQA7T/EeK73xJpeqXNn5unpHIUOTJIwCcdFHvXFaBqt7P4ssrHxLLH5ELAxw7AwOOQCwr0MPy1HKpJJvd9x1FyxtB6nVeDPEMF7Fc2uoebDdwrwzjiVT3A9q63RtXsobm3tXuYzdFfMEROGUeuPSvPPiVpuo+ItdB023R7OFcrPGdvkAYzk5qr4G0CFbi8k1O+nmvpAI/OkkOGX8s+lRKlCpB1L28txRUr8jPdLzRbLXYVmguTBdZDeYjc+wqlp9tKdSks9SDSYBxKjY3e+K8dM9z4Zv/tVlcXMsMzkLEXyQw4PT+ddHH4i0u903+0tM1Se3uwRHPDInzqSRyAeoB9K5ZYWaWjuvTYzkuR8rZ2t9oFxphndE86F33ggZK1zfivT7fWdGe0uIhOikSrG3r3H411vg3xG+p2ctuZfOuLdQXJXBINUde1jR7O5ij1W1ktvN53AgfyrGLqRnZrVFU6t9JamT4LtdMHhG/wBP0aOaOCxcsYpR8wLc45PPSojZ299AI7u3Dxn54n3Y8s5+b6iuh8LP4dvDMNJuWMpb54zIckjpkd6oyCGMz20gzGu4kehzVuo3NvW++u5VJqzjEy7m4utHmiWz3LEuNmGyCa6u51S11nShDqERaUhQHVeVb+hFcl5SXPkQbXEJyrLu+62eDn0xitm3t4i0fkriNEKMW6Pjt9aJqLs3uXOKdu6KOoW0unzC2vAEgY/LIOQ3oarm0RpFEBR8jr61f1i5TyltpoXdY23Kz/wHuPcVkr5U4LWzGLgZwDtP0qo3tc2pSbjqallK0P30Jxx6EVzHxC8Wy6QI7e02JczDcC5xge3vW/CLyzl2vmQMOB1yPard+YL+COK90+3lC4I8+IHB9c0QcYzUpK6JqxdvdPMtF0TxF4gWG51a9khs2PyqT82PYGu10vw1YaOWVBLLPKNpkaTBA+nrWgLma8meBYQZs/dGPu+ua0Dp+yURTYUbQ7DPOe2PyrWriJS02XZGShGGj3K0PhnSrswtcRPMxB+8fu4+lZmswG20rV2s4liW0tnfy4yQVIB5rjPFfi3xRonje2XTropYqgCwkZjbjJyK9I0u8W4hfVmBMV9GVlhPI5zkVM6dSnFTk7p7GKm3KUY7nz58I9LOseKJHu1c2cS75H5GGzxz617pq2maT4ctxrUTJDIU8tpH+YsemOfXHauh0KDSra1aCws4YYpPmkAUAMQMCuT+JOhx6x4fljt5mV7YmSFGzg4yf6mtauK+sVlvGO3yMYRa3Wpq21/ca9pEs1hNbyIFyGTpkdjVjS0UMBdyJGxTJLcc47V4z8J21aPx1ajYUtJUYyITgMuDzj+te163bo/z8qXbO30NZ4miqE/Zp6M2pSc04o2NJjjjj01PMATYZWIPUjv+tVPE10HtwRcOjADa27v61UttQzpNtBJb7vszsu8DJA57VWkudPkuDbyzou9dyZ4z6iuVRfNdkKm4yuzP8PfbLbxK11cSLOhjYMwGMGqnxTs31jwpqMelRGW8lCqqA8kEjJH4VpKllBDHc210JzNjYDkBV9eetOuZghTcQVboccCtub31NLb9DqjDnT1tcxPDGit4e8KWdk0sbSom0qvOCeSc/WrIWE3cJdtqqCAah8Q6g2nWSyGAuzNgDIA/E1zv/CaaFDfW637FpZWCCGP+AnjLH9fwrVRqVW52vcuMqdKLTexp+KtdHh7TvtJG+MPtVfVhWb4Z8bS+OGltWslF4q4znqvqDXWa9Z2Go+H47WZhKGkMijjOPUenek8PaFYadN51rbKk2zZlfSmpUlTba97oYc0pPmS0M+XRL61t3nuJEW1AAkJbKr9amsNa8Km5itk1aL+052JkZwcf8CPQVpTmG8nlsGY75IiT1KnnofwryrxJ8NZ1uX1Czv7ZIBz5jOcBe/FOko1dKkrdiKs29jc+MlrZ/Y4ZHuR9rA8qJRjaRnJOa5Dw/oOuGyjvtISYMpyZIZMKao+OII30SwS2zeKu7dIu4BGwOBnn3r0H4L+K9KsfC8mmyti9Rt375vlJPAAPauz36OH933tTG95FbxYmsf8ACB7Z7hYdYjGXkR88AnuP4iMdKyvhwL7U4vDra48twj3MrySS8vsjXIGeuMg16alouq300E6RMr/wjkEdatXFjZxXkaW1shEMZijjQYCkjkgfSuL26UXG2uptKnd6voebfEQ2d3450mCztREZ5ozO2SN25gPw4rr9QESC5FtEyny2jRV6oxGMk0x/C9u2uDWLy4JeIACIjGGAwDV20T7bd3QJ+QIWZ84zinOpFxil0Q4KzZ4dqHhLxFLKHeKYLngeZn8etek+EbG50zSZW1QLLdJnyywDPGoHTPvXR2uu2F+32BJUkKtgFB0I569+lRxXtjcOYZPPS5QHYroAHGecMOp9q1q4idRcso2HCKWrOQ0n4mSSeMbfSI7KaO2lHzPONp49BXe61cxX00flRR+YpDJk7ScVyWveEbTWLy1vJt0b2blkkRsF+eh9q1A4MiRoA2Fyz9hXKqaUuZFxV3qL4j1uKw0pXuYJC7SBfLQDI6d+/WugW1lW1heQCJPLBG5ucn1rk9S1rTLMWWnXhSWdpBOQy524I2nPua6ubVLi605Z5o9ssj7F442nvSqRaSshJTb8jGuZLi0RZE3bQW7dM5Brzi48WeKtDuJbOC8Bg3l4/N+YhSeACe1eryXsctqlpcxlSjY8wck+9ZUqSWrmJbWC5Qcq7IrcenPT6VrSnFXU4pk1qc38Dsy54N8+WawS4ULNcIjsS24Y29au6nqcOqxQR20jyvYzSW7zMm0Pg8kA9RwazfDsEHhaWx/tO93GFG3M5A3Nj7orlNT12VNXa7WQLZPdAbFGRtY88UciqVW47dPvNY3i1OXRHo95NGliUY74N28Rk4BOCMj865y00aztNRbUCc5XMiyRgEMBjKk9sV0enBZtN+wvHGZhh1Y8gjOaxPHV7Dp9qkl7DIcrhdmc5+n+etZ021LlXUbSejM/wfdQ3EWtaXDcSPcW5aZd/AkQngc1zemG/bVtlxbSJZSOAJWyMN6e9Ov/ABZ4fePS7jT4/M1GPEVxGilQy5Bwf1/OvWJta0rWrOC02bcRmRAijPpyK65ylS97l3/Tqc6ly6J6DxpFpcurXNmqR7N6EDB3d/m+lJ9m8O31jPHJo8aRW65eYJ8x/HqfxqOaJbHUFZr+RLZAhXByM9+PfNVLLWkh8e3GlWkTS28kZ8xn4DZ6ACuC0pfC9tSnGNncv6PfWGmu6adY+VExBZ2k+YgD071u65pmkeIdAledBOyKQpI5VuvA9a5rXNFaGSW4jZlgIyFzzGenFN0u5utOZV2F4JTkruzk4qJR5vfi9RujGSTgeYWHhnVtN1m/1DS7kpCoyVLkOnUZHrzmvQ9OiMGh2N3fXaSX1zuDLnkjPBz+ArUZIp7A3mmWhgEbYmjxwO9VpTZ3NzbXEsbR28WAyDoT610VK7qJc3T7zSO91sZmoTyLqNvFBCxhkYq8obHljHX3GQK1bLcl+pmMhVAAI88E+vvVPU7YrryxkExjIZem4kZ4p08MtjMYjyNokjZW5I9KjRpIu19nuaWt2H26EQvIF3HJPQ89aSz04Q2v2W12Mq8s5HA9yTTkH2rbMXJULk9uQB+tYuryXWqatp+g6VIsU0x3zNuwwTPzMPw4FTFOXupmNSo6UfQ17m50rTwE1DVVdxzsUgAH0BJFJaajpV2riHUUKnjY7A/kc1xHxd0DQ9BuLGG0d1vJTmQtIzs69ycn1rt/Aeom/sdP0w+GPstm6MGcgFNo/iJ9TVypJUVVi27+iON4ud7FdJxYayqwFVBwN+Acg1ynjXX9V03xg0oYm3jSMRxsOJcnnBHvXW3FvCb+/wBJtpUklgKzQYOcD0P5Ut9aI1nBqoSK4g/jSQAmF/bPainOMJJyV9PzOvm9slKLsyrpttBrUsT3FnG5crJ84+734PauqvLeK2UJHHlGP3SOmetZuiXdvLGZpGWJiCFOPQ9K3pJZDFK0wVcINuDnJNc9STvboOelTVHO6mE0u1ku5BiCMZ4PI+ledp40ub/xTYJBbyHTXzDJCo3Fst39a7Hx6klv4UvrmRmkhVCvlr1DHgE+wNcP8IoPtWsiWOFykcJVmYfKr5GdtduHhH2UqklexNWab5Uz0Ox0PSdJ1O8uNLjkjkfgEjJHqAfSr5PmMFl5BPU9RVg2iWlzvZy8YbDEe/Y1XupraQu0SFtvCsBj2rjcnN3buVTajokVJHe2MkUQ3K3JPes02gzuYE+YDxjp2rf0eWJb/fJtEW053DJxXNeOPEMWm21zcsPLihjxn1bsB9aqF3LlRtGpZvTTuPitDujCIxiU+VApHetz+xBbhpbqUAxx7iP4QT9a5f4R3Vzd6PY3erytKXllmiLnHU4H4dcCuu8RTmWXdcBNgwAqH+f41VZShU9n2MfbyqWS0KEOmWs2nS3F8ykSZDCTpt9K8xtfhxZnxMb6fFxbRyGZYUXJc54Un0Fel3MTtaB2G5tuRkZUj0+tQWUMmnaZlXYT8nI5wD2rSlWnTTcXuDpqXxanK/Ee6n0fT7G8iZVVpgjqF+7wTWJqXxFih8PFLOZV1TC+VgdQepHvik+KxlPh4B5GOJFdgTjPXBrD03wANd8GWutaer/btwjKHoVGea7aMKXsoup3M6rlFtF7wR4guLrw34xuL1pUuV0+RorgEkqx4wB+Nct4W1fUB8PpLa4kk8ia7Eas+SSACSB+Yrc8PRX3hWGXT9XtG8nUAFVx8wBBOAT9TXqFlpelyaVpiPbRuIQZB0BRz1p1ZQpScrXTat8kc0VKT0MDR9DW50E2F7GtsiqJjI3diO34YzXD3nh2S2vdyQssYPysq4EmDXp95M8nmJCGlit2GFYVm3Uc91biedWZIweAp+UAdsVnTryi2+52qkuXmkdB4B8w3G852pbhGzz81aNx9otLh5ocA5J+bkis74b38cXhKaTUY5IppJ2MeR8xUcA/zqxe3xecrExY/eA74rimn7RoqLdRtpaEl3OklhNLKVaR3woP5c1wPjg6qumf2dokVyXuVPnyIDyM8LnsK6xxL9lUAbCWIHAyxzknNULpZZWkjV229uf0rai1CV9wdJyVrmB8P/C6+H7Y63rFwr+Sn+px8gyOpPc1r2Gq2+sK9wimK2kZjG4H3WHp+lYvxTv5LPw79giaT7TPtLHIwoHJH8q1/hrpFyPCNgTsGVMzedjBye3HpW1S7h7ab1bt8jGL5Jcpjaj4r/4R8mPVYmmSTIiaNuv4VseEtQj1O1SZbSRo5jtDONu0DrV3VNC066uIJ7iwgnETFlUsc9fWt1jHNFI9u0e9cZVflKnFZ1JwcVyrU05p3u9jyqWz0LWPHOwtem4+0lSbdQYiq9sk57de1bXir4n2mmeJk0BdPlkiQBfPR8tubnGMcgVraX4es9NuJntkEM9yPndj9wE8gc1hXKxp4nEtrHHLMSfnKhiqjvVz5Ksu6S0Moxktb9Ts5LW5YpGw2PON0ZK+i5/pXOWuo6OTOmo6iYriKVo2VQMcfjVHU/Hl/wD2tpWl2VuJLyWcKcLnCHg/oazPiDdLp3im7ttP0CCSJDzIyHLt3NKjQk3yS0bV+hnOuyTUfB2r67dRSXty4gUg7nk3Yz1xXoPh/R9E0mG4kmjaaGIeWPPXczMPQfXvVvwnHNqEbRYL5wxSQ9s4NX9bNlbTXYgxLclBGyA8IB6e9Y1K8pfuunkdsorm5ER2+1xGybBJIcjC/c9BXJfEO/htYUhvYHa6Y7mKNksvY/pW7o6XBlUI7KQM4I6j2qTxf4XGt3trPaTZuIowJADyE7mlDljUXNsVU/d7Hg/h+4h0+/N5q+jSS4kBR4hjHOR+NexeE9Wi1qKS8sYpISjfdlXBx0/HvSadpMOm6bJG0skkcLecgl6FMdAPWuP1/wAeWF5fafYWsZ07bNl3Qggr2DAe9d9SX1mXLBfP/gGULx1l1Ox8YRXl3pcuwkFCGBXgMKy/h9q8Ot6nqVs0rfarRwFkb7zoD8vPtXSeKPEFjY2lmXkDpqECkAKMbuma5v4fw20vifUrfR7LE/yi6nY4ypOeB26VzU9aUuZen3q5tO7SmtD0Sa4k+1K90xdmG3aOpX37VR163jgFo6O8tnkDk8qw65xWzcmKK4KAMdo3YOMKazbu1nvNNmjAk8lySCnQkc/0rii9UzODs0yt4ct7zRNQsYoL37TpkmWnkf5jJu7e2K1r7S4Yr6QW0yiKQ5G7nGe1c1ZyrNp+zBjZGI3Z7+h96uWepxNNCQ8jXluMbX+6w96ucZOVxum4+9EZr0t9pm9Svn+VzjPzAex71S8XLfavHo76G6bs/wCkK7DcvAIB9vpXYWeoWWqyPY3cBjMqkpJjgDsM+1cvPp7WOrLKwB8tyrvG3BHviinOzV1qvxJS5/Jo1bO1b+yzIXQNG219nGcjvXlXirVb+x8TR32nXBtrhIvkZerAlgRXollbajeX14Le7CadI6Y7OhHU89R/jXK6/YW9y1zFJHI1xHlo3I2scnt/h710YaUYVLy1uY4iMpxaW6OQ0/w7r3jW+mu4Yzcv96RmYDPsD617xc6NcaJ4LjGhC6hu4YtkcMcgYMx7nPUA1yXg/wAZ+HfDdlZadZQyT3khC3IC7GBJ6nPpnmrWoeIrCDWdQvbO9lmhx5cFkrsVaQADcF6VWKnVqyUFG0VtpuebFW33OO8AXk9v4xljmHmXRAE0nUcnn9a9G0q+gsNQvtL1Nf8ARLhzuBH3WB61wegL/Yes2R1Xet7qNwGYouNgzx/OvQvGdnBPMZYCqzEBwcYIPTB+orPFtSqLTRr8j0MKlZwfU5+5Nva6oI7aYy2olWRUUckZ611JvJBdPvzhzu3MpHTtjvXk17o3i2DVbe70eymuIBhJsMCrfTmvR5bi5ktEtbhWSYHOWbkccioq00lF3TOhT9pp1W5r31qktsqh2Rp0w+QCjA+oNN0dLLQ4XitLEDcBll/i/wAKgsFkkiSKdztT5V56VYvXLBI7djtYFMDqe2a5ne3L0MXHWzKs7BpdtuzbGJJQjdg+lUNSuxY2rz3rCNR90d2PoBWpGGt3iJB/djkYxiuZ8TtpYtBf+Ir9bSwifC7udzHnAHU9K0prmkkbcygr9B+jatBel0gilKKAXb+7XA+NNPuvEvj7T9GtC506FfPlLA4HUszHuccV6ZpttpkWmWrae5mtLtRNDKARvH0PevJrfxvd6L4+uSDIYHlKS27/ADDGeefyrtw0W5ylSWqXU5q1XnWux6/aGLCQ20MbKMRxiPgKAO35VW1qGa4YhXc46v06Vr6uloml2+oW0fkJKq7tpwB3yPfrXK+G/Fdv4gs75baAxm3kCGRpAcqcgN+lcUeaSc0tjSna6aJ7LVZLeFrVtkkYOEI5K1FqF6zhIg43BecjGfSuJ0HUNQ1v4iy2WnN5NtAXDMBkFVB6/jXoN/DZpFbyOHF621RkZOPet50/ZyV92rmzqQ57RRzep6APE9nLp95Ktujr5iPnJ46fz6V0f9n2fh7RdL02yud0NvGFkYYCycdT+PNRWMcq6rp4kIWFZCpGOoJz1qrrexNRntYrkAIGcwgf6xenJ9s0nJytC+m5E0p1bs0J59mn7YIIiVJID9++RWRYM3lyedGFycrxxWVoMWqQ3Mq3scoskOIt3G5R3/KugutW8sLIyLIQu1cjG0VTjy+6tQhTT2RU+2Qb5dqspPYE4NOhuJGEkWJFTbg7eg962JLdDpsWoLHHLHIMkKu0mqtnI008jPbqIjj5QRyKz5k0bxlpohILaSdIcyg45CjnFV0uhZXTs8KySYIBbkD8K1WhhguUEbmO2ZSzMR0x6V514q1kWd9DBCJN5II3HjJOKqlB1HZC9orNy2OpF7cXkiI0SO6nKKgwFHrUlzcSK0YZE3oMsn3sfXFY/inxOvhfw7YQx2cYvbpsy3DrhcDqPepINU0u5tI7u8uoYY5EEjfvAAvsPWq9m0lK2hMa0G7JWscv8SUur68s4I4yzEABQvXJ6CvRtNjuf7Nt4JZGhNvAsYjwBjAA/pTUjiu4IHhtTkANDcN8xGfSlkuEgicXFxCH2M77zyfrTqVOeCglsZLdvYwvFeqX+maZPdae0Us0a5PcEZwah8I+JtL1+BIVuRDqjZVraVSMN/snoaZpupabql1LFDJuVVOWK4Qc4/rXH+K/CNzpMiappkpZfMz5kfy+Xj39a3hShJezlpLp/kKpJrWLujrfGt3H4asFvQwuJX4ih3FgrfxbvTFQ+AZZdU0eK9uYAJ7iRsFOAVBI/wAa0NMl03XtL3a4fK/dqCXAYzHbhnA7c1pabBb6PY21tp729zbwbvKw27hjnp+NZSmlDkt7xPvXvfQnS2trS++0+TGtzkKsq9fcZrzvx1q81l4hmhglYqACTk9cnNbnjLW59L0+1kTbJPPdiNUAGAvUnFZuv+HItW1N7trnyi6r8u32rXDJQmp1NmiJJvY9kkFh4f8AEd07TLE033QxyMHsBXP3c5vtZddJjEreZvZlHWs640u48Va4ZUuNyKBvc/Lj2H/1q9As7KPRdPa30yGVrjb808g6+pFec7U0m3eR1cypW1vIzrOyuoC9xc7UlYEBR/DUWnRvZtLemU7wQjptzlfr+NQQ6hLPOUuWBHzKWHcg/wCFVdS33WnS4ZiY3xwcbumKaT2fUrlb0fUl8X6PHr8R06FRZtIqsZQ5K7e4/KqOi+BPC2kxxW0GnebKp3G4kO7c3rzWxo5u5dORriLAX5Nx+8yjgVrWwkmiRZCu2LgGq9pOnHkT0M2ls+h5N8VbayeGBHRjfQcQtEcBRnvXXfBjSktdIvdRuiFurtwNzfewBx/MmrutQafd6k6zwb1CgKzdz61PMh0sQwGP92PujPByP/r1pKs5UVSXUuceeKitC5YIbrVZHkUyYyCoyAPc1Z1nWIba2W3tAqwbCQY+SGyQfw965DUPG2n6DqcdhcGU3F0m0Og+VTkAZrlvF2r+IYNatdO8MmIyzwlpJXXKBc4A9KzjhpVJK6sul9iXFN3fQ2NJIj1S5ljXzILgDzGwSAwzg8/U1fu7aZr+6SKLBRAwlxxjjNSaNYX8+npYsYpb9owbmSLIUt7V1erxG10u0sIk87UdvzRA8kY6k9qdSpaWn9eZp7ZQa8yO1sUOhIHPmybCVul6KT0FY8rSLaJ5siPGFIY92kIOM1ct9N8UWOnvCkMYgOTsDg9Rzisu6RVhS1KOGB3uHO3BxyD9Oayhq3rczpyTbs7kuj2l1JdIRKqO5G5VPAHfJqDU7O4vZJUtJYJII3CyuzcgZwKhuPE1pFp91bWCfvI0LuQx5A7fiRWlot9FFpU9wbUJ5yDMbjr+foTWtpL3rF88rt9SHTtItkcrdQx3WOpCjcPbmtpo9H0+BZbXS2Zj9xsAA/jWFOkkca3VtGYXjAkbb0Kk8kVMdTJt0kSbaWOflH58UpJy6mcqEZS5rHD+I49Yl8fWF+jxhGdWjx0jAPI/LP516frbfaoFulVVkuIdw7g4HFYvk3upLJ9l8tWYEMXGCQB39KSO5MmjQWqptktgYtqnhRnqDV1Jc6irfDoEaKUuZEuka2tuYrb5hIHy2PU/XtWssS6hqd6kcS4GBGN2M54PNclpWkzXswkUiMPkbmPU9q6SyhmtbN3lAwWMcbZ+6R71nOMU9Nx1FFSvB6ljWNQi0uBLXyf3o4yvtWctyfsc8rgQRyDAcnkHNLfwzSiCaVlaJn2lscr7k1ZfRXtrk2d0Ge0nw0bgj5SBUrlS1Juo27kNrftLapHMdzRjaXGfmFMS0W4mkt9Rigu7EJvaGWMPyO4B+tPeJ7FI3aRXtwxBYcn8auM0QtpJF3+fINoZeiihu2qHJqStbc4rxZrviG31fSk0vS0exWTa20ABEHGOOnHP4Vq6X4K8PXOoXEjec16ckOxzsJOcgdPzrQmgMsCQopknP3+eQKr6fdrZ30ltchlkQDDjqR71rzvktDR+XUzdJNOxgR3Go2ttqeg6veRu9lK6wzyceYhXKnHrXM/A/SppoNfvGQPaLH5Aw3V85z+H9a7fxdaWHiC+WdlZJFhETNn69R/Wk8Opa6H4bu7DSiDnLD3J+8zGtfa/upJbyt/wSfZSUY26HG/DS1vtL1jWNQuLaRWlO2MsMKVJJJHr0FT678R7C41kadcGVAkg8xhgDI6gGuqljvJtJnuLa8jFqkRjBPCjjOSfTmvKrT4fXGtzfbIXj+zRgM04wwcd2AHX61tB0603Oq7bBKVvgWp7PJbI0EvkyHy4iDEcZ3AjOaoGwtryO51R963qR+Wm5yMr7jp1qxoml7NPitXuGxBHlXbngD/9VZusTySWpt4flZWOXwTuB6DNccd7Jmr6dx1xLPNabX4aFSDk5zj+Gs+1ubT7X9jvJfKZ+Ii/3Se4/WtaZD9mt1cmOORQC/c8AE1Q1Hw7batYND9peO4ckxynopHSri4/a0RvzWjodhYxzPpsNtgGFg/B6gAdfaqTyR2MhWD94v3Wrhfh94s1Ww1m40TWC8yxByr43EFR0yOxxS+G/Gt3q8tyfsUBnEgMSrnaQOuTQ8NUUpdV/mcqld27noniGH9xbRhcusYdge+e1eWaZrFnf+KIZdR05Giik8pXJOQc8Ejoea743l1HcTPOUe4nAUkfd5HQd64u/wDDsthqxhiQzLN+/WRDxFgkkGqw6jFOMt/6uNppJHR+NNCsvE+nGGXAWNvlwclT7VxOkfCm0W9MeoXV1cQrysUC/puJ4r13R9M3iC5uI/mlJ2RHp06/rWsxW0uGSVFL4GFiXgA1lHGTpLkgzKfI3ZHlWr2Pj7VVSx0SwbTLG3HlxiSQbiAOCW78Vl6d4B1nw9dy694wkFxbW8ZUxW5MhfcCCD04r1q51QRiMCJuuAN3JNaSTwfZEhyy3EgG4ckpn1oWMnFcqikn23+8xlGS1ueFac3hG7eW30R7iy1KbMv75iwXH8A9icV2WqaOsvhSz0yaGWeW5fLMxxhl6Vf8T+B9NmvYL7T7SEXEb+axRcBiBjBxxXJ6V8Q7S1trrUNR3QXdk6pJbjPJzjgV0ubrJTpXdu+9+hdOzVmJq+p6XoFnBNdq8MQZYW2ruwemT7DFdCZobw2b2bR7btgN8YAVuOD7cZqn9s0jx5pN1rOkgSbD+/gK/Mv1B61k6tfapYxWf9m2ENxasQojjB3DHf2rO3PZLR9bnTzcyuTavpcR8RwzOMwwK+1W7yHjP5VZQSSRIwaJQV4yOSPWrr3RusQXbqkrIrqW/iPofcUg+0wfu9kbKv3dy5wKXO7K4OHMvd3L3hqJljLyCSCJJd29VyEYf0ru7XUbm6uHtRIsqtD8pz1I759+K861P+07bQIgkjzW0iFbiVVz5cgOCrAdOg/Oui+GENxJZzXUkUq3EKMEL8qRjgCsK0VJOb6Dqcs4e0K/2JxZZjjkcxMZZH7A5IIq48UUelyZIBaUEZ7ggVQs7qW3mu1v5CRIhBjUnAbOcmrU9j9ntLb7QxP2knYAeCuM5o1vqWtNJBY3ksFv5R83yJckZOeM9B6Cr1o0q7Rh/LkXKktms2ONdQtWtyEKR/vUJYjYV47dj6e1P8y48uPlV8kDnPG3NOSuC6qxavo4Y4/tDlZGiA+UetNvL8augnjjy8WFI/u+tZ91qECXj2So0kjLvZ14C1hfDzXE/tPVNHuA/nRTOwdh8rqScA89acabcXLtr8i2mlcseO/CFhqWs6ZqT5CGP5kTnnH860L2GPRNI8iJx9oCjnOWA9/8K0o41a+WIqYo1IYsTlRn0rJ8R+X5epJECfLKyGWQYLZIGB/OqU5SUYSeiCkkmkbnw1/dz3dzKXZzECzN0HfFW/hdGdSa/wBcuJHle5mdYyxzhA2Bj8q53R9Ze21FtOjhdhNY+cGUYVSF5yfWuj+Cl5HL4PhtDtW5tmaOVO4OSc/iKxrxajKfe33a/wCRy4lu8mtmehkZGK4T4kaQJbdLq2AWYZViOMg13WRXGePrj7R9nsI3QCVhvyegzXFRbU1YwotqaaPGNP0rUNI8Zm6nhJsZmUiXGUcbRwB7EGu/vIG80yEnyJSP3ZP3h6D+dZ+t6ta315Pa2GJHgARNp5BA5OPStGbVIo9EspZApvGHlhBz8w6n8q9Sc5z5W1rsd8bqz7k2ozBXin01lEKJiRTzkcZGPSso5nmZhE0e4HChe/qM/wA6bp7s+2d5CUlYjYOhHfirWp3A0iZdsYkhY4Vm/wCWYP8AOpS5XZbmsVb3VqTzN9hs4mhdm85cyEdRngCnpak6WzqiiWUFF55Jx1qd2hu7FYomHlblDHPJI74qLU3kuLeDbIQCMICMDg4I/HFRcx1JdCtGtLdbe5kAIUkyKw9f/r1PDaLOUH29Gt92XTfuyfUeleW/Bme41Hxl4qttULG1tJS6bxjYSxAH0rv7TTJbiV57YyQ25n2b2AI29Pl71dWDhJpvXT8TGM1NuVxURohPZ+dv/eFShOQyHv7Vfsft1tc21heFpIgd0Mrtzt9PfHrTdd05bPV4o4ckYBOT26c/WqsjOWVXMjuj/uot2din3PSs7qS9S/isywsVxbGaydA4Z9u49sHitBnEZjQ/KoUY3DkevFZdtfPcTO6MQytld3Geav8AiPxFpen6AdQ1WCd4UYIzwoGZCeMnnpUtSbStuTVfJqyK+na3SSRUIlGAvH3geOK5/wARx+Xc2M8XynaEk7571qpfjVtLsrixlimsmO6OYHG4Z6H8qiu0t7u4knThC33Ce4PUVpD3XqVF2synGFW2a4VV3KxVhjOP/rVia5LKmlXAtYZGjkVg/lKSwXHbHNbGpCXS7W5aMM9tIGUjHTI+U/riofDd2lzCgbaqsAQS2ceufSrWi59y370WjmdC164uNCEYWSWBHMZhZSoZcYwR3ro7r7P4d8Ex6g8sdoGRkjtVwpOeAgFbGsRwi5SJnSVHGV2qAMYrg/FfhjUvEN5BPb3KmGLCiKRsAY6gemeK0i4VZK/uoxnFuCcUdlpWrLZpbNdJ5gKYkyQOMdCPTpXleo6xeHxjJaTLJbETBCozgJu4/Q16Dc2l1DYxvcqAxAQoDknA9fwzUF/d6Kl1a3Wp2vmXc/ypNGM42gYB96qjKMG3a9yqkdpxNaQJJpDW90siXVtny2PIcemfpis5Lpbaw2qWZwclQfbrWtfyySw20k9o0azBUV88k9jj8apWNpFaapA98wS3AckkZBPQA1hG1tTog0oNnLfD7Triz8dXjeIrxY2njLW0YcYm354x9P1rlrjw3qGg+Mlk0m7mh0yeRiWYbfKUno2eOh610HxItrmy8f6DqdsGe3Iijt9p4JB5z+Bq78X4LuWydEQxRhxIxxyxK/yrvhNucZX+NfdY4UtWx/jnUJf+ESjudFnWUQSBJpo33bh35HTnFavwxe61i3ge+3PFACxc5O4dgfxrzz4X3Tm5vNMvCZbeaNi0ePlyB1r2vwTBBa6TLHaBVYnCr2AHPP41hikqMHT69/UtzvHmNXU5RFYJcidkmXARDxn2FK9w8KmZIeZEGR3z2zVkoZS4vY4WA6EelPsIRqcEga4Hlxy4TYADgeteTdLcwvZamYqxDT5SYnLq2VmZepz+lTaW1zdiZtqIjL5fz8k47/rWdO17NFqNk06MI3MarGMEj+laVnAltp8YuFPmhOfmO5j0qpaFS2GWM80VlbW10sMcMhK7g2D3x+deIfF/wlbSeN4RZyeTbaouHcD5RKvr9QRXtbjT4NJZblNswU4Eg+YE9MVz3jbT47jR7B72JftEDiRWU5+YjBFdWEqulUuuuglHmkjlfhb4S1Lw1d30UMBeB4MvuyAeuCPXNMGt2thJNJqRkgijLB1CZZT7Dv611fhfXmis7wg70RSADzhsZ6dvSnaja6Fq2nR3mopDG+Nkjudqj8a1dS9Ruot7bG0pNXsjCOn3Go6PDqekgXFo7ZBYEEpjqP8ACp4INReJTFkr0Gamur7+yLCPTNFeEaW6kJ5bBuO+D2qhFbam8atCsvlkZX5u1JXa1tboWm7XZ7T4ZsPJ0stcLE0twfNk2gEMT396nvL2206zbaEjABO0DFU/ArFvCOmHzPMJhBJz+lcT8R4L+21CG5gll8kuT5PVSeOa87k5qrg2cdOPPKzI9du0mvIpreNoy6bJSqZ696t63c298+mx27ZW3Q5JBzzxiq9vfxwWDO7ea03DYH3PaqKXqrdW8MSl7iZsRxp8xOO59B9a7Yx2VtjuSsuZ9CzLaQ2FyYRKFaRArDOWUNzn6c0KkU4VIxlovvE9MCofEKvHci7kgaG4lQ7g3GQMZ471xfhrXH03VGmndpLK6Vjub5sFW6A1tCDnG63LTfLzHbX1sUuZBHKGEh2uyLyBjgZNcbpVzpel+J7y/SV5ryYmKSF1I2sM/N6Ee9d5pUtlPby3VyjJ5hJHzZDe/wBayNRs4WcyTWyGBxtOAMsD0OKVOfLeMvQdpS925o6be/aNUuLlZPt1pIEaIjGIMDBH1yDVDxBuuJXnkckbS2M9AP8A6wrMTWdO0VSCqQJINhjT5QPwpT4i0q41SW2W6R554MxqPmAGfaj2cr3iioR9mzK8KePry68Rw2t1bRwWzlktuSNyA45z1JrqpdEudB8Qz6lpErQpMmZSDkOewxXnfiO4t5td0pI49s8MhkkKJhVX8K9Wu9Xtbzw3byrKwMi+VtiXl2FXXjy8soK19GhShaXKtUT/APCValcosZuLaNQMl8Nn8q8p8Z6t4iu9Z8iO3m8jcAshX5pDjrx29K9E09I7ZYBNb4UAYL/1NXYr2K+ll+zLEyg8tjPI7ZrGnKNGXMo3InSivhR5z4N8J6muom+nZQAWWRVyGBxnv2rUmhnGr2wlDokEmUHbpzXfx6vB/ZckrRoURgGYHqfb8qwbnybq5kb7QgbeApyMsSOw9O1afWJ1JOUkFKDScZFqaaKGe1mZF8tZFARTt2jOSeKueIhGuotHLEGtZSHXuMEDNZ9tZNMxEm6KVmKBcce2KfJLd3aNaSiN3iiK4P3hjpisLK9y1FXWuxHZQGI7bfyniGcbidwA96dBczX1kYIUkIhJOwgH8jXFfEHXr3w9pCwaewEkhGLg9l9vQ9qX4Ra3q2p6FfxX8zrJIzJbyyNlmB7Z9ufzro9hJ03V6ETqWny2uzc0XSrXRp9V1CHeZL5l+1KTnkdPpzXUafdw298n2dibZiCkeM4J61k6PE93qEtpcoBNco2wkc5Hc/iKYm5YGjyIpom2vng5HvWU/eer1G4xaaidBqUcl9rRmYuUTA9Bj/Jqo6gXzM7Z3IfLB7kVaj1gy28SSPEiDEe5pAGc9MY9asCOKeJw6Y2nIJHesLuOjITaVmYNoIWkI2sd/I3dQQas6lYvdaVcW95GJLaRTG6N1waGVRJ5kZHXnt+FW7S4k+zkgbv3oOW9B6/lirk3uiqmqPKfC1jq3gnxvDpdgJr3QdQ6Kyk4z1J7Aj17ivR9Tj+0XoESojoCF46Y6V0HnSXE26C3SNcZG7jmqlxbPNcLMijz1XOM8kjrV1MQ6klKS1tr5nPSj7NtFTSlbUNK1G1iMbzOuGRv4TjkVieErO2Ntd289siXMEm2VlXlkPQn3rT0/UP7P8SrKlssdvNxI+7nJ7n6Vnavez6Pql9cWK/vLq3eLb6SY+Q/nj86Svql11NZJpu3qTarHaW15HFb7v3abRzxzz/Wl0S1kW6ML4VS28ZOeRyAR6GvNPhF4k1jxBqeoQa6wdoHBAcYO7pt+vFe3ajp8l9pds1uscd0PvDozKB2qqydF8khqtFxS7nL31wTdzW87zMX/hJyAT6elUPEVq+k6KxggWSXnySOQxx3PrWtbiO8jmJSNb2Jgu4j5sf41mz3EsYura5HnW28bsHocdacd9Ohot+VHOfDTxzfarBfw63aGaa0YIUB+YITgNt77e+K7LUrV9V00SK2xlznLAD24rmvBWgWtr4jv9Xt3cSFcKjnA59fWt/xDdme8ji2CIsASOwboautyuremrEUoyjOzGaBOs2La+GVi+5IedjH0zVG8uY75L2PVAzgDYFI521vaYsMMTrdRgAKSwx/EBn+VY4t4r1pmiAJOdpAJPPrURau2aLlcm7aHn8Gv6Zpl6HtbKOFWyhkySdteyeEWgutIiMcm3dK3zJxkcHNeRa/4JN3ciex2xOr/PkZQ+2O1R6Jrlx4a8ZQ217N5dljbJtYtGvHBHoK661KNeF6b1OOupQ06Huut2VxNMtpbXIEXl72J5YHPA+hqO/uzYaS66XHi9iAyAvH1PrUGianZ63pEkunM7TPlUmDctjuD6VYncpmExNEWOyWZuR04rx2mnaS2MYu+jKMVvHpUEWpCJ7m4l/13ruJrYnkbzbe7W234+UDcMjNc5cQ30Vu7tcboNwCgLy2DxmtGykvleZbsDAAaIR9jjvTa6mko9SfWiLm6sXuUIh34kC87fr7ZrG8fJHJaww2e0u54IPQAf8A166aCcxWKSXu0ELlxjgmuJumhub7zF+SPccY6Bf/AK9XRWt+wUl71+xwWlade+H7LJ3OnmO03IIORXJaJZ6n4o0zV9EEzySrL9sCSMQCBnofxroPDOoXfijxdrOmX8bGCzlbZGpwFwSCD69K7zQPB0fhy7vrx7jMssGwJnBVQc5HvXqzreyupfHoyZNTStscV8NPDl1p+kTNdoE8uRjt7scDtXpmjz28Ngkc1y0bLn5ducD615vrUGszappmo6RLutrdm87953JOSR3+XArrbK+thbr5nB9DXNiE5PmfX8DphHmXJLoen/DWR5PCVoJV2SKCpX0xxUviSWOK7g+2oJLV1Zen3W7Gt+ONIxtjVVHooxVa/sYrqJhICTivJc+abn3OGLszxvVbNkuYEt5cKZSFiU4GPU1v6RbSwTIGuFEgJO9V5weBWF4miltNVPlgIIVIZSeSSev6Vcg1gvNEYo2kdVDv2yK9JXlBWPR1cDd8cRG18PefIXuWD+U77R8inqTXkfhyweK7vLO7jzBFP5kIzkeW56ivd47i1vJJba4ti0d5FmTuMY715fc20ceq3QiVgqHGc/wj+nFVhajipRf9f1qTQd1ys6KSwuprW1ZiuxAFVQcKi+/vzUkkBuyBE+FTBVs5+gNY2i+IbTV7y8tncEqfKWLHU/WteB9pAMgUIvCqPTtUyUo6M0U9bdinf6Na6pBP/aFtDLLAhKhhjfx14rkrnSNHs9Ujk0+08m5dCQWJwpHXFdxc3NpFYL9tZo3cGVCoJ3ewrl/GYf8AsjTZbYP5sal26AsD/hxWtKUr2vo/uGpW1sYN89vDYXMx3eaFJIT7x7Yrf+HlnPeaRb+bIyBXZkXPQk5xTvCZtJGJuvJLMRuiTBZyPXNW7xr+3e1OnXEdvaFz5sRQZAOaupPRw/E1Tc2dRq1lPK1qkbtEqOFeMLu3r/jmsvyn0SG4t7e3effwZGkHHJ4OPSt6y1j/AEZFuF3zbQu/HXiuVYJPevbeVPFkk4xncCe3tXHC70exlTTUmpCWhkv9Omt03QGMh96jIIz0P51DrWnQ2FtavdKC/D+ZjAUg8EVu29za21rJbwW7265yXXqccd+tVtaEuswbSCEjTaiue3vVqT5tNEaRk+bVaFrQz9qQ3W4urMJATwSxPYdhTLqILq4nkQbN3C5wfc0ulQva2dw0twm5Il2Kx4TA6f8A6qgW3E9ubmdSyHkBlI+YnIwanq+xCauyvqenW+tx6i0iBzgBYnXIJ64qh4T05bTSbhBFGqRPmEqecHrj9KsvFdRyyy3EflRZBRlzu3e/bGMVvQ6hplzoS+ZiG4jUIyrxk56irc5RjyrVCmrapXMvxG2oLos19oodLq2h2wzsBwxGM49jXP8AgGx1+48JzTeIIWbVSjtG8smTIc5BbHsf0rsZtSR9NudOih81JF2oxOMlucelQ2cFzPZGOQtGUG3aucfhSjNqDVjFRfNzN2OeHhOC+nsdU1G5aC5SDcbWNvl89f4gc12ImeWNI5UCSlR36cVz+rwzwvbIhLbfu4Hetm3cnTYrmfITn5f4s+x/pSqSc0m36Fyjyq+9ypbOqXXlzn5XBG3tn61YsSYpgilgrMQVfkD6Ut9fabcWMEEDok68quCGHsc02OUyWZMoAKnDYqXqtSuZyV2jVEwiBzuYio0ujFrUIkUKCTyO+RUcE3miBgAHA2Nu6N6Go9TtibhVYlCPnVh2as0lezMnFMlitYp9alsZkDxzFpEz/CcfyrAv0VdVnguQMJ8pB/Af0rX0y526rFeSsFWIkPx6jv8AWsTxDMbnxVcyQHDDAUgcHgVpC/NbyCPNzWfYdMsGk3Ev2iyghupD5rThADJjofrxTPBniyy1rUWEFyTdQhnZTwxwOw70/VxLqun2/nKpMTeW7Dn8Pxrhrbw3B4a8WnWxcP8AZFLlYFUk5KkbTjtzW8IQqRkpP3ugSi1C9j0QEakXuNPuIcoxZ3Thh67h/Ws7Xo4bTTLl7hSLhYwzS46Afzqn8PvDrpp51z7R+6nkYeWmflBbnNa3jeAaxpWoWNvObZWj8tZFHIPY/jUO0anInoEJ80tOhyXhe8h8S2V02k3DTPbN+84KsM9Djv0rVaC/l1uGK1ZZJCA5J5+UDkkVS+EPhtfDfh65gmuGTVL2YGd/7oGQoB98mu+hshpmoQNEwSEcTXEhGWyOn0q6tSMJyUduhcK0n8S1OZ1bVI5LC6aQMZ5ZRGgx90AdT/KqelRvDLcM8zJi3LAD2Gc1POSZLiNvLlYv8me46cUW9kdO8+bULhGjZGSNIxuZCwIyfakrKNkaqXLBxXUuaReWOtQiezuo/KxvIC4YnuMf41wvj7w1Lq4HlK1vMox+8447c1ieDbu80LVnhx5lv5rRNweV65+tery6sPsskM6JKBh13nOP8K2nGWGqXhqjCnLm0av5Hlfw2fxD4Q1VUEL3Fg+VdA4GfcZ75r321u7e8hCTuNrYY7iM59+1eb3d0JLeSTysRJ2HHJ96n00GGDzrYEllyVLEA+orPER9s+dqzCWGitnY9DjMPlqss2SmSFJFZut+JNK0GFry/nURjAJB3NnsABya5yG5iths1gw2jvyD5LE49zmqWtXWlygFfLuMjHlgfKfwrCFBc3vaolYdvQyb/wCKkGr3UsFnY3rW4UtGzKAJGHY+grjV8T+Itc1uC305GdY5BvWJMKR7969I0u88N2oWZ9OkSTkMsf3cY9Kz73xJZ6bomotpOnxWMioXTyxgux6Zrug4x92nT+8h0ZxV+iCx8S6J4X8W/ZbiCKLUdSPmXkqAH5j0B9Op6Va1zWnuNUDSIzWx4AB5PYYNcD8LvBba3Jc+JdZmSUxzbir5yT1ya9RS/jhvgqi2aJxwgYA49qyqxhCbUdWlqKk0tyvaWpMGxoyioc4A/nVFoXLtst2iXJwoy3HrnNaTM4EzQo3ysPkc+prRMMbuzTFkYkYUMOOB7euax57M0dr3TPXQefxpWPWmUZ5ryTzzwL4yaJr9942WbTYbgaesStLcLnanqPyrYvtLFlBotzp0m83cQQsx6sBXpHjHWbTRtHllvEMvmfuxEvVye1ed3dssfg2E3Uk6RyS5t1dMNF/WvSoV5Spxg9lp63OulJmp4b1Ge2CRf6zblSCd2PUA98Vh6lG93I/2RT+/dlB6fh/OnaA7QQq1sWBPy5fuTxWDo93LF4g1a2eRmeCRphGwPCdMgjv81dMYXlJo3+HU5rw/Znw/4/tzLMxgvFcMxOArAE4/Suyea/lkl+yyQqzE+WZRlRk98fpTfE+j2nlaPe25zGF+8Tk5APP5VQk1OCe7g022VQ1vJvmkPB5HGPWtpS9raXVK33FJLlbX2vzOtQA6baW8xQzRlvvc7cnOMelc/wCJ5rq6Jtkj+c42y46cdMVt2U6G2UiRP3kuVbHP0q7dWIaWO4nUPHzuwf6VzKXJK7NFbZnn+m6FLY3Yv0lkSZJVMmDwec9PSuxv72G9kiWxaORm+Z2Qg7j6cVNFpttfTTwFHVxGWLl/kIHesPSNChsRMYJXCzP5kaqpHlD1B9O9XKaqayeqGnFSvEv6dqX2mV7iKTCWTspTHyuw4wa6PRNcguFubho2hMUJAQgEE+oOM1w+lqDO0EFrLbaNbNtaYkl5epLc9zXQ+HLyC6W7Szt0t7BB80hYs7k8AHNZ1YKz0InFSTbWpyvj/VNU06CF9JRJCCWkwMsOOgre+H+rNr2mwTHbLJJ8kygnMZAz831pNStXv9MkbRol/tIExCNnAIBPLc9TVkWV1onh+10+zidWyzzSQLhmJx+f/wBarcoOnyW1uTO7e9i5qH2aWZ1i2+Qo+Z/vEnPYVX0/V/7RVvONxHZw5jUMMbiD1wak09IHtbZPKuUkcbnmdgNvHQ4NaEWkOXOZ0b5cqw5U5rG6joy7xW7KkUtjqn2izRplkWMuoZ+XI5OB9BXmng3xjaa/fXWnSWckU0Lksr8ggHAzXoWpaZJpksNyJtko7ockr9PSsHTPDGi6fe6vq8BkS+1AgmPHAbJJ2j3JzWlNxSfnt6hzSTTi7xe5sWlxaWcDRTM6JtEgKjADDtXXaHqlrdWhlT7rjow5JrhZLJkNpFdKGYj5wDkgE8ZrX0y2ntUljtyGiA3KxOdvpxUVIqS3HVpxcdy54hkhlkjijbZJ5gVivVcnrU+si3mtI9Jt51W4T96EGC7KOTx1xWJ4ovJ9O0cuFVriTMqj+7gDFeO3Fx4jt/E66/bxztdQ8F924BcdMela0MO6q3tb8zGaaSaPbLWxjn1O0aQiSKfzPlKgbDj2plxusLuWGdiY1baQDyVPQ1J4fn/tzT7a9lcwSKu7YpA2seSKra8Z212GS6ieJZiqrInKt2B/+tWWvPysunK7s+xqxTotvEJeE3YUtU0968busqB0HQ1jXBYW7W2QJ4JM5zxtHNa7WbXKsVmYyMMo38LD0NQ0lqxNpPUwPD/iG1udUu7Ur+9JMZyeDzinXEP2TU3Z9pVVJB3dqxdH8PvBq15dSTpERIXEY5Lehz+dbF7J56xHhxnoeuM962moqXulU7yuabjNsfKLKi5b5Rz9altIoMxm3Pm7zmTzAG9qs2siTGMFMc4btgVzsxOm30kMoIjLbon3Yxzx9ayir6ESvJWRq36nTJvIbMcUzEiJOFYdc4HSs0NNIHVwDDu4LcfhXS3MS6ummyOf31vncR0OOvNc9Nd29rrl5ZupaCRsq+emaUHf1ClNW21KQVWlnWOTIwOBxzmtSxltox/pF04ft5vP5e9ZN5aHTJAhkLBx5gP94VeuohqW1ocIPkVYyvOSOtaOz9DolyyW+hnSxg6sJS42t8q/UVf1abzLYom1XcgHcMEEVn+XHDKhjZWcORgnrxwahmlu3nRLhZ2ELb2K9MH+YqrXs+wOPM7roWP+EfsrxrWYttcygOffFWddtbeG6WG3hDRImDITkMRxg471BbwyGwN1auylpQrE9EGa15YPtuppbW03l2/dSOehyx/EUnJ31exi0qcrpmHciaDTIYAqNJMCzBRwo7DFQwN9iDJqVu8kkgHl5bpzxx2rfktf7HvgZJoZVU7gWYbm+oFVvOF/fGa8jVmV8xInQgdz60Kf3Bzpx20OG+LcWpyJHqMFyVijwrpkglieo9R7Uvw0U+ItF1a3Axqdu6PEx6svOV9jxXUeLtK/4SPwzP8A2dgSKVHls33XBBx+IqHwppkvhzRbqSVI4LyeRVZQclAB1J9+a6Pap0OX7Sf+RhGU+a0WPsru1azktb21T7QiH99twWI7GubvtGk1MxfYx5UUijORnnmuk1bUJLmOBTCsVuo5VON3vmtG01yyjs2aOxMdqoChmGC7e1RGcoLmijerBpXtuc74a0y60Kya3geWNZ2JLMTtyO2O1cz4i+HcmowtrtrrT2+xyXMhIwc9Aa9Gu9eh2772Mtbj7kCgZYVU8XLba/4Zis7BXtoXKykKd2MdQfzojVmpX2vuznlBtL3SH4eWqy2n9oahfw3sdmCMBwWLdifzpdY8UW1rfNHb23mJjcSg4yf51V0iGy8N+Hr9LYKpYbpJpP4gB2FcnH4zhlLtDEjruxuaMHJohS55yna6FUu3vY+rM0tRg/N1p2eteIchXewtZLn7RJCjzdAzDOPpVLxFpq30G4KGKKwwfpWsDSnkYNNNrYadtTxPw7I4tr+3mTy5bZ/4jyeau37FIrkWaoJriPe5PrS+OdNksfEMkqfJBPhs9AT3H8qTTrf7TapI8eZYvusRkEd69VSUkqnc9BO65jM0LW2upNO0vUrZJIYyUadOF+YcDBrnviHpVzoF2L23jLOsijcOrIehPrW54kinn1K3aJ0ggiP8OBzjrXQ3ixeKPD1rb3EirMOrnnOOMe9bKp7OUaiWnVByW32Zzmla8t3bKy2nkiKElhIPnJx1A69a0NO1FpIntd+6dfuc/eJ7D8KwhpTwau6WoVpmjEXXJAyMn26CtjTNIt9Emk1C9uTLcpkRRhSEDnoT6kUqnJ0NIpQV5b9DQWZtPeJB8qSER3AxmszxL4ltNInhRQXaVhHFHjBP4UzUpry+mtGjyYY9vnS/wl88kmsHU/Ct1q/iL+0Lu92tC6tCqDOPb2HFFOEG06jHPmUbrc7OK0u7ryZNogtASXMjYBz/ADq1c+RBMlnbtFHDv8x1AOXPUfn1qkLiO3sXtP3jtkcOxKjHeobm3ubqdZhI4lIG442jGP04rG13rsLlcnqXdKijuIxcpjKsQHC4Kn8alisvLby2lkJY7jGW/XmqscEitDbQgnzWX94GySe5+lbcduseorGzCVYpPmcjO/2qZOzHKXL6mbGdoZIwGjTjAORmhFvTIyqzlBjjPSrGq3bWrbYoVG5jk4xxU1vM6R+cM/dyGXkUru1xqWl7GdqN2ILKe4vGEJjQqHfkhSecV45qPiPUvEniC2s9HU29n5uGmLHLAdye1euSW41a6khGx4Au194yCMZIANcV4u1mw8LxQJp+lxMc5bgDnjv2rswzSlZRvL8iJQb2dl1OuvknguHad0ZmjXaOeMAA89+9JAl9Fbu9qjbSBvJ52g+tXd58Q+H9L1KBI1muIwDHv6Z7A068S90+3RLiHZBn5lzu7cc1z3+y9zSFRSikipceXNp0rTlxeIAIyB24qtYWkEVqiSIvmzSbtrDPBPOfwxUlsyXmpIiE7CCTk8AAZ5qxp8n9sJFJYIiSQu0bE8gD1p3aQ5+6Q6fbJ4ftLx7KJngMpG9m6k8YA9hWpqJZPC1rJdb5CGDoWHKnsDU01/b2emSNcIrmBlVFx1yQM+/WsbV9Su3ll3KIrVgQ28cEdsf/AFqjWbuYU4u9ug61mExLSrgk4JC8AeldFpFy9vd2+2RGV8qyk/w9uKwdKW01LTBPpcpdlXbMM5+ce1Mt7qOYtGybLuHlG6E+oolHmuipWnoi3q+gWll9pWzY+Y8wmKu+4AE9AeoHtUaIturBk+brntVyadNSVZnVlmjUB2B4P4U1/wB5GAcknjPep5pWswpXirMSGVW2mBiFxtYnsfaoru1TUof3bZuISQp9hzUE0bWhAZGUNgnI4bFJbI0N1FPC5/evtAb1NO3VF+aF8LRSG7lmS6eNWVhLbqOWJ4yO3Wrd7p39reKkDJ5a/Z/uoOSR+lZN5HJYXkpbcBISDj+lbejXTXVv5cMwhuOnmk8miV176M5xafPEwrvzNxhlBVoGKtGWyQM9jVuyuC0B2OqTS/uoyOvXk/hViXR4ra/jSdjJcXCkeYCSn+8awNQgvNGuysuAYW4b+Ek+lUrT0RrFxqR5U9SzpumLFrTYkUxQsVy3fg1elYNLKYEwrRnJJzhfSoY2e1s2nlicxXXzblG7ofarEM9rBEJnbdE0PA29DRJt6kuTbuXtDCppFzbygqk7qFLDoO9YniTWZY5pbLaglQbXfHLL2Ga27cGTScwrsSU4DkdADwR7VxWpmO6151WczguS0m3sKKaTk2woxU5tyJ7i1a20+0luHk82blWAzwe2fxrSszBCPKjVjOq5y/HJ6iuM8T+J5dISNJEmkt433xqnIXmuvGorq2k6fqrRgSvF8yMMMVzgH61rOElFN7MqTafLIsQzPY2clpFDGC58x2VjnPTIpkEUl5GnzbpAdgDMAXzz360jAwkoWLo6gr6/5FcLrPhXWbu00y2bUJHWC8kkEuTv2MQR35I5/OiEYyersRO8dYK56TqsqjR57Z7eOKFCBDIR87HuK5h7+VrFLYxrIofcBg/TFXZbifZ9guSZ4sgqz5DA+tW4dFNmnmytuDLnAHP4VEbQWpquWEffWpmxaXPLbme7wm0cJuy341XtDNbXaEIWJ+XZj1rtra1sp7MRgIbhk3HOSf8A9dM0uxEFnNd36r5NupKZ4LZ7Go9ro7mTr7qRm2mlRXs0/wBueKKyjQJJuxtJPUE1yreE/D1pLJFaLFJAGJVnXJP41s6q4n0VEPLFiduep+lYdrD5sW59wOcYXOK0ipJN3IjT5nzSPo880DvTQetKe9eOeYh688UvSoweKdQhnGfEpIZ9JRzh2SUKcN93NcTYasbUIxzhSI1U9CDnk/lW78UY7u0MFxbKpti26UAZI965u5e3a2ine5QpgPvbgA47V6WGS9n3R2UrclmWNUtItRs55Qy4b5fkbnJ/lWZpFnGtjb2v9oktuKrFC25859e1bjzaX/wjE2pDElvMMRv0+b/9dVPh2kDWuoXsLo915fkQZ/vYycenbn3rdNxhLyN5T9y9yF/Eek+H5LiGwgLaip8tmnbeRjrXU6D4buPFNsl/4jlYRvykEXyDnucd646fRrHTl+1XcQGp3ORulbdg9eOxNeveDb5LrRIF+7LGoR0PBBFZYiSjC8N+/wDkc9VtK6Oa8Y6FNpXh9zplyYrSAbnVkDbVHU1xOhamdSKvGhDyHKdxjnkeor2HxTewWWgX0ly6BBA/Dd+DXzl8OIr6zYXDNm1ZzJb4YErycjHbrTwd6lObl0FRm/h7np1ukc2yWeBlTJRm3YAPrTtUMW5bYskVvFgF858z3Iri7vVNafxJaWOhqjRId92W6queozx/+uu8vYoxp88+IprkJuZGGWXPenODhZvqdCdpa9DEtta0638RR6SZA15PEWhyTtYDtn1rf3xC3b7PGETALHPOf/11xOhWVhH4si1MiaXWHIjWNlzGic8jp7V0/iOQ2+rYYPACQ0qcFT/u/WicFdJdhc16jutjN1GaS3nS5ufLe3kkCOjE7mTPOPr6+1XJr1bm2txpPm/vrgwqZP8AlkvoKyNQmeS1F0kT7ZWwGIwVPOBzWNMt9pptZ0vkOH37Y+Cp9D61ooKSRr7Ny95PU9X1DR9O03w3cTOgBjUHf/Fke9ee/EDQ7a+0uO98jCODwo5BwCDj8a2NZ8WWeqaPYwNK3mNKvnJjnj2rY8S6hBZ6Esr7dgQFRkfMTj/CsKXPTab3bOenzwl73U81uPEX/CMaNpem2zl7y2j3FcfcJ9vxrvvCy3uq+DIf7RmDSGYuxcZYr25rx7TtKm1XxhLeliLaViZVPQAHjB+tenzwNYhX3sq/eVkPB9q68RGKSS+J6s19n7TbSxWv4Tb35ELGO2Y9h+ma6Xw4LHTtNkbTxlny0mTgkn2qnYTXGpQb/Lt8MpRVYYLD/GsyW2TLR7SjIcOr9M+lc0veXKyuX2itJ7DvEmJbSOSQMsglAdCMHBo8TbbfTIrGSTAHKOO3FUr15JZYoZk2ojAhT9e34U++sHMbIJ41G8KskhyP0q0ti4RULcxkfDm3bQLmaSaUz2E7bTgkkHPJ6V6LqFra3ISe02NMMbXHHHoapazBY6VotlaRqjSscsVXBJ9TWM7XFvcItu7smQeM4NTOTrS5/wCmZRipe9HQ27a3CXL7VwCPmGeAaFi3hwCAQQAfrWg+4BZ/lEcgBLKeARQ4gLPI5VMjjB6+9YcxKn1KLxKxQTqXQNkZOQB/Osq/jEW9R/qpHxGxONpzwakvJpby1u3t2LiJRtRBljkgfXjNT6xaxxaJbXAMovVKkxtjg+4rSKtYuMknYr30yXlvCLhmFwiBWJXGfesRLqWyLISxiJG72rWs7oX12sUkW6dhsUVLqkEau1rcoHnjxwOCAapaOxomo+60aGnmK9itrhbiaSFHCumQNgarXiXTbeO0ke8Aa2lbKsAdynH3q5C3+1aQTdWbsIt3Iz1we4710Vj4hh1iwntbr9y7jKOD8v0+tZyhJPmjsc8oOMuaOxhW9xeWtzJgCexHyFTyFyOo96RjaRaX5MEhctnKNnOa2ZdNuZNLW6kjVJEk2pt6Sp6H9awpV8rU4hCw3rKHVcZ3D0/pitItM3UlO7XQvXtzfNo8FiPkgC8Hpx1xWXocL2l1NM0KtDjDFvp2rT1V77V/JhtbCSCJWxuk43H6elU/FEN1pOnSXdzexFIkOYAcdPT1px/l7hGSUbS0uZtvFa3l7eXGpRxskY3pD2J9K6K2vtLkso5TZBSePKjOSB2FeeeAPEFp4h1RrF0bzJckkc8Dp+FdbqSsloRHH5YWXZHtByRjqa1q03GfJLcSlGpLc2YbWfU52NvaYVVxErHaBz3P41Dd2jWLRWrzrNcmThk6KfSl0/TdXktVKy4yNqoThyMdfpUX2CS0s7iLzWS8dgogkbCuDwaxTV7XJcrOyYyfRtZUmYiF4+uQ+eKmW6YQAp/rTlRJJzgHg0mjaBrMF35SXBgtt2SrHcuP9nmrniSMxSra4SRVT5QpGS3/ANahyTfLe5DqXlZ6mG9/Ja34ltVaRgm1cZIBxVp9YvbizkhIAjcD5yM4Pp9agW0kUxpIxjkbnHt7VszWsFpaBYpGLlfmxzRKUdDSaj0RgaTbefdfOxYkYQjpu9DWu+ny2m2I2yJgZwM8+9U5rwxW7XNnGHkVsHHBqxd+IPNEDTBll8pQwJ780nzSZlWc3qkewZxSg9aZnk0A9a8s80f260opgNLmmh3GXFtDcxssyKwIK8jsa8h1vwXAviBLSPfFpxG5xIDtOT0DV7FmqeqafBqdm9tcrlGHXoR9K2pVHSd0aQqOJ4H8RbDWbFLfRtOjjOhW0fmzOvGM5zk+lZ3wX1MQeI2t445pbUPl3zhI+Opz9K75ra80XV49Ov41uoLklQ0nIZR3rAll26ktppu21tWck+UoUcHua9elV5qbptXut/8AM2dJ1OpqeOrObUNSjv0bEdvIHiXHBOO/pmtC5hu/MtdXtb2S1cqBMkZGG/XnnvVTxDLbDS4YI7tmL7Qzxnhjmpr8fZrS1iJkEyqNoVcK47/U1zrSKRvy8yVipq0eoa7EovLtnhU75ISp5x0B55Fc/dQT6Et7LdGL7NlZY5IkCqGIO5cenSt+3v7O3t0S6DRiflVLc/TP1FZnjiM61pkdjbM0cDH52PVWHQVrTbi+Xoaxp80lYm8K6nHezJfrZkedgA4x+vpmt+61ORLqW4OAIyYiuOHPIxUOhW8SadHH+7xEojBUY3MB2rC+I+t3cEOm2NjATPMpVpT298etS0qlTliim9dUYfiHzr/xPo14t0sRhuVJSM88EdQK1vivDqj+JrW90m7llR2WOSFUyI/f6VS8H+G71CCLiF78sWRW6/hV+eLUf7VKX7yQJK37x+2fet+ZRnHlafLf8SJUlUbd7M0LvWWk0kWqwq00jfvfMOSMenpnjmuFfXrKaVYbhDb3MDFcucB8c8fjXpVu2n2iv5FqZ5AwVpH5JPp7Csy/g0zUJLnztPEkLR/eMfKt659qinOMb+6PVfAUvCOmDW/tOrSW1uoB39S2fXj9K6DxLZvr9lFcrIbY26FGjhOMAf8A1qy9Hu5tCR4rMldNb5ghX52YnBwccdutOtdZms71vKja4Er7ZYu6g9z74FTJSc+aPTYzTk3zNbFFbV7PSbgWKtJMR8qr19fxpvg/xjYX8Y0++aJpjxJE5wUbHJHtVnSPEljd6jJcRWskShlwCwxyOcd6ytZ8KaW7y3kRiW6aTJ2Ehquyd41Vv1OhS51eOx2OjyJY6lGoJktGyu/OAABnmqVjeyarqvl3Eg+yyylTx9084rM0fUEtoJba6L+WiEmTqCMdaWbWYWt5DahRIrAIUGDkVn7N3egre9dbm5c27DUV0+fBfd+7k/Dj8KLs+VcRQzxr5yjdgj5SQeuKdqskiWun3NxGbe+2Aqp7j8aNYWW+tYbqBUFw2NuenbOfwrNbq5Dd0pCXx+0Xn2tywyvC9f8AIrzzxV4/ksnaCxdJWT5ZEIIOc+vpXpEe+NkjZFJ2ZCnvXKaj4P0qW/N5Kh+0FhICh4OD0xW1B04y/eK6FNtxtE1/Buv6lrNvFDZ6fKkPkhplf7pbvtB5Fat3IrSPHHE20ffhI+ZfpUdlZxeTLfacDFNG4AEZxuHoBUOqX0pZBMm24JG5scjtWLtKV4qxC91lbSb+ez1mJNPyZSSWidT8y+hrpfE0sWojMCGK5iTLxkckD09aqRSfYtTtblrT90CFLk9M96f4qlePW4JImVVlXC4Hr1FTJ8000Lm5ql1uc7pE0lrdNqTbAkIz838Qz0HvWvqslvd/8TW0Vy6sDICclhj9MVkaW1tqVqLCXKXETsytnhuemK1LfTZbJibhhDGFZkCtgEAZ71c7Xu9zWTTld7lrX4Eh061dItyuvDL05GcGuYjs0MstqHCs3KkcbT159K6P+1Dc6F5JQFlTcMHp7VyunySytNcspYue464P86KaaTTJhKUUdt4b1b7U/wDZlyI4Y0jK4Y8l/oaxNRt/7O1WC6UIypJjPc+9bp0+zv7OJZk23jANG6ttYexNUbfSLiwfN8izhvRskfSsouKbt9xEZRUm116FW31u6tdSd7r97azHruyUB9K0dcTw9JYLBep5hnBGWByc5HArJtdLutQlu51iP3/ljzjaOnNJPqEdxcm2QRK6Dy4ZTyeOuAfxq+VXVunYJ04t6dDnfDPhOw8E3cl/bySTyXUZEe5PuLkcfUGrutatcm+DNAYAPmCPzkHv7Vvx3K61ZzWU0Sm+t12Rsvy5GetbmjadptxYRm4t0luyoR2kXPNOdWz5qmrJU40t1qef+K9ZutXtYW0i4uLW4igEe6NyPmzzjFY+g2fiC2xf6hfJcyq20R3DsXP4GvcW0nRrCF5VtLePYNxIUZrg/EBiuNVgcYwTvKA52j3NOliLrkirImEozdkrFaxub02zO0v7xydxVjtX2UVJaCWGdXaMNK3BkJyfoBVq4McEb+SAhYYOOQD1qHRLYXmoiSeQpbxRkcnqSOtTzaNm07KN0Wb+zuZZILgwusipgDduHXv6VQ1e7e2tzEVYXHcjkAf40rXs/wBtfyTIIOgGemMj9ayNRm82ckBjjjb6/WiMXfUmlcp6dJIbpnDyAd2zgEfSteJoNmbu7USHnDRgkDtWQ7pZk3d42LeIhpm7AHgCtmLTbPWF+22UmYZOnt7VU+72KnUTdj2vPJo7mm5pM8n6V5B5Y8U7PNRg4pR1poCTJ9KUGmA0o5PFO4HG/E20eXTba6iQs9vKCSOoUjBrxe91m1Ui0hkberMGJBG70r6R1OJJbGdJMbGQgkjPGK+b59JfUL2Wa1jXbbybyxXAIB9/pXoYCpHWMuh24eV4tHV6Lo5v9KglhjVYtw+939cV12q3MGmi0t5AbxIwItka5254HNc/ouo+dbNZW6FWCFgi9OPetPSLj7RdQxzYGAcnPOOcj3NXUbbbeyNJN9ehzPjC1lubW9/sz7nn4jPoA3b61pmOHS9KtmucPqtwm5sj7pIwf0rdsdKe0gvb2aeNrVGEkURAONp6ZrzfxZPqWpeIY5Hcm3C+ZIY1IAX/AOt0q6TVT3L6L/LYuNZvbZHYabIRII7giKKNQ2RjA/8ArmsvXWljZjOreY8gMRK5wp6c1wusRapZaJdXYnfCMCrEn5gzYH+far3hDWb/AFW3mGozrK9sV8tmbO3H8Ix61uqGnOnexTq2klbc7nTGSK/jlhKpPHklmOOcdB61Day3F9fXEN2vmrKTvBXBJ9c9qZbr57vPJsIU8A5PPfFW0SaW9uXtJRGihSNncc56/nWPmTJ2buZ8gEMF2p3obcEhfvE4BI/pzXPeC9avrua5ub8ARKxESD39Pw/nXU30U0omuUJVnO1iB94Ed6wLawWFVjtkCq7/ADHdz/8AWrSEouLT6miV3q9EdJbQXF9YOdhZ1wY85z+Pt1rjPEuq3VlrdrpEdvJI0wMklyg+VVHvXZWkaaVp8yFpmnDeXGoYnv3PpVRXhYzPeGKTygAYwxwT3qISs77oI801oZmhaHI9k90sbrHH8ysO7f4YzWpcPD/Y5uI/m+fYpA56V0GhTPqmgz/ZQ2TGYREFGOo5H4dawLm0+wj7ASwO4sHI6k9gPwpe0cpNSGpNya2OZSW5ubsW90jrBnCFRgMPUn8qH0B7a7knEh3qCxX+Fh7V3umaQmoWrq4ZGiUkycEs3t+VZuobrIR2k6hlCMEZ+CG7fhWnt9bREmpO27NlHfX9Fj8oxySW67omzlxgfdbPeqOnsbmy8yAgbDzHn7rdwK861DxteaXqNlFFD9jtIs4ZeN8meSfwxxXf+HomublrgIVt74ecjk4Uk8jb+dRUpSpxv0exnBqN4tmtbqsNrbvIRIAfmVuoHpVe8tQuxt26NzjdkZxVO8ElnL5d3vQZ6H0qG0uA0o8vLxuCNhOce/1rNJ7opwa1Rk69qviDSrezs/DECzSNc5lDgEkccAelbWtC5k1AvdDbPsBcdecZ6U5IZZlguYGMVxDKAx7n3rb1gWd7eyEcX4QSB+qkAdPbpTdRJrTuZv3Z8xzlvc6nNp81rafvEODh+WxwCBWxf6cyeFrYXLLFfkhwP4j7fWqcdtcLm7s5ld0HKRkAgA5IOK1tH1FdX/dMisyZb94Ryew+oqZvqugpTtrE5aO1329xFFExmDBllPDbvQ1Z1Ca9NlZ2+pRsDCpxJs5x6E966LV7C31jTvPspkj1a13B4o2GWAPQ/wBDWbaa3cuhhu1DA8ZljwD6jPrRzuWtgjWb1KuhxtLpl49wEjjQ7wzjqe1XbO6sQfs8y/ZnC/Lt5Xk5zU5FvCkkd8hEEygrtGRnvis3zUtmWbaZCp4V0wrL0wfbFTfmuU3zNl+S7jjmYiRSfusAMCr1tBFeWc7RuzsvJUn5l+lYU8ZuAyLZQmJiCT2HuPSs25hk0/EunzSo6nG1XPH/ANb2pqKez1Bwvsy1D4jmfWri3tpxA4jzjGA4HXJ9ayisM+sDzEO1WLEqeAaLfwjcXF0l59rKl/nkXaTgema1IVR7prUxbyjZ3BQoI961bhH4CoW1DSVSHUf+PjyFc72kbLFxn7o961dX8QSM3k2ZEcJG1SOGH0rA8RX/ANkSOSxs5Lp0yihR1P8AhmrUt5B/ZtgbuzhS9kiy8IIYq2fXtUuF7SaIajKSurkjvcSRM8sz7toGWbcWNP0+yldSW2xx53fP1b/61EaI0aYDvIibtq9/880sOrRWsbRlHlbB2bT8wz1B9qltvRFuTWkEaV1awQWjs7nEgzwOM1zV2Z0j2xvuhYf1q4dREkT7gxRVIWENkgk96qF72x0Z75LGS5lY4jh+6AO5NOCcdzK/KtdSteak62Um5NkUSZ6enU1wfhzXtW8TeLo7fTImSwiO6WQjjb7mu1l8Rrb6bNqF5BFFGi4ZM7lU+mO/Nc/oWo/2vYX0djAlpbyowWSFAilu3St4pqDsvK/b/gkzTe3TWx1FnBaanbSxrIlxa7yki9cYPAOK1rOYWdskFlAI4UGAAD+dc98MPDUnh/QLltVvYy9zNvEit0XHTn1roX8ReH7F2gGqIm08hiMiuaSc5OME5JGUqkYr3tz2Pym9RSeS3qKKK8pHML5R9qXymz1FFFNCDymGORTljb1FFFMY2e2MsLxnHzKRXG65o0djoLwJHCHkjZWZR14OKKKcG7mlN6nIfDnSbmO7uVLw+WF3Z5Jx6dK1bvTrmwluLmIW+2UZ27m4yeQOOKKK9Ccn7X7je7c7Fy3sZGthaRsoSUqz7mJ7Z4/KufvdOmkvRGJFVdxAAOMjHfjmiilTb5ma0yxq+jHUtBuIJiiqu0gDnp26e9R+HvCkWjae7Wyw75Fycj+LoDRRVOcknFPS47smuNAktp0VZEyy/Mcnk96gvNGuoTHJBNFsY7MHKkflRRThNtocZN2uX7q0uI9SaNZEMZ65JzxWfNaGaGdZIYBNbyqdyEgMp6jpRRRB6XJqbIlktJbq7kLSBFQgRqvQY45qvYeEjLKz3dwPLfLbY+pGTnrRRSc3FOxq6kqd1F2Nme3Ol2NsNJ2wiFiyhud2euTWNeWt3eXUstw8Rwfm2sQc4zxx70UU6e1+oqb0v1Lj2FxYaSywyr5OVESZI2N3OcZ9arL4fnuJBcXM6ShiUIJOQfUcUUUcztccJNPQ5XxN4SXUo3t5Wj+RuCSeoPXpXbQaQRp+kQowSOCNQoVj6AUUVU5y5Urjrbpm2+jjV4HtrzYZEHySrwR6ZrkdP0e6gkuITJFuRiQykjjuOlFFY0pPVEQk9V0N21tD55B2sSvJJ6+lPu7bBZ0wFC7XGeqk4IoopX1M09TKt7SWxaWK2ZVhnAXP8e3uM4qtrkDeG4IJNNCAT4BDnJBHeiitoO80n1FJ62H+FdNurqcaks6xvcK0cqgn5iTjOcVf1Oyv1mFpLJbtFHgqRnJPvxRRUzfvtdh0viGyyX5jhklS0l8pCGBLLgD0wOvFatjO9yii4ghEbDjByfx4ooqZxXLcJJFO4051uALcohIHBY4x9KhvtHnzGTLHv6jAwMflRRUqTCLaKqQajGyPDcpGN+CAT0/Krc1mwJQbSXO5mJOTRRVN6mr3M7bNBbPCqQsjfLhucD24rJtdDmjlM4aI5BwuTx+lFFa3stDSnpF2NtILiO2SXegm5X5TxjH0pulaJIlzJLcTKxcHaFHbGaKKzk2k7HJVm4xdjy7wtHrttqmueI7m5t54IWMa2xZsbieDjbgAAV7Tp0p17wulyEWJCgUoTnHrzRRWmK1vLqpW+Why0m1ZeSOXv/DQ1XwnqWnKYk887RI3JXHI4x7VleC/BVmljcaFK8kiQESFt5GT6jFFFQ5y5ZK+2vz0NZP3r9za03QGuLg7PLWBfkRC7EADjBGKk1b4T2F7d+eWVS6gkBiKKKzqVqlOXuOxNR6H/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Spherules of Coccidioides spp in a transbronchial biopsy specimen stained with hematoxylin and eosin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Houck, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4438=[""].join("\n");
var outline_f4_21_4438=null;
var title_f4_21_4439="Hypospad Onlay island flap";
var content_f4_21_4439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Hypospadias repair: Onlay island flap",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Proximal hypospadias with the abnoraml urethral meatus at the penile scrotal junction. A strip of tissue \"the urethral plate\" is outlined on the ventral aspect of the penile shaft which will be ultimately be the roof of the new urethra. The circumfertial incision around the distal end of the penile shaft is placed in the normal position where a circumcison is performed. B) The urethral plate has been preserved and the penile skin dissected off the corporal bodies (this typically straightens the penis of their was any inherent curvature). The inner prepuce of the dorsal hooded foreskin has been outlined in preparation of creating a vasculized flap that will be patched onto the urethral plate. C) The vascularized inner prepuce is sewn to both sides of the urethral plate to create the new urethra. After completion of the new urethra the glans will be reconstructed and the extra dorsal penile shaft skin used to cover the penis and complete the repair.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Transverse Preputial Onlay Island Flap. In: Hinman's Atlas of Pediatric Urologic Surgery, 2nd ed, Hinman, F, Baskin, LS (Eds), Elsevier, Oxford 2008. Copyright &copy; 2008. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4439=[""].join("\n");
var outline_f4_21_4439=null;
var title_f4_21_4440="Treatment of chronic fatigue syndrome";
var content_f4_21_4440=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of chronic fatigue syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/21/4440/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4440/contributors\">",
"     Stephen J Gluckman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/21/4440/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4440/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/21/4440/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4440/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/21/4440/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic fatigue syndrome (CFS) is a complicated and sometimes controversial disease characterized by unexplained, persistent, and relapsing fatigue. Diagnosis can be difficult due the lack of objective clinical or laboratory findings associated with this disorder. The long-term prognosis is favorable in many cases, although treatment options are limited.",
"   </p>",
"   <p>",
"    The treatment of CFS will be reviewed here. The etiology, clinical manifestations, and diagnosis of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30825?source=see_link\">",
"     \"Clinical features and diagnosis of chronic fatigue syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many therapies have been tried in chronic fatigue syndrome (CFS), but only cognitive behavioral therapy (CBT) and graded exercise therapy appear to produce meaningful benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of 350 studies revealed only 44 that met inclusion criteria of controlled trials (either randomized or not); even these studies varied substantially, especially in size and outcome measures [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/1\">",
"     1",
"    </a>",
"    ]. The only two interventions found to be beneficial in some patients were CBT and graded exercise therapy; however, neither of these modalities is curative. A randomized trial that was published after the meta-analysis also demonstrated that CBT and graded exercise therapy lead to significantly reduced fatigue [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/4\">",
"     4",
"    </a>",
"    ]. There is no known specific medical therapy for CFS. Similar conclusions were reached in a clinical practice guideline from the Royal Australasian College of Physicians [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result of these findings, patients and their clinicians should be circumspect about trying potentially dangerous and often expensive regimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cognitive behavioral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive behavioral therapy (CBT) has been effective in patients with CFS and may be useful in those with idiopathic chronic fatigue [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/4,6-8\">",
"     4,6-8",
"    </a>",
"    ]. This approach typically involves a series of one-hour sessions designed to alter beliefs and behaviors that might delay recovery. In a trial, 641 patients with CFS were randomly assigned to receive CBT, graded exercise therapy, or adaptive pacing therapy, which involves helping the patient to plan and pace activities to reduce fatigue; all patients also received speciality medical care [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients received 14 sessions of therapy during the first 23 weeks, and an additional session was offered at 36 weeks. When assessed at 52 weeks, CBT in combination with specialist medical care was associated with less fatigue and better physical function compared with specialist medical care alone. Graded exercise therapy led to similar benefits, but adaptive pacing therapy did not.",
"   </p>",
"   <p>",
"    Similar findings were observed in a randomized trial that compared CBT with relaxation training in 60 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/7\">",
"     7",
"    </a>",
"    ], and the benefit persisted at five years following the intervention as assessed by an interviewer who did not know to which original group the patient had been assigned [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a trial that compared internet-based CBT with usual care in 135 adolescents with CFS, internet-based CBT was associated with significant improvements in all three primary outcomes at six months; these included full school attendance (75 versus 16 percent), absence of severe fatigue (85 versus 27 percent), and normal physical functioning (78 versus 20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/9\">",
"     9",
"    </a>",
"    ]. The benefits of internet-based CBT were also seen at 12 months. Usual care involved face-to-face CBT, rehabilitation treatment, graded exercise therapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alternative treatments. Sixty-three percent of patients who received internet-based CBT recovered at six months, compared with 8 percent of patients who received usual care. Although the results of this trial are promising, there are important limitations. An accompanying editorial pointed out that the usual care regimen was not described in detail, so it is not possible to determine which differences in care were responsible for the differences in outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, the investigators defined recovery post-hoc and the criteria used to define recovery were not stringent.",
"   </p>",
"   <p>",
"    Another way to administer CBT is in a group setting. In a randomized trial, cognitive behavioral group therapy was more effective than enhanced usual care (defined as management by a primary care physician or medical specialist) at improving physical functioning, bodily pain, and vitality at 16 months among patients with a variety of somatic syndromes, including CFS; the patients who received cognitive behavioral group therapy participated in nine three and a half hour sessions over four months [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/11\">",
"     11",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    CBT appears to be more useful than participation in a support group. In one three-arm trial, 278 patients were randomly assigned to CBT, a support group, or no active intervention with follow-up at 8 and 14 months [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/12\">",
"     12",
"    </a>",
"    ]. The CBT group had significantly improved fatigue severity, strength, overall sense of improvement, and lower sickness profile scores compared to the other groups at both time points.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Graded exercise therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged lack of exercise in patients exacerbates physical weakness and adherence to graded exercise therapy alone can be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/4,13,14\">",
"     4,13,14",
"    </a>",
"    ]. In a randomized trial that included 641 patients with CFS who were followed for one year, graded exercise therapy in combination with specialist medical care was associated with less fatigue and better physical function compared with specialist medical care alone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/4\">",
"     4",
"    </a>",
"    ]. As noted above, cognitive behavioral therapy led to similar benefits. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Cognitive behavioral therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Many patients experience recurrent symptoms after exercise, particularly with aggressive regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/15\">",
"     15",
"    </a>",
"    ]. This can be reduced by the cautious setting of less ambitious exercise goals in combination with patient education.",
"   </p>",
"   <p>",
"    Although exercise can worsen symptoms temporarily, deconditioning can do so on a sustained basis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. Thus, increased rest is not recommended and should be strongly discouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/17\">",
"     17",
"    </a>",
"    ]. We encourage the patient to gently push himself or herself. Compared with normal controls, women with CFS in one report were found to have low normal fitness on treadmill testing with no indication of cardiopulmonary abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/16\">",
"     16",
"    </a>",
"    ]. Maximal testing did not result in a major exacerbation of fatigue or other symptoms. In another controlled trial, more patients rated themselves better after they completed a graded exercise regimen than after flexibility treatment (15 of 29 versus 8 of 30) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, patients to whom a graded exercise program was recommended generally did better than those for whom no exercise regimen was suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Supportive approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best approach for the clinician is to establish rapport with the patient to be able to provide support and reassurance.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Promise to be thorough and honest, and be so. It is often tempting to avoid such patients, since they can take up a great deal of time. If a patient gets this message, you will not be able to help. Accept the fact that you will not be able to satisfy all patients with this disease. Some are so invested in a specific diagnosis, such as the purported entity of chronic Lyme disease, that they will not respond to any other suggestions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=see_link&amp;anchor=H21#H21\">",
"       \"Clinical manifestations of Lyme disease in adults\", section on 'Post-Lyme disease syndrome and chronic Lyme disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Address the issue of specific diagnoses that concern or worry the patient.",
"     </li>",
"     <li>",
"      Explain to the patient that this is not a new disease, review the history, and emphasize that we have considerable knowledge and experience with CFS.",
"     </li>",
"     <li>",
"      Explain to the patient that the severity is variable, but can be completely incapacitating, and that the symptoms are real. CFS is a real illness, and the symptoms are not due to malingering [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/19\">",
"       19",
"      </a>",
"      ]. Because of the lack of laboratory abnormalities, most patients struggle with the validity of their disease (as do many of their clinicians) and may experience feelings of guilt. The patient must believe that you understand that they have a real disease or you will not be able to help them.",
"     </li>",
"     <li>",
"      Avoid debate over the psychogenic versus organic origin of symptoms. This debate does not benefit the patient. If the cause is psychologic, the symptoms are no less real (a difficult concept for some patients",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      their families); if the cause is organic, we do not yet know how to find it or treat it. In one study, belief in a viral cause of the illness was associated with prolonged functional impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Most patients with CFS have an element of depression associated with their physical limitations and inability to lead productive lives. This component of the illness has a treatment and it should be addressed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given the similarity in epidemiology and symptoms, some clinicians consider CFS and fibromyalgia to be part of a spectrum of disorders and treat them similarly, beginning with patient education and perhaps a low dose of a tricyclic antidepressant, which appears to be beneficial in some patients (",
"    <a class=\"graphic graphic_table graphicRef53766 \" href=\"UTD.htm?34/58/35755\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14586?source=see_link\">",
"     \"Initial treatment of fibromyalgia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Medications and diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of medications and special diets have been evaluated in patients with CFS, but none has proved successful [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/1,2,21\">",
"     1,2,21",
"    </a>",
"    ]. Among the modalities that have been tried are immune serum globulin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     galantamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    and other antidepressants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    (stimulants), glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    , magnesium, evening primrose oil, vitamin B12, Ampligen, essential fatty acids, bovine or porcine liver extract, dialyzable leukocyte extract,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    , interferons, exclusion diets, BioBran MGN-3 (a natural killer cell stimulant), and removal of dental fillings.",
"   </p>",
"   <p>",
"    Only a few of these approaches have been tested in controlled trials. A major problem with evaluating the effect of therapy in CFS is that the symptoms fluctuate over time, may remit spontaneously, and are subject to substantial response rates to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"       Galantamine",
"      </a>",
"      &mdash; Galantamine is a centrally acting acetylcholinesterase inhibitor that has been used to treat Alzheimer disease. In the largest and best designed randomized, double-blind, controlled trial that has been performed for the treatment of CFS, 434 patients at multiple centers were randomly assigned to one of four doses of galantamine or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/22\">",
"       22",
"      </a>",
"      ]. At 16 weeks, there was no benefit from galantamine in the primary end point (improvement in the Clinical Global Impression Scale) or in any secondary end points.",
"     </li>",
"     <li>",
"      <strong>",
"       Immune globulin",
"      </strong>",
"      &mdash; Intramuscular immunoglobulin injections appeared to be beneficial in one small controlled trial [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/23\">",
"       23",
"      </a>",
"      ]. However, this finding is in contrast to the more general experience. Controlled trials of intravenous immune globulin yielded conflicting and unimpressive results with a high incidence of adverse effects [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/15,24,25\">",
"       15,24,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       Rituximab",
"      </a>",
"      &mdash; Rituximab is an anti-CD20 monoclonal antibody, which leads to depletion of B cells. In a double-blind placebo-controlled trial, 30 patients with CFS were randomly assigned to receive rituximab (500",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      or saline, given twice two weeks apart [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/26\">",
"       26",
"      </a>",
"      ]. There were no differences in the primary endpoint, defined as effects on the fatigue score at three months after the intervention. However, a major or moderate response, defined as lasting improvements in self-reported fatigue score during follow-up, was seen in 10 of 15 patients (67 percent) who received rituximab and in 2 of 15 patients (13 percent) who received placebo. The mean duration of response within a one-year follow-up period among the 10 responders in the rituximab group was 25 weeks (range 8 to 44 weeks). There were no differences in B cell levels between patients in the rituximab group who achieved a response compared with those who did not achieve a response. Though intriguing, these findings are too preliminary to support the use of rituximab, a drug that can cause immunosuppression and serious complications. This study needs to be repeated with a larger number of patients.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"       Acyclovir",
"      </a>",
"      &mdash; A controlled trial of intravenous and oral acyclovir was based upon the possible association with Epstein-Barr virus infection [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/27\">",
"       27",
"      </a>",
"      ]. The outcome showed no benefit of treatment. More important, the study revealed the wide, natural fluctuations in severity of illness and the close linkage of mood to the perception of symptoms.",
"     </li>",
"     <li>",
"      <strong>",
"       Antidepressants",
"      </strong>",
"      &mdash; The results of small controlled studies of antidepressant medications have yielded conflicting results. As an example, a randomized, placebo-controlled trial of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      in 96 patients, 45 percent of whom were depressed, showed no benefit of therapy at eight weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/28\">",
"       28",
"      </a>",
"      ]. In contrast, a study of the monoamine oxidase inhibitory",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/42/20135?source=see_link\">",
"       phenelzine",
"      </a>",
"      noted significant improvement in the treatment group compared to placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/29\">",
"       29",
"      </a>",
"      ]. Nevertheless, antidepressant agents may have utility in treating associated depression, insomnia, or myalgia [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"       Methylphenidate",
"      </a>",
"      &mdash; A double-blind randomized placebo-controlled crossover study of 60 patients who fulfilled the CDC criteria for CFS evaluated treatment with methylphenidate (10 mg twice daily) compared to placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/30\">",
"       30",
"      </a>",
"      ]. Methylphenidate compared to placebo had a clinically significant effect on fatigue in 17 percent of patients and on concentration in 22 percent of patients.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1159?source=see_link\">",
"       Modafinil",
"      </a>",
"      &mdash; In a small double-blind placebo-controlled cross-over study that included 14 patients with CFS, modafinil, a selective wakefulness-promoting agent, had a mixed effect on cognition; had no effect on fatigue, quality of life, or mood; and had a negative effect on mental flexibility and motor speed [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/31\">",
"       31",
"      </a>",
"      ]. We do not recommend this agent.",
"     </li>",
"     <li>",
"      <strong>",
"       Glucocorticoids",
"      </strong>",
"      &mdash; The results of studies evaluating glucocorticoids have also been inconsistent. A double-blind randomized placebo-controlled trial of 25 to 35",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      for 12 weeks in 70 patients showed modest benefit at the expense of adrenal suppression [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/32\">",
"       32",
"      </a>",
"      ]. By comparison, in a randomized crossover trial, clinical improvement was observed in response to 5 to 10",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of hydrocortisone among 32 patients with chronic fatigue but without a comorbid psychiatric disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/33\">",
"       33",
"      </a>",
"      ]. No adrenal suppression was observed, but the duration of therapy was only one month.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27877366\">",
"    <span class=\"h3\">",
"     Antiretroviral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although DNA from xenotropic murine leukemia virus-related virus (XMRV) and related retroviruses was detected more commonly from the blood of patients with CFS than controls in some studies, later studies have suggested that these retroviruses were detected due to contamination of samples, and that the available assays cannot reproducibly detect XMRV or related viruses from blood samples. Certain antiretroviral agents that are used to treat HIV infection appear to have activity against XMRV [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/34,35\">",
"     34,35",
"    </a>",
"    ], but they should",
"    <strong>",
"     not",
"    </strong>",
"    be used treat such patients since it is unlikely that these retroviruses play a role in CFS, and since antiretroviral agents have not been evaluated in clinical studies of patients with CFS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30825?source=see_link&amp;anchor=H70034242#H70034242\">",
"     \"Clinical features and diagnosis of chronic fatigue syndrome\", section on 'XMRV and MLV'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27877551\">",
"    <span class=\"h3\">",
"     Antibacterial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is often a great temptation to give patients empiric treatment with antibiotics, especially if the patient happens to have a positive Lyme serology. It is important to appreciate, however, that a positive Lyme serology does not diagnose Lyme disease, which is a clinical diagnosis. A true positive Lyme serology merely confirms past exposure to Borrelia burgdorferi. Clinical trials have failed to demonstrate a benefit of prolonged antimicrobial therapy in persons with fatigue and a positive Lyme serology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28425?source=see_link\">",
"     \"Diagnosis of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27498?source=see_link&amp;anchor=H26#H26\">",
"     \"Treatment of Lyme disease\", section on 'Post-Lyme disease syndrome and chronic Lyme disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Concern about misdiagnosis and the treatment of fibromyalgia as Lyme disease led the American College of Rheumatology, in collaboration with the Infectious Diseases Society of America, to perform a cost-benefit analysis of antibiotic treatment for such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/36\">",
"     36",
"    </a>",
"    ]. The incidence of false-positive serologic results in patients from endemic areas with nonspecific myalgia or fatigue was four times that of true-positive results. Treatment of such antibody-positive patients with parenteral antibiotics cost $86,221 for each true-positive patient treated and caused 29 cases of drug toxicity for each one caused by treatment of true-positives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Neurally mediated hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study suggested that neurally mediated hypotension may play an important role in CFS symptoms. In this report, 23 subjects with CFS underwent tilt table testing: 22 were found to have an abnormal test (compared with 4 of 14 unmatched controls) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/37\">",
"     37",
"    </a>",
"    ]. Those CFS patients with a positive test were treated with escalating doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/49/35607?source=see_link\">",
"     disopyramide",
"    </a>",
"    ; almost all reported complete or partial resolution of symptoms. In a subsequent study of 600 patients with CFS from the same investigators, 77 percent of patients were found to have an abnormal tilt table test [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/38\">",
"     38",
"    </a>",
"    ]; however, no control group was mentioned.",
"   </p>",
"   <p>",
"    Although these results appeared intriguing, these studies were not placebo-controlled, blinded, or randomized.",
"   </p>",
"   <p>",
"    Several blinded studies have not confirmed the effect of steroid therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A preliminary blinded study of 20 individuals with CFS who had not undergone tilt table testing found that low dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"       fludrocortisone",
"      </a>",
"      (0.1 to 0.2 mg) did not provide any benefit compared to placebo after six weeks of therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"       Fludrocortisone",
"      </a>",
"      (0.1 mg per day) was compared to placebo for nine weeks in a randomized controlled trial in 100 CFS patients with neurally mediated hypotension diagnosed by tilt-table testing [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/40\">",
"       40",
"      </a>",
"      ]. No differences in improved global wellness scores, other symptom scores, and subsequent tilt-table tests were observed between those receiving fludrocortisone or placebo.",
"     </li>",
"     <li>",
"      The combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"       fludrocortisone",
"      </a>",
"      (50 micrograms per day) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      (5 mg per day) did not alleviate symptoms in a six-month crossover randomized, placebo-controlled, double-blind trial in 100 patients meeting the CDC definition of chronic fatigue [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We do not routinely perform tilt table testing on our patients with CFS since it is expensive, moderately uncomfortable, and without proven utility. However, after carefully explaining to a patient that the efficacy is not established, we are willing to try",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    alone or with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    , if the patient wishes. We start with low doses which are increased slowly over several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The short-term prognosis for recovery of function is generally poor in chronic fatigue syndrome (CFS). The long-term prognosis may be better, although studies have been conflicting. In one report of 144 patients followed by questionnaire, for example, the proportion of patients with functional impairment was 73 percent at six weeks to six months, and only 33 percent at two to four years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/20\">",
"     20",
"    </a>",
"    ]. However, other studies noted a poorer outcome. A prospective study found that only 4 of 27 patients achieved sustained remission during a three year observation period [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/27\">",
"     27",
"    </a>",
"    ], and a retrospective evaluation of 495 patients with CFS or idiopathic chronic fatigue (unexplained debilitating fatigue lasting more than six months that does not fulfill criteria for CFS) reported symptomatic improvement in 64 percent at 1.5 years but complete resolution in only 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/42\">",
"     42",
"    </a>",
"    ]. In the latter series, patients with CFS had a greater symptom severity and a lower level of functioning at follow-up than those with idiopathic chronic fatigue. Regardless of the long term prognosis, neither CFS nor chronic fatigue results in organ failure or death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=see_link\">",
"     \"Approach to the adult patient with fatigue\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study attempted to identify medical and psychiatric predictors of persistent symptoms of chronic fatigue at 2.5 years after diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/43\">",
"     43",
"    </a>",
"    ]. Five factors present at initial examination were found to be most important in predicting persistent symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      More than eight medically unexplained physical symptoms (excluding symptoms in the case criteria for CFS)",
"     </li>",
"     <li>",
"      A lifetime history of dysthymic disorder",
"     </li>",
"     <li>",
"      More than 1.5 years of chronic fatigue",
"     </li>",
"     <li>",
"      Less than 16 years of formal education",
"     </li>",
"     <li>",
"      Age exceeding 38 years at presentation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A poor prognosis may also be related to the patient's belief that the illness is due to a physical cause [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4440/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/47/4850?source=see_link\">",
"       \"Patient information: Chronic fatigue syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/11/42161?source=see_link\">",
"       \"Patient information: Chronic fatigue syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a number of sources of information for patients with CFS and those caring for them, including:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Center for Disease Control and Prevention (CDC)",
"    <br/>",
"    &nbsp; &nbsp;US Department of Health and Human Services",
"    <br/>",
"    &nbsp; &nbsp;1600 Clifton Rd",
"    <br/>",
"    &nbsp; &nbsp;Atlanta, GA 30333",
"    <br/>",
"    &nbsp; &nbsp;Telephone: 404-639 1338 (direct CFS line) or 888-232-3228",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp;(general CDC voice-mail which leads to CFS",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; information)",
"    <br/>",
"    &nbsp; &nbsp; (",
"    <a class=\"external\" href=\"file://www.cdc.gov/cfs\">",
"     www.cdc.gov/cfs",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;National CFS and Fibromyalgia Association",
"    <br/>",
"    &nbsp; &nbsp;P.O. Box 18426",
"    <br/>",
"    &nbsp; &nbsp;Kansas City, MO 64133",
"    <br/>",
"    &nbsp; &nbsp;Telephone: 816-737-1343",
"    <br/>",
"    &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.ncfsfa.org/\">",
"     www.ncfsfa.org",
"    </a>",
"    )",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7449220\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic fatigue syndrome (CFS) is a complicated and sometimes controversial disease characterized by unexplained, persistent, and relapsing fatigue. In some situations, diagnosis can be difficult, due the lack of objective clinical or laboratory findings associated with this disorder. The long-term prognosis is favorable in many cases, although treatment options are limited. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many therapies have been tried in CFS but only cognitive behavioral therapy (CBT) and graded exercise therapy appear to produce meaningful benefit. The best approach for the physician is to establish rapport with the patient to be able to provide support and reassurance. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Supportive approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CBT has been effective in patients with CFS and may be useful in those with idiopathic chronic fatigue. This approach typically involves a series of one-hour sessions designed to alter beliefs and behaviors that might delay recovery. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cognitive behavioral therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prolonged lack of exercise in patients exacerbates physical weakness and adherence to a graded exercise therapy alone can be beneficial. Many patients experience recurrent symptoms after exercise, particularly with aggressive regimens. This can be reduced by the cautious setting of less ambitious exercise goals in combination with patient education. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Graded exercise therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of medications and special diets have been evaluated in patients with CFS, but none have been clearly proven to be successful. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Medications and diet'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There have been a number of viruses that were initially reported to cause CFS. With additional studies, none have been found to be causal. The most recent example has been xenotropic murine leukemia virus-related virus (XMRV) and related retroviruses. Although a laboratory reported that they were more commonly found in the blood of patients with CFS than in controls, later studies have demonstrated that these retroviruses can be detected due to contamination of samples, and that the available assays cannot reproducibly detect XMRV or related viruses from blood samples. Antiretroviral agents should",
"      <strong>",
"       not",
"      </strong>",
"      be used to treat such patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30825?source=see_link&amp;anchor=H70034242#H70034242\">",
"       \"Clinical features and diagnosis of chronic fatigue syndrome\", section on 'XMRV and MLV'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H27877366\">",
"       'Antiretroviral therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The short-term prognosis for recovery of function is generally poor in CFS. The long-term prognosis may be better, although studies have been conflicting. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/1\">",
"      Whiting P, Bagnall AM, Sowden AJ, et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001; 286:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/2\">",
"      Straus SE. Pharmacotherapy of chronic fatigue syndrome: another gallant attempt. JAMA 2004; 292:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/3\">",
"      Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006; 367:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/4\">",
"      White PD, Goldsmith KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/5\">",
"      Working Group of the Royal Australasian College of Physicians. Chronic fatigue syndrome. Clinical practice guidelines--2002. Med J Aust 2002; 176 Suppl:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/6\">",
"      Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. BMJ 1996; 312:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/7\">",
"      Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry 1997; 154:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/8\">",
"      Deale A, Husain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry 2001; 158:2038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/9\">",
"      Nijhof SL, Bleijenberg G, Uiterwaal CS, et al. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012; 379:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/10\">",
"      White PD, Chalder T. Chronic fatigue syndrome: treatment without a cause. Lancet 2012; 379:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/11\">",
"      Schr&ouml;der A, Rehfeld E, Ornb&oslash;l E, et al. Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry 2012; 200:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/12\">",
"      Prins JB, Bleijenberg G, Bazelmans E, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001; 357:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/13\">",
"      Fulcher KY, White PD. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2000; 69:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/14\">",
"      Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997; 314:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/15\">",
"      Reid S, Chalder T, Cleare A, et al. Chronic fatigue syndrome. BMJ 2000; 320:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/16\">",
"      Sisto SA, LaManca J, Cordero DL, et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. Am J Med 1996; 100:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/17\">",
"      Sharpe M, Wessely S. Putting the rest cure to rest--again. BMJ 1998; 316:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/18\">",
"      Powell P, Bentall RP, Nye FJ, Edwards RH. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ 2001; 322:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/19\">",
"      Cluff LE. Medical aspects of delayed convalescence. Rev Infect Dis 1991; 13 Suppl 1:S138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/20\">",
"      Sharpe M, Hawton K, Seagroatt V, Pasvol G. Follow up of patients presenting with fatigue to an infectious diseases clinic. BMJ 1992; 305:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/21\">",
"      McDermott C, Richards SC, Thomas PW, et al. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome. QJM 2006; 99:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/22\">",
"      Blacker CV, Greenwood DT, Wesnes KA, et al. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA 2004; 292:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/23\">",
"      DuBois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Res 1986; 2 Suppl 1:S191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/24\">",
"      Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/25\">",
"      Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997; 103:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/26\">",
"      Fluge &Oslash;, Bruland O, Risa K, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One 2011; 6:e26358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/27\">",
"      Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988; 319:1692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/28\">",
"      Vercoulen JH, Swanink CM, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/29\">",
"      Natelson BH, Cheu J, Pareja J, et al. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology (Berl) 1996; 124:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/30\">",
"      Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 2006; 119:167.e23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/31\">",
"      Randall DC, Cafferty FH, Shneerson JM, et al. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. J Psychopharmacol 2005; 19:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/32\">",
"      McKenzie R, O'Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998; 280:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/33\">",
"      Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999; 353:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/34\">",
"      Smith RA, Gottlieb GS, Miller AD. Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology 2010; 7:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/35\">",
"      Singh IR, Gorzynski JE, Drobysheva D, et al. Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. PLoS One 2010; 5:e9948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/36\">",
"      Lightfoot RW Jr, Luft BJ, Rahn DW, et al. Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med 1993; 119:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/37\">",
"      Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/38\">",
"      Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105:15S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/39\">",
"      Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998; 158:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/40\">",
"      Rowe PC, Calkins H, DeBusk K, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001; 285:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/41\">",
"      Blockmans D, Persoons P, Van Houdenhove B, et al. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am J Med 2003; 114:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/42\">",
"      Bombardier CH, Buchwald D. Outcome and prognosis of patients with chronic fatigue vs chronic fatigue syndrome. Arch Intern Med 1995; 155:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/43\">",
"      Clark MR, Katon W, Russo J, et al. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med 1995; 98:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4440/abstract/44\">",
"      Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM 1997; 90:223.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2742 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.123.134.1-8BED796ECD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4440=[""].join("\n");
var outline_f4_21_4440=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7449220\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cognitive behavioral therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Graded exercise therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Supportive approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Medications and diet",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27877366\">",
"      - Antiretroviral therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27877551\">",
"      - Antibacterial therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Neurally mediated hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7449220\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2742\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2742|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/58/35755\" title=\"table 1\">",
"      Rx fibromyalgia chronic fatigue",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=related_link\">",
"      Approach to the adult patient with fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30825?source=related_link\">",
"      Clinical features and diagnosis of chronic fatigue syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28425?source=related_link\">",
"      Diagnosis of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14586?source=related_link\">",
"      Initial treatment of fibromyalgia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/11/42161?source=related_link\">",
"      Patient information: Chronic fatigue syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/47/4850?source=related_link\">",
"      Patient information: Chronic fatigue syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27498?source=related_link\">",
"      Treatment of Lyme disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_21_4441="KS invasion of bronchial wall";
var content_f4_21_4441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76580%7EPULM%2F78341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76580%7EPULM%2F78341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endobronchial Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows dark, hemorrhagic Kaposi sarcoma tissue (arrow) lining and invading the bronchial mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endobronchial Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power light micrograph of endobronchial Kaposi sarcoma showing spindle cells surrounding thin vascular channels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven E Weinberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4441=[""].join("\n");
var outline_f4_21_4441=null;
var title_f4_21_4442="Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children";
var content_f4_21_4442=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/21/4442/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/21/4442/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial meningitis continues to result in substantial morbidity and mortality, despite the availability of effective antimicrobial therapy. The risk of dying or of developing complications is related to the age and underlying condition of the patient, the causative pathogen, the severity and duration of illness at the time of presentation, and, occasionally, to delays in the initiation of antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complications of bacterial meningitis can be divided into systemic and neurologic. Systemic complications are usually the consequence of the bacteremia that frequently accompanies meningitis. The neurologic complications of meningitis may be sudden or gradual in onset and can appear at any time after the onset of symptoms, including after the completion of therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The neurologic complications of meningitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Impaired mental status",
"     </li>",
"     <li>",
"      Cerebral edema and increased intracranial pressure",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"     <li>",
"      Focal deficits (eg, hearing loss, cranial nerve palsies, hemiparesis, or quadriparesis)",
"     </li>",
"     <li>",
"      Ataxia",
"     </li>",
"     <li>",
"      Cerebrovascular abnormalities",
"     </li>",
"     <li>",
"      Neuropsychological impairment, developmental disability",
"     </li>",
"     <li>",
"      Subdural effusion or empyema",
"     </li>",
"     <li>",
"      Hydrocephalus",
"     </li>",
"     <li>",
"      Hypothalamic dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     Dexamethasone",
"    </a>",
"    and other measures to prevent neurologic complications of bacterial meningitis in children will be discussed here. The use of dexamethasone in adults with bacterial meningitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23080?source=see_link\">",
"     \"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment and neurologic complications of bacterial meningitis in neonates, children, and adults also are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link\">",
"     \"Treatment and outcome of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24246?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18280?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Permanent neurologic sequelae, such as hearing loss and focal neurologic deficits, are common in survivors of bacterial meningitis, particularly patients with pneumococcal meningitis. These complications are as much a consequence of the host response as of the bacterial organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=see_link\">",
"     \"Pathogenesis and pathophysiology of bacterial meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies in animals demonstrate that hearing loss is temporally associated with inflammatory changes and that neurologic outcome is related to the severity of the inflammatory process [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. These observations led to the evaluation of anti-inflammatory agents (usually",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    ) as an adjunct to antimicrobial therapy in the treatment of bacterial meningitis. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Dexamethasone'",
"    </a>",
"    below.) Antiinflammatory agents have the potential to prevent neurologic complications of bacterial meningitis by decreasing intracranial pressure (through reduction of meningeal inflammation and brain water content) and modulating the production of cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/5-12\">",
"     5-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other measures, aimed at preventing vasogenic edema (glycerol) and inflammatory mediators (eg, nitric oxide synthase inhibitors), are less well studied but potentially promising. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Glycerol'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H18\">",
"     'Other agents'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEXAMETHASONE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have evaluated the use of adjuvant",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in the treatment of bacterial meningitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/13-28\">",
"     13-28",
"    </a>",
"    ]. Individual studies, performed in various populations and using different antimicrobial regimens, have come to differing conclusions regarding the beneficial effects on survival, hearing, and neurologic sequelae. The issue is complicated by temporal and geographic differences in the microbiology and treatment of bacterial meningitis, as well as the conditions of when and where the individual studies were performed. These factors are discussed below. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Limitations of evidence'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A 2010 meta-analysis that included 2431 children found that the administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    did not affect mortality, but reduced the incidence of severe hearing loss in children with bacterial meningitis, particularly those with Haemophilus influenzae (Hib) meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ]. However, as described below, the effects differed when analyzed according to etiologic agents and income level of the country in which the study was performed. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Limitations of evidence'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Another 2010 meta-analysis of individual patient data that included five trials (2029 patients) published after 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/17,26,29-31\">",
"     17,26,29-31",
"    </a>",
"    ] concluded that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    did not affect mortality or various combined outcomes that included death and neurologic sequelae",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/27\">",
"     27",
"    </a>",
"    ]. In this meta-analysis, the effects of dexamethasone did not differ according to subgroup (etiologic agent, duration of symptoms before treatment, severity of coma at the start of treatment, timing of administration of dexamethasone, and HIV infection status). However, there was moderate heterogeneity in the studies with respect to age and preadmission symptoms. In addition, the mortality rates in the two studies from Malawi [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/17,30\">",
"     17,30",
"    </a>",
"    ] were three- to fivefold higher than in the studies from other countries, raising questions about the appropriateness of use of a summary statistic [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28,32\">",
"     28,32",
"    </a>",
"    ]. Factors that may contribute to increased mortality among patients from Malawi include poor nutrition, delays in presentation, and increased prevalence of HIV infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    does not affect survival in children with bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26,28\">",
"     26,28",
"    </a>",
"    ]. This was illustrated in a meta-analysis of 17 studies including 2431 children [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ]. The mortality rates in the dexamethasone and placebo groups were 13.2 and 13.8 percent, respectively (relative risk [RR] 0.99, 95% CI 0.78-1.14). However, as discussed below, there was substantial heterogeneity with respect to study interventions and mortality rates in the studies included in the meta-analysis, and the results may not be widely applicable [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26,28\">",
"     26,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Retrospective data from 27 tertiary-care hospitals in the United States provide additional information about the effect of adjuvant glucocorticoid therapy for bacterial meningitis in developed countries in the post-conjugate vaccine era [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/33\">",
"     33",
"    </a>",
"    ]. Among 2780 children admitted with bacterial meningitis between January 2001 and December 2006, 9 percent received glucocorticoid therapy. The overall mortality rate was 4.2 percent and was not affected by administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    ; the results did not change when analyzed according to infecting organism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Hearing loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    is associated with a reduction in the incidence of severe hearing loss (bilateral hearing loss of &ge;60 dB or requiring bilateral hearing aids) in selected patients, particularly those with Hib meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ]. In a meta-analysis of 14 studies including 1524 children, the following findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For all organisms combined,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      significantly reduced the incidence of severe hearing loss (7.3 versus 11.2 percent with placebo, RR 0.67, 95% CI 0.49-0.91).",
"     </li>",
"     <li>",
"      In subset analysis,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      significantly reduced severe hearing loss in children with Haemophilus influenzae meningitis (RR 0.34, 95% CI 0.2-0.59) but not in those with meningitis caused by other organisms (RR 0.95, 95% CI 0.65-1.39).",
"     </li>",
"     <li>",
"      When further analyzed according to the income level of the country in which the individual studies were performed,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      reduced the rate of severe hearing loss in children in high-income countries (RR 0.52, 95% CI 0.35-0.78), but not in low-income countries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A multicenter trial that was included in the meta-analysis compared",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , glycerol, and placebo in children (aged 2 months to 16 years) with bacterial meningitis and found that neither dexamethasone nor glycerol prevented hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26,34\">",
"     26,34",
"    </a>",
"    ]. Age and presenting Glasgow coma score were the most important predictors of hearing outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/34\">",
"     34",
"    </a>",
"    ]. The strong correlation between severity of illness at the time of presentation and hearing outcome suggests that delay between onset of infection and initiation of appropriate antibiotic therapy may contribute to the relative lack of efficacy of adjuvant therapies in low- versus high-resource settings and in pneumococcal versus Hib meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Limitations of evidence'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Neurologic sequelae",
"    </span>",
"    &nbsp;&mdash;&nbsp;The administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    does not appear to affect the incidence of serious neurologic sequelae other than hearing loss (eg, focal neurologic deficits, epilepsy, severe ataxia, and severe memory or concentration disturbance) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26,28\">",
"     26,28",
"    </a>",
"    ]. In a meta-analysis of 24 studies including 4041 participants, dexamethasone did not reduce the risk of long-term neurologic sequelae (15.3 versus 16.7 percent [RR 0.9, 95% CI 0.74-1.10]); subgroup analysis for children was not performed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In subgroup analysis of 10 studies including 1271 children,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    reduced the risk of short-term neurologic sequelae (within six weeks of hospital discharge), but the reduction was not statistically significant (RR 0.9, 95% CI 0.72-1.13) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ]. When analyzed according to income level, dexamethasone reduced the rate of short-term neurologic sequelae in high-income countries (RR 0.67, 95% CI 0.46-0.97) but not in low income countries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     In TB meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid therapy appears to be beneficial in selected children and adults with tuberculous meningitis. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=see_link&amp;anchor=H30#H30\">",
"     \"Central nervous system tuberculosis\", section on 'Glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Limitations of evidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The studies evaluating early administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in the treatment of bacterial meningitis in children have limitations that hamper their widespread applicability. Among the trials included in the meta-analyses described above, there was heterogeneity with respect to study interventions and mortality rates [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26\">",
"     26",
"    </a>",
"    ]. The severity of illness at the time of presentation appears to play a more prominent role in outcome than the administration of adjuvant therapy with dexamethasone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/34,35,37\">",
"     34,35,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, the microbiology and treatment of bacterial meningitis have changed since the majority of trials included in the larger meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ] were published (between 1988 and 1995) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With the widespread use of the Hib vaccine in developed countries, Streptococcus pneumoniae has become an increasingly important pathogen. In contrast, most of the studies of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      were performed when Hib was the most frequent cause of bacterial meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/25,38\">",
"       25,38",
"      </a>",
"      ]. Children with pneumococcal meningitis generally have a longer duration of fever before presentation than children with meningitis caused by other bacterial pathogens [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/36\">",
"       36",
"      </a>",
"      ]. The delay between onset of infection and initiation of appropriate antimicrobial therapy may account for the lack of efficacy of dexamethasone in children with pneumococcal compared with Hib meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Few of the studies of adjuvant",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      therapy were performed with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      , which is now an important component of the empiric treatment for bacterial meningitis (because of the increased incidence of S. pneumoniae nonsusceptible to cephalosporins). The benefits of dexamethasone for patients with bacterial meningitis caused by S. pneumoniae requiring vancomycin therapy are not clear [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Antibiotic regimen'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Findings from studies in developed countries may not be generalizable to developing countries, where there may be delays in treatment with appropriate antibiotic therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/39\">",
"       39",
"      </a>",
"      ], which also may affect outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/35,40-42\">",
"       35,40-42",
"      </a>",
"      ]. A meta-analysis of studies of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      therapy in children with bacterial meningitis from low-income countries found no beneficial effects [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"       28",
"      </a>",
"      ]. However, many children enrolled in the included trials presented to the hospital late",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      had received antibiotics before dexamethasone, making it difficult to accomplish any benefit from dexamethasone therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/43\">",
"       43",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Timing'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Trials of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in adolescents and adults in the developing world are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23080?source=see_link&amp;anchor=H4#H4\">",
"     \"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults\", section on 'In developing regions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Considerations in decision-making",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to use",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in children with suspected bacterial meningitis must be individualized. In addition to the potential benefits described above, factors to be weighed in this decision include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The etiologic agent",
"     </li>",
"     <li>",
"      The ability to administer",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      before or at the same time as the first dose of antibiotic therapy",
"     </li>",
"     <li>",
"      The empiric antibiotic regimen",
"     </li>",
"     <li>",
"      The potential adverse effects",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Etiologic agent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy vary depending upon the etiologic agent. Dexamethasone appears to be most beneficial in reducing hearing loss in children with Hib meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Experts continue to debate the efficacy of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    for children with meningitis caused by other organisms, including pneumococcus [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     Dexamethasone",
"    </a>",
"    should be administered before or at the same time as the first dose of antibiotics. It is probably of no benefit if given more than one hour later, although this time interval has not been clearly defined [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/24,25,28,46\">",
"     24,25,28,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adjuvant",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    may be less beneficial in children with delayed presentation to medical attention. Delay between onset of infection and initiation of appropriate antibiotic therapy may account for the relative lack of efficacy of dexamethasone in children from developing versus developed countries and pneumococcal versus Haemophilus influenzae type b meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Limitations of evidence'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Antibiotic regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy may depend, to some extent, upon the empiric antibiotic regimen. Patients with possible penicillin-resistant pneumococcal meningitis are typically treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    plus either",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    , pending results of susceptibility testing. However, there is concern that the entry of vancomycin into the CSF could be reduced in patients who receive adjunctive dexamethasone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/47-51\">",
"     47-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a rabbit model of penicillin- and cephalosporin-resistant pneumococcal meningitis,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    substantially reduced the penetration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    into the CSF, resulting in a delay in CSF sterilization that was not seen in rabbits not treated with dexamethasone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/47\">",
"     47",
"    </a>",
"    ]. In comparison,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    penetration into the CSF was not affected by dexamethasone, and the combination of rifampin and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    produced prompt bacteriologic cure.",
"   </p>",
"   <p>",
"    Whether these experimental findings in rabbits apply to bacterial meningitis in humans is uncertain. Therapeutic CSF concentrations of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    in the CSF were noted in two studies involving 9 children and 13 adults with pneumococcal meningitis who were treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    and vancomycin plus either",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Nonetheless, some experts suggest the addition of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    to the empiric regimen (vancomycin and either cefotaxime or ceftriaxone) for bacterial meningitis if dexamethasone is administered [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12970?source=see_link&amp;anchor=H19#H19\">",
"     \"Pneumococcal meningitis in children\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential adverse effects of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    include interference with the ability of the clinician to assess clinical response to therapy and gastrointestinal bleeding (in approximately 1 to 2 percent of children) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/46,54\">",
"     46,54",
"    </a>",
"    ]. Secondary fever (recurrence of fever after at least 24 hours without fever) may occur after discontinuation of dexamethasone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who receive adjuvant",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy do not appear to have slower clearance of bacteria from the CSF. However, children with S. pneumoniae meningitis who receive dexamethasone early in their course should be carefully observed throughout therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12970?source=see_link&amp;anchor=H27#H27\">",
"     \"Pneumococcal meningitis in children\", section on 'Response to therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Therapeutic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     Dexamethasone",
"    </a>",
"    reduces the risk of hearing loss in children with Hib meningitis. However, there is no clear evidence that dexamethasone dramatically alters other neurologic outcomes in children with bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28,46\">",
"     28,46",
"    </a>",
"    ]. Experts continue to debate the efficacy of dexamethasone for children with meningitis caused by organisms other than Hib [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2004 Infectious Diseases Society of America (IDSA) guidelines for the management of bacterial meningitis recommend",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy for children with Hib meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/46\">",
"     46",
"    </a>",
"    ]. The American Academy of Pediatrics (AAP) Committee on Infectious Diseases suggests that dexamethasone therapy may be beneficial in children with Hib meningitis if given before or at the same time as the first dose of antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AAP Committee on Infectious Diseases suggests that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy be considered for infants and children older than six weeks with pneumococcal meningitis after weighing the potential risks and benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/45\">",
"     45",
"    </a>",
"    ]. Many experts recommend the use of dexamethasone in pneumococcal meningitis. However, the issue is controversial, and the data are insufficient to make a recommendation for children [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/45\">",
"     45",
"    </a>",
"    ]. If used, dexamethasone should be given before or concurrently with the first dose of the antimicrobial agent.",
"   </p>",
"   <p>",
"    In accordance with the AAP Committee on Infectious Diseases statement that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    may be beneficial for children with Hib meningitis, we recommend adjunctive therapy with dexamethasone for children with Hib meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/55\">",
"     55",
"    </a>",
"    ]. We suggest that decisions regarding the use of dexamethasone in children with pneumococcal meningitis, or in those in whom bacterial meningitis is suspected but the etiology unknown, be individualized depending upon careful analysis of the potential risks and benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/45\">",
"     45",
"    </a>",
"    ]. The author of this topic review usually does not administer dexamethasone to children with suspected pneumococcal or meningococcal meningitis. In the same patients, other experts may choose to use dexamethasone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12970?source=see_link&amp;anchor=H16#H16\">",
"     \"Pneumococcal meningitis in children\", section on 'Dexamethasone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend not administering adjunctive",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy to infants and children if more than one hour has elapsed since the first dose of antimicrobial therapy. In such circumstances, administration of dexamethasone is unlikely to improve outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     Dexamethasone",
"    </a>",
"    is not indicated in the treatment of bacterial meningitis in infants younger than six weeks or in those with congenital or acquired abnormalities of the central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/28,46\">",
"     28,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     Dexamethasone",
"    </a>",
"    also is not indicated in the treatment of patients in whom aseptic, nonbacterial, or gram-negative enteric meningitis is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/46\">",
"     46",
"    </a>",
"    ]. If initiated before the diagnosis, dexamethasone should be discontinued as soon as a diagnosis of nonbacterial or gram-negative enteric meningitis is confirmed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Dose and regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the decision is made to use",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , it should be given before or concurrently with the first dose of antibiotics. The regimen for dexamethasone is:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       Dexamethasone",
"      </a>",
"      (0.15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose) every six hours for two to four days [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/46\">",
"       46",
"      </a>",
"      ]. Two days of dexamethasone appear to be as effective as and less toxic than longer courses [",
"      <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     GLYCEROL",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest routine adjunctive treatment with glycerol for children with bacterial meningitis. Glycerol is a hyperosmolar agent and osmotic diuretic that has been used in neurosurgery, neurology, and ophthalmology to reduce raised tissue pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26,57-63\">",
"     26,57-63",
"    </a>",
"    ]. In theory, it also may reduce meningeal inflammation by scavenging free oxygen radicals [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adjunctive therapy with glycerol is appealing, particularly in low-income countries, because it is safe, widely available, inexpensive, can be administered orally, and has no special storage requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/16,64,65\">",
"     16,64,65",
"    </a>",
"    ]. However, additional study is necessary before glycerol can be routinely recommended.",
"   </p>",
"   <p>",
"    A 2013 meta-analysis of four trials [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/16,26,66,67\">",
"     16,26,66,67",
"    </a>",
"    ] of glycerol in patients with bacterial meningitis concluded that glycerol had no effect on death (four trials, 1091 participants), neurologic disability (three trials, 732 participants), or seizures during treatment (three trials, 909 participants), but may reduce the risk of deafness (relative risk [RR] 60, 95% CI 0.38-0.93 [four trials, 741 participants]) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/68\">",
"     68",
"    </a>",
"    ]. In the only trial in adults, glycerol was associated with an increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H28#H28\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Reduction of intracranial pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limitations of existing studies include the lack of long-term follow-up for subtle neurologic sequelae, variations in population and environment, the use of different methods to assess hearing at different institutions, and the lack of provision of information regarding variations from the study protocol or the consistency of results among participating institutions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/26,68,69\">",
"     26,68,69",
"    </a>",
"    ]. Additional studies regarding the effects of adjuvant glycerol therapy for bacterial meningitis in children are warranted before this therapy can be routinely recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     OTHER AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The search for additional adjunctive agents that target inflammatory mediators or mediator effector molecules is an active area of investigation. Agents that have been studied in animal models include antioxidants [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/70\">",
"     70",
"    </a>",
"    ], nitric oxide synthase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/71,72\">",
"     71,72",
"    </a>",
"    ], TNF-related apoptosis-inducing ligand [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/73\">",
"     73",
"    </a>",
"    ], melatonin [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/74\">",
"     74",
"    </a>",
"    ], caspase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/75\">",
"     75",
"    </a>",
"    ], adjunctive daptomycin and rifampin (antibiotics that are bacteriocidal but not bacteriolytic) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/76-80\">",
"     76-80",
"    </a>",
"    ], and roscovitine (which induces caspase-dependent apoptosis in neutrophils) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     FLUID MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful fluid management is necessary to maintain cerebral perfusion pressure while anticipating the possibility of inappropriate secretion of antidiuretic hormone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Fluid management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PRIMARY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best way to eliminate neurologic complications of bacterial meningitis is to prevent bacterial meningitis from occurring in the first place (primary prevention) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/21/4442/abstract/69,82,83\">",
"     69,82,83",
"    </a>",
"    ]. Primary prevention of bacterial meningitis through vaccines and chemoprophylaxis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/31/42489?source=see_link\">",
"     \"Prevention of Haemophilus influenzae infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=see_link\">",
"     \"Meningococcal vaccines\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25609?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment and prevention of meningococcal infection\", section on 'Antimicrobial chemoprophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=see_link\">",
"       \"Patient information: Bacterial meningitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anti-inflammatory agents have the potential to prevent neurologic complications of bacterial meningitis by decreasing intracranial pressure and modulating the production of cytokines. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children with bacterial meningitis,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      appears to decrease the risk of hearing loss (particularly in those with Haemophilus influenzae type b [Hib] meningitis). However, it has no effect on other neurologic sequelae or mortality. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend the use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      for children with Hib meningitis (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Therapeutic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decisions regarding the use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      in children with pneumococcal meningitis, or in whom bacterial meningitis is suspected but the etiology unknown, must be individualized after careful analysis of the potential risks and benefits. The author of this topic review usually does not administer dexamethasone to children with suspected pneumococcal or meningococcal meningitis. In the same patients, other experts may choose to use dexamethasone. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Therapeutic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not using",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      if more than one hour has elapsed since the first dose of antimicrobial therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Therapeutic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       Dexamethasone",
"      </a>",
"      is not indicated in the treatment of bacterial meningitis in infants younger than six weeks or in those with congenital or acquired abnormalities of the central nervous system. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Therapeutic approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Feigin  RD, Cutrer W. Bacterial meningitis beyond the neonatal period. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.439.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/2\">",
"      Bhatt SM, Lauretano A, Cabellos C, et al. Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. J Infect Dis 1993; 167:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/3\">",
"      Scheld WM, Dacey RG, Winn HR, et al. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest 1980; 66:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/4\">",
"      T&auml;uber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985; 151:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/5\">",
"      S&aacute;ez-Llorens X, Jafari HS, Severien C, et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991; 88:2003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/6\">",
"      Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis 1989; 160:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/7\">",
"      Kadurugamuwa JL, Hengstler B, Zak O. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis 1989; 159:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/8\">",
"      Mertsola J, Kennedy WA, Waagner D, et al. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis. Am J Dis Child 1991; 145:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/9\">",
"      Mustafa MM, Ramilo O, S&aacute;ez-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990; 144:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/10\">",
"      Lutsar I, Friedland IR, Jafri HS, et al. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J Antimicrob Chemother 2003; 52:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/11\">",
"      van Furth AM, Roord JJ, van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun 1996; 64:4883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/12\">",
"      Ichiyama T, Matsushige T, Kajimoto M, et al. Dexamethasone decreases cerebrospinal fluid soluble tumor necrosis factor receptor 1 levels in bacterial meningitis. Brain Dev 2008; 30:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/13\">",
"      Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324:1525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/14\">",
"      Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/15\">",
"      Wald ER, Kaplan SL, Mason EO Jr, et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics 1995; 95:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/16\">",
"      Kilpi T, Peltola H, Jauhiainen T, Kallio MJ. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J 1995; 14:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/17\">",
"      Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002; 360:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/18\">",
"      Qazi SA, Khan MA, Mughal N, et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child 1996; 75:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/19\">",
"      Ciana G, Parmar N, Antonio C, et al. Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis. J Trop Pediatr 1995; 41:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/20\">",
"      Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989; 8:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/21\">",
"      Kanra GY, Ozen H, Se&ccedil;meer G, et al. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995; 14:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/22\">",
"      Lebel MH, Hoyt MJ, Waagner DC, et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child 1989; 143:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/23\">",
"      Schaad UB, Lips U, Gnehm HE, et al. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet 1993; 342:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/24\">",
"      King SM, Law B, Langley JM, et al. Dexamethasone therapy for bacterial meningitis: Better never than late? Can J Infect Dis 1994; 5:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/25\">",
"      McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997; 278:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/26\">",
"      Peltola H, Roine I, Fern&aacute;ndez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007; 45:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/27\">",
"      van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010; 9:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/28\">",
"      Brouwer MC, McIntyre P, de Gans J, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010; :CD004405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/29\">",
"      Nguyen TH, Tran TH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007; 357:2431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/30\">",
"      Scarborough M, Gordon SB, Whitty CJ, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007; 357:2441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/31\">",
"      de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/32\">",
"      McIntyre P. Adjunctive dexamethasone in meningitis: does value depend on clinical setting? Lancet Neurol 2010; 9:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/33\">",
"      Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA 2008; 299:2048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/34\">",
"      Peltola H, Roine I, Fern&aacute;ndez J, et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics 2010; 125:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/35\">",
"      Yogev R, Pelton S. To treat or not to treat is the nagging question. Pediatrics 2010; 125:e188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/36\">",
"      Bonsu BK, Harper MB. Fever interval before diagnosis, prior antibiotic treatment, and clinical outcome for young children with bacterial meningitis. Clin Infect Dis 2001; 32:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/37\">",
"      Roine I, Peltola H, Fern&aacute;ndez J, et al. Influence of admission findings on death and neurological outcome from childhood bacterial meningitis. Clin Infect Dis 2008; 46:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/38\">",
"      Prober CG. The role of steroids in the management of children with bacterial meningitis. Pediatrics 1995; 95:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/39\">",
"      Molyneux E, Riordan FA, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann Trop Paediatr 2006; 26:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/40\">",
"      Lebel MH, Hoyt MJ, McCracken GH Jr. Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr 1989; 114:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/41\">",
"      Kaplan SL, Smith EO, Wills C, Feigin RD. Association between preadmission oral antibiotic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenzae type b meningitis. Pediatr Infect Dis 1986; 5:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/42\">",
"      McIntyre PB, Macintyre CR, Gilmour R, Wang H. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child 2005; 90:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/43\">",
"      McCracken GH Jr. Rich nations, poor nations, and bacterial meningitis. Lancet 2002; 360:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/44\">",
"      Schaad UB, Kaplan SL, McCracken GH Jr. Steroid therapy for bacterial meningitis. Clin Infect Dis 1995; 20:685.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Pneumococcal infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th Ed, Pickering LK, Baker CJ, Kimberlin DW, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.571.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/46\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/47\">",
"      Par&iacute;s MM, Hickey SM, Uscher MI, et al. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994; 38:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/48\">",
"      Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/49\">",
"      Brady MT, Kaplan SL, Taber LH. Association between persistence of pneumococcal meningitis and dexamethasone administration. J Pediatr 1981; 99:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/50\">",
"      Friedland IR, Paris M, Shelton S, McCracken GH. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J Antimicrob Chemother 1994; 34:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/51\">",
"      Moellering RC Jr. Pharmacokinetics of vancomycin. J Antimicrob Chemother 1984; 14 Suppl D:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/52\">",
"      Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39:1988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/53\">",
"      Ricard JD, Wolff M, Lacherade JC, et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007; 44:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/54\">",
"      Pelton SI, Yogev R. Improving the outcome of pneumococcal meningitis. Arch Dis Child 2005; 90:333.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Haemophilus influenzae infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.345.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/56\">",
"      Syrogiannopoulos GA, Lourida AN, Theodoridou MC, et al. Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen. J Infect Dis 1994; 169:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/57\">",
"      Singhi S, J&auml;rvinen A, Peltola H. Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatr Infect Dis J 2008; 27:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/58\">",
"      BUCKELL M, WALSH L. EFFECT OF GLYCEROL BY MOUTH ON RAISED INTRACRANIAL PRESSURE IN MAN. Lancet 1964; 2:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/59\">",
"      Gilsanz V, Rebollar JL, Buencuerpo J, Chantres MT. Controlled trial of glycerol versus dexamethasone in the treatment of cerebral oedema in acute cerebral infarction. Lancet 1975; 1:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/60\">",
"      Rottenberg DA, Hurwitz BJ, Posner JB. The effect of oral glycerol on intraventricular pressure in man. Neurology 1977; 27:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/61\">",
"      Bayer AJ, Pathy MS, Newcombe R. Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet 1987; 1:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/62\">",
"      McCurdy DK, Schneider B, Scheie HG. Oral glycerol: the mechanism of intraocular hypotension. Am J Ophthalmol 1966; 61:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/63\">",
"      Zoghbi HY, Okumura S, Laurent JP, Fishman MA. Acute effect of glycerol on net cerebrospinal fluid production in dogs. J Neurosurg 1985; 63:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/64\">",
"      Nau R, Prins FJ, Kolenda H, Prange HW. Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol. Eur J Clin Pharmacol 1992; 42:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/65\">",
"      Tourtellotte WW, Reinglass JL, Newkirk TA. Cerebral dehydration action of glycerol. I. Historical aspects with emphasis on the toxicity and intravenous administration. Clin Pharmacol Ther 1972; 13:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/66\">",
"      Ajdukiewicz KM, Cartwright KE, Scarborough M, et al. Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis 2011; 11:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/67\">",
"      Sankar J, Singhi P, Bansal A, et al. Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatr 2007; 44:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/68\">",
"      Wall EC, Ajdukiewicz KM, Heyderman RS, Garner P. Osmotic therapies added to antibiotics for acute bacterial meningitis. Cochrane Database Syst Rev 2013; 3:CD008806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/69\">",
"      S&aacute;ez-Llorens X, McCracken GH Jr. Glycerol and bacterial meningitis. Clin Infect Dis 2007; 45:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/70\">",
"      Ge NN, Brodie SA, Tinling SP, Brodie HA. The effects of superoxide dismutase in gerbils with bacterial meningitis. Otolaryngol Head Neck Surg 2004; 131:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/71\">",
"      Winkler F, Koedel U, Kastenbauer S, Pfister HW. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J Infect Dis 2001; 183:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/72\">",
"      Boje KM. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res 1996; 720:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/73\">",
"      Hoffmann O, Priller J, Prozorovski T, et al. TRAIL limits excessive host immune responses in bacterial meningitis. J Clin Invest 2007; 117:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/74\">",
"      Gerber J, Lotz M, Ebert S, et al. Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis. J Infect Dis 2005; 191:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/75\">",
"      Braun JS, Novak R, Herzog KH, et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999; 5:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/76\">",
"      Grandgirard D, Sch&uuml;rch C, Cottagnoud P, Leib SL. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother 2007; 51:2173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/77\">",
"      Spreer A, Lugert R, Stoltefaut V, et al. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit Care Med 2009; 37:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/78\">",
"      Nau R, Wellmer A, Soto A, et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis 1999; 179:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/79\">",
"      B&ouml;ttcher T, Gerber J, Wellmer A, et al. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis 2000; 181:2095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/80\">",
"      Gerber J, Pohl K, Sander V, et al. Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone. Antimicrob Agents Chemother 2003; 47:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/81\">",
"      Koedel U, Frankenberg T, Kirschnek S, et al. Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog 2009; 5:e1000461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/82\">",
"      Kaplan SL. Prevention of hearing loss from meningitis. Lancet 1997; 350:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/21/4442/abstract/83\">",
"      Grimwood K. Legacy of bacterial meningitis in infancy. Many children continue to suffer functionally important deficits. BMJ 2001; 323:523.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6026 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-E943584887-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4442=[""].join("\n");
var outline_f4_21_4442=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEXAMETHASONE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Survival",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Hearing loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Neurologic sequelae",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - In TB meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Limitations of evidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Considerations in decision-making",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Etiologic agent",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Timing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Antibiotic regimen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Therapeutic approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Dose and regimen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      GLYCEROL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      OTHER AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FLUID MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PRIMARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=related_link\">",
"      Central nervous system tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23080?source=related_link\">",
"      Dexamethasone to prevent neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=related_link\">",
"      Meningococcal vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18280?source=related_link\">",
"      Neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=related_link\">",
"      Neurologic complications of bacterial meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24246?source=related_link\">",
"      Neurologic complications of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=related_link\">",
"      Pathogenesis and pathophysiology of bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=related_link\">",
"      Patient information: Bacterial meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12970?source=related_link\">",
"      Pneumococcal meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/31/42489?source=related_link\">",
"      Prevention of Haemophilus influenzae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=related_link\">",
"      Treatment and outcome of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25609?source=related_link\">",
"      Treatment and prevention of meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=related_link\">",
"      Treatment of bacterial meningitis caused by specific pathogens in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_21_4443="Prothrombotic risk factors";
var content_f4_21_4443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F52263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F52263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prothrombotic conditions associated with increased risk of cerebral venous thrombosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Genetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein C deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein S deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antithrombin deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Factor V Leiden mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        G20210A prothrombin gene mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acquired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antiphospholipid syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrotic syndrome",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4443=[""].join("\n");
var outline_f4_21_4443=null;
var title_f4_21_4444="Causes of menorrhagia";
var content_f4_21_4444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of menorrhagia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Coagulopathies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            von Willebrand's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thrombocytopenia (due to idiopathic thrombocytopenic purpura, hypersplenism, chronic renal failure)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute leukemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Anticoagulants",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Advanced liver disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neoplasm",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endometrial adenocarcinoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Uterine sarcoma",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Structural lesions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leiomyomata uteri (fibroids)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Adenomyosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Polyps",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Other",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endometritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypothyroidism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intrauterine device",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hyperestrogenism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endometriosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4444=[""].join("\n");
var outline_f4_21_4444=null;
var title_f4_21_4445="Treatment of leprosy in children";
var content_f4_21_4445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Multidrug regimens for treatment of leprosy in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        National Hansens Disease Program (NHDP)*",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        World Health Organization (WHO)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Regimen",
"       </td>",
"       <td class=\"subtitle2\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle2\">",
"        Duration",
"       </td>",
"       <td class=\"subtitle2\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle2\">",
"        Duration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Tuberculoid (\"paucibacillary\"): TT, BT",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dapsone",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        1 mg/kg daily (not to exceed 100 mg/day)",
"       </td>",
"       <td rowspan=\"2\">",
"        12 months",
"       </td>",
"       <td>",
"        50 mg daily",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        6 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rifampin",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        10 to 20 mg/kg daily (not to exceed 600 mg/day)",
"       </td>",
"       <td>",
"        450 mg once a month",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Lepromatous (\"multibacillary\"): LL, BL, BB",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dapsone",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        1 mg/kg daily (not to exceed 100 mg/day)",
"       </td>",
"       <td rowspan=\"3\">",
"        24 months",
"       </td>",
"       <td>",
"        50 mg daily",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td rowspan=\"3\">",
"        12 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rifampin",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        10 to 20 mg/kg daily (not to exceed 600 mg/day)",
"       </td>",
"       <td>",
"        450 mg once a month",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clofazimine",
"       </td>",
"       <td>",
"        1 mg/kg daily",
"        <sup>",
"         &yen;",
"        </sup>",
"        (not to exceed 50 mg daily)",
"       </td>",
"       <td>",
"        150 mg once a month, and 50 mg every other day",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Additional information available at NHDP website:",
"     <a href=\"file://www.hrsa.gov/hansensdisease/diagnosis/recommendedtreatment.html\" target=\"_blank\">",
"      file://www.hrsa.gov/hansensdisease/diagnosis/recommendedtreatment.html",
"     </a>",
"     .",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Additional information available at WHO website:",
"      <a href=\"file://www.searo.who.int/en/Section10/Section20/Section2000.htm\" target=\"_blank\">",
"       file://www.searo.who.int/en/Section10/Section20/Section2000.htm",
"      </a>",
"      .",
"      <br>",
"       &Delta; TT, BT, BB, BL, and LL refer to the Ridley-Jopling classification (see text).",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Oral suspension may be compounded. See Lexicomp Pediatric drug information: Extemporaneous preparations.",
"        <br>",
"         &sect; WHO advises dose adjustment for children &lt;10 years: dapsone 25 mg daily and rifampin 300 mg monthly.",
"         <br>",
"          &yen; As there is no formulation of clofazimine less than 50 mg, and the capsule should never be cut open, alternate day dosing (2 mg/kg every other day) may be used. Clofazimine should be taken either with or immediately after food or milk to facilitate absorption. In the United States, the NHDP holds the Investigational New Drug (IND) for treatment of leprosy. For further information or to request investigator status to use clofazimine, contact the NHDP: 1-800-642-2477.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4445=[""].join("\n");
var outline_f4_21_4445=null;
var title_f4_21_4446="Four habits model";
var content_f4_21_4446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69929&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69929&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Approach to effective clinical communication",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Habit",
"       </td>",
"       <td class=\"subtitle1\">",
"        Skills",
"       </td>",
"       <td class=\"subtitle1\">",
"        Techniques and examples",
"       </td>",
"       <td class=\"subtitle1\">",
"        Payoff",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Invest in the beginning",
"       </td>",
"       <td>",
"        Create rapport quickly",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Introduce self to everyone in the room",
"        </p>",
"        <p>",
"         &bull; Acknowledge patient wait time, if appropriate",
"        </p>",
"        <p>",
"         &bull; Convey knowledge of patient's history by commenting on prior visit or problem",
"        </p>",
"        <p>",
"         &bull; Attend to patient's comfort",
"        </p>",
"        <p>",
"         &bull; Make a social comment or ask a nonmedical question to put patient at ease",
"        </p>",
"        <p>",
"         &bull; Adapt own language, pace, and posture in response to patient",
"        </p>",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         &bull; Establishes a welcoming atmosphere",
"        </p>",
"        <p>",
"         &bull; Allows faster access to real reason for visit",
"        </p>",
"        <p>",
"         &bull; Increases diagnostic accuracy",
"        </p>",
"        <p>",
"         &bull; Requires less work",
"        </p>",
"        <p>",
"         &bull; Minimizes \"Oh, by the way...\" at the end of visit",
"        </p>",
"        <p>",
"         &bull; Facilitates negotiating an agenda",
"        </p>",
"        <p>",
"         &bull; Decreases potential for conflict",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elicit patient's concerns",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Start with open-ended questions:",
"        </p>",
"        <p>",
"         &nbsp;&nbsp;- \"What would you like help with today?\" OR,",
"        </p>",
"        <p>",
"         &nbsp;&nbsp;- \"I understand that you're here for... Could you tell me more about that?\"",
"        </p>",
"        <p>",
"         &nbsp;&nbsp;- \"What else?\"",
"        </p>",
"        <p>",
"         &bull; Speak directly with patient when using an interpreter",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plan the visit with the patient",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Repeat concerns back to check understanding",
"        </p>",
"        <p>",
"         &bull; Let patient know what to expect: \"How about if we start with talking more about..., then I'll do an exam, and then we'll go over possible tests/ways to treat this? Sound OK?\"",
"        </p>",
"        <p>",
"         &bull; Prioritize when necessary: \"Let's make sure we talk about X and Y.  It sounds like you also want to make sure we cover Z.  If we can't get to the other concerns, let's...\"",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Elicit the patient's perspective",
"       </td>",
"       <td>",
"        Ask for patient's ideas",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Assess patient's point of view:",
"        </p>",
"        <p>",
"         &nbsp;&nbsp;- \"What do you think is causing your symptoms?",
"        </p>",
"        <p>",
"         &nbsp;&nbsp;- \"What worries you most about this problem?\"",
"        </p>",
"        <p>",
"         &bull; Ask about ideas from significant others",
"        </p>",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         &bull; Respects diversity",
"        </p>",
"        <p>",
"         &bull; Allows patient to provide important diagnostic clues",
"        </p>",
"        <p>",
"         &bull; Uncovers hidden concerns",
"        </p>",
"        <p>",
"         &bull; Reveals use of alternative treatments or requests for tests",
"        </p>",
"        <p>",
"         &bull; Improves diagnosis of depression and anxiety",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elicit specific requests",
"       </td>",
"       <td>",
"        &bull; Determine patient's goal in seeking care: \"When you've been thinking about this visit, how were you hoping I could help?\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Explore the impact on the patient's life",
"       </td>",
"       <td>",
"        &bull; Check context: \"How has the illness affected your daily activities/work/family?\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Demonstrate empathy",
"       </td>",
"       <td>",
"        Be open to patient's emotions",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Assess changes in body language and voice tone",
"        </p>",
"        <p>",
"         &bull; Look for opportunities to use brief empathetic comments or gestures",
"        </p>",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         &bull; Adds depth and meaning to the visit",
"        </p>",
"        <p>",
"         &bull; Builds trust, leading to better diagnostic information, adherence, and outcomes",
"        </p>",
"        <p>",
"         &bull; Makes limit-setting or saying \"no\" easier",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Make at least one empathetic statement",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Name a likely emotion: \"That sounds really upsetting.\"",
"        </p>",
"        <p>",
"         &bull; Compliment patient on efforts to address problem",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Convey empathy nonverbally",
"       </td>",
"       <td>",
"        &bull; Use a pause, touch, or facial expression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Be aware of your own reactions",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Use own emotional response as a clue to what patient might be feeling",
"        </p>",
"        <p>",
"         &bull; Take a brief break if necessary",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Invest in the end",
"       </td>",
"       <td>",
"        Deliver diagnostic information",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Frame diagnosis in terms of patient's original concerns",
"        </p>",
"        <p>",
"         &bull; Test patient's comprehension",
"        </p>",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         &bull; Increases potential for collaboration",
"        </p>",
"        <p>",
"         &bull; Influences health outcomes",
"        </p>",
"        <p>",
"         &bull; Improves adherence",
"        </p>",
"        <p>",
"         &bull; Reduces return calls and visits",
"        </p>",
"        <p>",
"         &bull; Encourages self care",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Provide education",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Explain rationale for tests and treatments",
"        </p>",
"        <p>",
"         &bull; Review possible side effects and expected course of recovery",
"        </p>",
"        <p>",
"         &bull; Recommend lifestyle changes",
"        </p>",
"        <p>",
"         &bull; Provide written materials and refer to other sources",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Involve patient in making decisions",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Discuss treatment goals",
"        </p>",
"        <p>",
"         &bull; Explore options, listening for the patient's preferences",
"        </p>",
"        <p>",
"         &bull; Set limits respectfully: \"I can understand how getting that test makes sense to you. From my point of view, since the results won't help us diagnose or treat your symptoms, I suggest we consider this instead.\"",
"        </p>",
"        <p>",
"         &bull; Assess patient's ability and motivation to carry out plan",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete the visit",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Ask for additional questions: \"What questions do you have?\"",
"        </p>",
"        <p>",
"         &bull; Assess satisfaction: \"Did you get what you needed?\"",
"        </p>",
"        <p>",
"         &bull; Reassure patient of ongoing care",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Frankel RM, Stein T. Getting the most out of the clinical encounter: The Four Habits Model. J Med Pract Manage 2001; 16:184. Copyright &copy;2001 Greenbranch Publishing.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.mpmnetwork.com\">",
"      file://www.mpmnetwork.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4446=[""].join("\n");
var outline_f4_21_4446=null;
var title_f4_21_4447="Genotype urine excretion T";
var content_f4_21_4447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F50268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F50268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Genotype urine excretion of testosterone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 349px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Men who have two copies of the gene uridine diphosphoglucuronosyl transferase (ins/ins) have much higher urinary excretion of testosterone glucuronide in the two weeks after a single 500 mg dose of testosterone enanthate than those with only a single copy (ins/del) or no copy (del/del). Because the glucuronidation of epitestosterone is not affected by this deletion, the testosterone/epitestosterone ratio also is lower in those with one or no copies of the gene than in those with two copies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schulze JJ, Lundmark J, Garle M, et al. Doping Test Results Dependent on Genotype of UGT2B17, the Major Enzyme for Testosterone Glucuronidation. J Clin Endocrinol Metab 2008. Copyright &copy; 2008 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_21_4447=[""].join("\n");
var outline_f4_21_4447=null;
